Omita y vaya al Contenido

Vitamina E


¿Qué es?

La Vitamina E es una vitamina que se disuelve en las grasas. Se encuentra presente en muchos alimentos incluyendo los aceites vegetales, los cereales, la carne, las aves de corral, los huevos, la fruta, las verduras, y el aceite de germen de trigo. También está disponible como suplemento.

La vitamina E se usa para el tratamiento de la deficiencia de vitamina E, que es poco común, pero puede ocurrir en personas con ciertos trastornos genéticos y en infantes prematuros de muy bajo peso.

Algunas personas usan la vitamina E para el tratamiento y prevención de las enfermedades del corazón y de los vasos sanguíneos que incluyen endurecimiento de las arterias, ataque al corazón, dolor en el pecho, dolor de piernas debido al bloqueo de las arterias y presión arterial alta.

La vitamina E también se usa para el tratamiento de la diabetes y sus complicaciones. Se usa para prevenir el cáncer, en particular el cáncer del pulmón, y el cáncer oral en fumadores; para el cáncer y pólipos del colon y recto; para el cáncer gástrico, el cáncer de próstata y el cáncer pancreático.

Algunas personas usan la vitamina E para las enfermedades del cerebro y del sistema nervioso como la enfermedad de Alzheimer y otras demencias, para la enfermedad de Parkinson, para los calambres nocturnos, para el síndrome de las piernas inquietas, y para la epilepsia si se toma junto con otros medicamentos. La vitamina E también se utiliza para la enfermedad de corea de Huntington y otros trastornos que involucran nervios y músculos.

Las mujeres usan la vitamina E para prevenir las complicaciones al término del embarazo debido a la presión arterial alta (preeclampsia), para el síndrome premenstrual (SPM), los períodos dolorosos, el síndrome de la menopausia, los rubores asociados con el cáncer de mamas, y para los quistes de mama.

Algunas veces la vitamina E es utilizada para disminuir los efectos dañinos de algunos tratamientos médicos tales como la diálisis y la radiación. Se usa también para reducir los efectos secundarios no deseados de los medicamentos tales como la pérdida de cabello en las personas tomando doxorubicin y el daño pulmonar en las personas tomando amiodarona.

La vitamina E se usa algunas veces para mejorar la resistencia física, aumentando la energía, disminuyendo el daño muscular después del ejercicio y mejorando la fuerza muscular.

La vitamina E se usa también para las cataratas, el asma, las infecciones respiratorias, los trastornos de la piel, el envejecimiento, las quemaduras de sol, la fibrosis cística, la infertilidad, la impotencia, el síndrome de fatiga crónica (SFC), las úlceras pépticas, para algunas enfermedades hereditarias, y para prevenir las alergias.

Algunas personas se aplican vitamina E a la piel para impedir el envejecimiento y para la protección contra los efectos de las sustancias químicas que se usan en la terapia para el cáncer (quimioterapia).

La Asociación Americana del Corazón recomienda obtener los antioxidantes, incluyendo la vitamina E, comiendo una dieta bien balanceada, rica en frutas, verduras, y granos enteros y no a través de suplementos mientras no se tenga más información acerca de los riesgos y beneficios de los suplementos.

¿Qué tan efectivo es?

Natural Medicines Comprehensive Database (La Base Exhaustiva de Datos de Medicamentos Naturales) clasifica la eficacia, basada en evidencia científica, de acuerdo a la siguiente escala: Eficaz, Probablemente Eficaz, Posiblemente Eficaz, Posiblemente Ineficaz, Probablemente Ineficaz, Ineficaz, e Insuficiente Evidencia para Hacer una Determinación.

La clasificación de la eficacia para este producto es la siguiente:

Eficaz para...

  • La deficiencia de vitamina E.

Posiblemente eficaz para...

  • El cáncer de la vejiga. El tomar 200 IU de vitamina E por vía oral por más de 10 años parece ayudar a prevenir la muerte por cáncer de la vejiga.
  • La enfermedad de Alzheimer. La vitamina E podría retardar el empeoramiento de la pérdida de memoria en aquellas personas con un caso de Alzheimer moderadamente grave. Pero la vitamina E no parece prevenir la progresión de la enfermedad de Alzheimer desde la pérdida leve de memoria hasta un caso completamente declarado de Alzheimer.
  • La menstruación dolorosa (dismenorrea). El tomar vitamina E dos días antes y por 3 días después que empieza el sangrado parece disminuir el dolor, gravedad, y duración de la menstruación, y también la pérdida de sangre.
  • El síndrome premenstrual (SPM). El tomar vitamina E por vía oral parece disminuir la ansiedad, los antojos y la depresión en algunas mujeres con SPM.
  • El daño a los nervios relacionado con la quimioterapia. El tomar vitamina E antes y después del tratamiento de quimioterapia con cisplatin podría disminuir la posibilidad de daño a los nervios.
  • Un accidente cerebrovascular isquémico. Algunas investigaciones muestran que el tomar vitamina E podría disminuir levemente la probabilidad de sufrir un derrame cerebral causado por un coágulo de sangre (accidente cerebrovascular isquémico). Pero el tomar vitamina E podría también aumentar la probabilidad de sufrir un derrame cerebral más grave llamado accidente cerebrovascular hemorrágico. Este tipo de derrame ocurre cuando hay sangrado en el cerebro.
  • La enfermedad hepática llamada esteatohepatitis no alcohólica. El tomar entre 400-1200 IU diarias de vitamina E parece mejorar considerablemente los síntomas en los adultos y niños después de 4-24 meses de tratamiento.
  • Reducir los síntomas de la enfermedad llamada corea de Huntington. La vitamina E natural (RRR-alpha-tocopherol) puede mejorar considerablemente los síntomas en las personas con enfermedad temprana de Huntington, pero no parece ayudar a las personas con una enfermedad más avanzada.
  • La degeneración macular. El tomar vitamina E por vía oral en combinación con vitamina C, betacaroteno y zinc podría retardar el empeoramiento de la degeneración macular senil avanzada (DMS). No se tiene suficiente información para determinar si esta combinación ayuda a las personas con casos menos avanzados de DMS o si previene la DMS. El zinc debe estar presente en la combinación para que se observe algún efecto en la DMS.
  • La artritis reumática (AR). Al parecer si se toma vitamina E junto con el tratamiento estándar para la AR se observa una mayor disminución del dolor en las personas con AR. Pero esta combinación no disminuye la hinchazón (inflamación).
  • La infertilidad masculina.
  • La presión arterial alta durante el embarazo (pre-eclampsia).
  • Trastornos de movimientos llamados diskinesia tardía y dispraxia.
  • La prevención de la enfermedad de Parkinson.
  • Los problemas renales en niños (esclerosis glomerular).
  • Ayudar en el tratamiento de un trastorno hereditario llamado deficiencia G6PD.
  • La beta talasemia.
  • La demencia.
  • Curar un tipo de herida en la piel llamada granuloma anular cuando se aplica sobre la piel.
  • La uveitis.
  • Las quemaduras de sol.
  • Ayudar a curar los ojos después de una cirugía.
  • El tratamiento de una enfermedad ocular en recién nacidos llamada fibroplasia retrolenta.
  • Disminuir la pérdida de sangre en el cerebro y el corazón en bebés prematuros.
  • Ayudar al buen funcionamiento de los medicamentos para el corazón llamados “nitratos”.
  • Mejorar el rendimiento físico y la fuerza en la gente de edad avanzada.
  • La fibrosis causada por la radiación.

Posiblemente ineficaz para...

  • La anemia en las personas que se están haciendo diálisis de la sangre.
  • El dolor en el pecho (angina).
  • Los rubores en las personas que han tenido cáncer de mama.
  • El endurecimiento de las arterias (arterioesclerosis).
  • La dificultad para respirar en los recién nacidos.
  • Las infecciones pulmonares en personas de edad avanzada.
  • La insuficiencia cardíaca.
  • El tratamiento de enfermedades musculares llamadas distrofia muscular de Duchenne y distrofia miotónica.
  • La presión arterial alta.
  • Ayudar a las personas que tienen la enfermedad llamada claudicación intermitente a caminar sin dolor.
  • Un tipo de artritis llamado osteoartritis. La vitamina E no parece disminuir el dolor o la rigidez y no parece impedir el empeoramiento de la osteoartritis.
  • El cáncer de la cabeza y del cuello.
  • Las heridas en la boca en la gente que fuma.
  • El cáncer del páncreas.
  • El cáncer de la faringe.
  • Disminuir las cicatrices después de una cirugía.
  • El cáncer del colon y recto.
  • Una enfermedad ocular llamada retinitis pigmentosa.

Probablemente ineficaz para...

  • La prevención de enfermedades del corazón. El tomar suplementos de vitamina E no previene las enfermedades del corazón. Pero el aumentar el consumo de vitamina E en la dieta podría ser beneficioso.
  • La enfermedad benigna de las mamas.
  • El cáncer de mama.
  • El cáncer de los pulmones.
  • El cáncer de próstata. Los resultados de las investigaciones que se han hecho sobre los efectos de la vitamina E y el riesgo de cáncer de próstata son contradictorios. Algunos estudios sugieren que tomar más vitamina E parece prevenir el cáncer de próstata. Pero otros estudios más amplios no encuentran ningún beneficio. Algunas investigaciones también han demostrado que el tomar vitamina E aumenta el riesgo de cáncer de próstata. En general, las mejores investigaciones indican que la vitamina E no ayuda a prevenir el cáncer de próstata y podría aumentar el riesgo de desarrollar cáncer de próstata.

Insuficiente evidencia para hacer una determinación para...

  • El asma. Hay evidencia contradictoria acerca del papel de la vitamina E en el asma. Algunas investigaciones sugieren que consumir más vitamina E en la dieta parece prevenir el asma. Pero el tomar suplementos de vitamina E no ofrece el mismo beneficio.
  • El cáncer. Algunas investigaciones sugieren que una combinación de vitamina E con vitamina C, betacaroteno, selenio, y zinc disminuye el riesgo de cáncer en los hombres pero no en las mujeres. Los investigadores sospechan que los hombres obtienen una menor cantidad de estas vitaminas de los alimentos y por lo tanto podrían obtener un mayor beneficio de los suplementos.
  • El cáncer del estómago. El tomar vitamina E más caroteno o vitamina C más caroteno no parece prevenir el cáncer de estómago. Pero hay cierta evidencia que indica que el consumir más vitamina E en la dieta podría retardar el progreso del cáncer de estómago.
  • La enfermedad de células falciformes. El tomar vitamina E con ajo envejecido y vitamina C podría ser útil para la anemia de células falciformes.
  • Derrame cerebral producido por un coágulo (ictus isquémico). Hay cierta evidencia que muestra que la vitamina E sintética (all-rac-alfa-tocoferol) podría ayuda a prevenir un derrame cerebral en los fumadores masculinos que tienen diabetes y la presión arterial alta.
  • Los trastornos de la piel.
  • La visión borrosa en las personas de edad avanzada (cataratas).
  • La diabetes.
  • El cáncer del esófago.
  • Las alergias.
  • El síndrome de fatiga crónica (SFC).
  • El cáncer oral.
  • El cáncer a la piel.
  • La epilepsia.
  • Los trastornos menstruales.
  • El nivel alto de grasas en la sangre.
  • Un derrame cerebral.
  • Los calambres en las piernas.
  • El resfrío común.
  • Otras afecciones.
Se necesita más evidencia para aprobar la vitamina E para estos usos.

¿Cómo funciona?

Volver al comienzo
La vitamina E es una vitamina importante para el buen funcionamiento de muchos órganos en el cuerpo. Es también un antioxidante. Eso significa que ayuda a retardar los procesos que dañan las células.

¿Hay preocupación por la seguridad de su uso?

Volver al comienzo
La vitamina E es PROBABLEMENTE SEGURA para la mayoría de las personas sanas si se toma por vía oral o se aplica a la piel. La mayoría de la gente no sufre ningún efecto secundario si toma la dosis diaria recomendada que es de 15 mg.

La vitamina POSIBLEMENTE NO ES SEGURA si se toma en dosis altas. Si sufre de alguna enfermedad del corazón o diabetes no tome dosis más altas de 400 IU/día. Algunas investigaciones sugieren que dosis altas podrían aumentar la posibilidad de muerte en general y posiblemente causar otros efectos secundarios graves. Mientras más alta la dosis, más grande es el riesgo de efectos secundarios graves.

Hay cierta preocupación de que la vitamina E podría aumentar la posibilidad de sufrir un derrame cerebral grave llamado accidente cerebrovascular hemorrágico, que es el sangrado en el cerebro. Algunas investigaciones muestran que el tomar vitamina E en dosis de 300-800 IU diarias podría aumentar en un 22%, la posibilidad de sufrir este tipo de derrame cerebral Sin embargo, por el contrario, la vitamina podría disminuir la posibilidad de sufrir un derrame cerebral menos grave llamado accidente cerebrovascular isquémico.

Altas dosis pueden también producir náusea, diarrea, retorcijones de estómago, fatiga, debilidad, dolor de cabeza, visión borrosa, comezón, hematomas, y pérdida de sangre.

Advertencias y precauciones especiales:

Embarazo y lactancia: Cuando se usa en la cantidad diaria recomendada, la vitamina E es POSIBLEMENTE SEGURA para las mujeres que están embarazadas y amamantando. Ha habido cierta preocupación de que el tomar suplementos de vitamina E podría causar daño al feto si se toma temprano en el embarazo. Pero es demasiado pronto para determinar si esto debe ser una gran preocupación. Antes de que no se tenga más información, no tome suplementos de vitamina E al principio del embarazo sin antes consultar a su profesional de la salud.

Angioplastia, un procedimiento cardiaco: Inmediatamente antes y después de una angioplastia evite tomar suplementos que contienen vitamina E u otras vitaminas antioxidantes (betacaroteno, vitamina C) sin la supervisión de un profesional de la salud. Estas vitaminas parecen interferir con su recuperación.

Bajos niveles de vitamina K (deficiencia de vitamina K): La vitamina E podría empeorar los problemas de coagulación en las personas cuyos niveles de vitamina K están muy bajos.

Una condición llamada retinitis pigmentosa: 400 IU de all-rac-alfa-tocoferol (vitamina E sintética) parece aumentar la rapidez de la pérdida de visión en las personas con retinitis pigmentosa. Sin embargo, cantidades muchos menores (3 IU) no parecen producir este efecto. Si tiene esta afección, es mejor evitar el uso de vitamina E.

Trastornos hemorrágicos: La vitamina E podría empeorar los trastornos hemorrágicos. Si usted tiene un trastorno hemorrágico evite tomar suplementos de vitamina E.

Cáncer de la cabeza o cáncer del cuello: No tome vitamina E en dosis de 400 IU/día o más. La vitamina E podría aumentar la probabilidad de que el cáncer vuelva.

El cáncer de próstata: Hay preocupación de que el tomar vitamina E podría aumentar el riesgo de desarrollar cáncer de próstata. El efecto de la vitamina E en los hombres que ya tienen cáncer de próstata no está claro. Pero teóricamente, el tomar suplementos de vitamina E podría empeorar el cáncer de próstata en los hombres que ya tienen cáncer de próstata.

Cirugía: La vitamina E podría aumentar el riesgo de sangrado durante y después de una cirugía. Deje de tomar vitamina E por lo menos 2 semanas antes de un procedimiento quirúrgico.

¿Existen interacciones con medicamentos?

Volver al comienzo

Moderadas

Tenga cuidado con esta combinación

Ciclosporina (Neoral, Sandimmune)
El tomar grandes cantidades de vitamina E junto con ciclosporina (Neoral, Sandimmune) podría aumentar la cantidad de ciclosporina (Neoral, Sandimmune) que el cuerpo absorbe. Al aumentar la absorción de la ciclosporina por el cuerpo, la vitamina E podría aumentar los efectos y efectos secundarios de la ciclosporina (Neoral, Sandimmune).

Medicamentos alterados por el hígado (Sustratos del citocromo P450 3A4 (CYP3A4))
Algunos medicamentos son alterados y descompuestos por el hígado.

La vitamina E puede aumentar la rapidez con que el hígado descompone algunos medicamentos. El tomar vitamina E junto con medicamentos que son descompuestos por el hígado puede disminuir la eficacia de algunos medicamentos. Antes de tomar vitamina E converse con su proveedor de atención médica si toma medicamentos que son alterados por el hígado.

Algunos de los medicamentos alterados por el hígado incluyen lovastatina (Mevacor), ketoconazol, (Nizoral), itraconazol (Sporanox), fexofenadina (Allegra), triazolam (Halcion), y otros.

Medicamentos para el cáncer (Quimioterapia)
La vitamina E es un antioxidante. Hay un poco de preocupación de que los antioxidantes podrían disminuir la eficacia de algunos medicamentos que se usan para el cáncer. Pero es demasiado pronto para saber si esta interacción ocurre.

Medicamentos que retardan la coagulación sanguínea (Medicamentos Anticoagulantes/Antiplaquetarios)
La vitamina E podría retardar la coagulación sanguínea. El tomar vitamina E junto con medicamentos que también retardan la coagulación podría aumentar la posibilidad de sufrir hematomas y pérdida de sangre.

Algunos de los medicamentos que retardan la coagulación sanguínea incluyen a aspirina, clopidogrel (Plavix), diclofenac (Voltaren, Cataflam, otros), ibuprofeno (Advil, Motrin, otros), naproxen (Anaprox, Naprosyn, otros), dalteparin (Fragmin), enoxaparin (Lovenox), heparina, warfarina (Coumadin), y otros.

Medicamentos que se usan para bajar el colesterol (Estatinas)
El tomar vitamina E, betacaroteno, vitamina C y selenio juntos podría disminuir la eficacia de algunos medicamentos que se usan para bajar el colesterol. No se sabe si la vitamina E, si se toma sola, disminuye la eficacia de algunos medicamentos que se usan para bajar el colesterol.

Algunos medicamentos que se usan para bajar el colesterol incluyen a atorvastatina (Lipitor), fluvastatina (Lescol), lovastatina (Mevacor), y pravastatina (Pravachol).

Niacina
El tomar vitamina E, betacaroteno, vitamina C y selenio juntos podría disminuir algunos de los efectos beneficiosos de la niacina. La niacina puede aumentar el colesterol bueno. El tomar vitamina E juntos con estas otras vitaminas podría disminuir el colesterol bueno.

Warfarina (Coumadin)
La warfarina (Coumadin) se usa para retardar la coagulación sanguínea. La vitamina E puede también retardar la coagulación sanguínea El tomar vitamina E junto con warfarina (Coumadin) podría aumentar las posibilidades de formación de hematomas y de pérdida de sangre. Asegúrese de controlar su sangre periodicamente. Su dosis de warfarina (Coumadin) podría necesitar ser cambiada.

¿Existen interacciones con hierbas y suplementos?

Volver al comienzo
Ácidos grasos omega 6
El tomar ácidos grasos omega 6, especialmente en dosis altas, puede aumentar la cantidad de vitamina E que el cuerpo necesita.

Betacaroteno
Ciertas investigaciones sugieren que la vitamina E podría reducir la absorción del betacaroteno. El cuerpo necesita el betacaroteno para hacer la vitamina A. El tomar 800 unidades de vitamina E al día parece reducir en un 20% los niveles de betacaroteno en la sangre. Dosis mayores de vitamina E pueden reducir aún más el nivel de betacaroteno.

Hierbas y suplementos que retardan la coagulación sanguínea
La vitamina E retarda la coagulación sanguínea. El tomar vitamina E junto con hierbas y suplementos que también retardan la coagulación podría aumentar las posibilidades pérdida de sangre en algunas personas. Algunas de estas hierbas incluyen la angélica, la asafétida, el clavo de olor, la salvia miltiorrhiza, el ajo, el jengibre, el ginkgo, el ginseng Panax, el castaño de India, la reina de los prados, el álamo, la cáscara amarga, el trébol rojo, el sauce, y otras.

Hierro
Hay preocupación de que grandes dosis de vitamina E (>10 unidades/kg/día) podría retardar la absorción de suplementos de hierro en infantes gravemente anémicos. Evite dosis altas de vitamina E en los infantes. No se sabe si esta interacción ocurre en los adultos.

Vitamina A
La vitamina E puede afectar la acción de la vitamina A en el cuerpo.

Vitamina K
El tomar dosis de 800 IU/día o más de vitamina E puede disminuir los efectos de la vitamina K. Esto podría aumentar el riesgo de sangrado en la gente que está tomando warfarina u otros medicamentos que retardan la coagulación sanguínea. Las personas con niveles bajos de vitamina K podrían sufrir un riesgo mucho mayor.

¿Existen interacciones con alimentos?

Volver al comienzo
Alimentos ricos en grasas
El cuerpo necesita las grasas para poder usar la vitamina E. No es necesario aumentar el consumo de grasas en la dieta para asegurarse de que la vitamina E pueda ser usada por el cuerpo.

¿Qué dosis se utiliza?

Volver al comienzo
Las siguientes dosis han sido estudiadas en investigaciones científicas:

POR VIA ORAL:

  • Para deficiencia de vitamina E: una dosis típica es de 60-75 IU por día de RRR-alfa-tocoferol (Vitamina E natural).
  • Para el trastorno de movimiento llamado diskinesia tardía: 1600 IU diarias de RRR-alfa-tocoferol (Vitamina E natural).
  • Para mejorar la infertilidad masculina: 200-600 IU diarias de vitamina E.
  • Para la enfermedad de Alzheimer: se usan hasta 2000 IU diarias. La terapia de combinación de 5 mg de donepezil (Aricept) y 1000 IU por día se ha usado para retardar la disminución de la memoria en pacientes con la enfermedad de Alzheimer.
  • Para la enfermedad hepática llamada esteatohepatitis no alcohólica: Se ha usado 800 IU diarios en los adultos; 400-1200 IU diarias en los niños.
  • Para la corea de Huntington en sus primeras etapas: 3000 IU por día de RRR-alfa-tocoferol (Vitamina E natural).
  • Para el dolor de la artritis reumática: 600 IU de vitamina E dos veces al día.
  • Para la prevención de daño a los nervios por el uso de cisplatin: 300 mg diarios de vitamina E (alfa-tocoferol) con cada tratamiento de quimioterapia y se sigue por 3 meses más después de parar el tratamiento con cisplatin.
  • Para mejorar la eficacia de los nitratos que se usan para las enfermedades del corazón: 200 mg de vitamina E tres veces al día.
  • Para disminuir la proteína en la orina de niños con una enfermedad renal llamada esclerosis glomerular focal segmentada: 200 IU de vitamina E.
  • Para la deficiencia de G6PD: 800 IU diarias.
  • Para el síndrome premenstrual (SPM): 400 IU diarias de RRR-alfa-tocoferol (Vitamina E natural).
  • Para los períodos de menstruación dolorosos: 200 IU de vitamina E dos veces al día o 500 IU diarias empezando dos días antes del comienzo del período y continuando por los 3 primeros días de sangrado.
  • Para la curación de los ojos después de una cirugía llamada queratectomía: Se han usado 230 mg de vitamina E (alfa-tocoferil nicotinato) y 25,000 unidades de vitamina A (palmitato de retinol) 3 veces al día por 30 días, y luego continuando dos veces al día por 2 meses.
  • Para la fibrosis causada por la radiación: 1000 IU diarias de vitamina E en combinación con 800 mg de pentoxifilina.
  • Para la beta talasemia: 750 IU diarias de vitamina E.
  • Para la prevención de quemaduras de sol: 1000 IU de RRR-alfa-tocoferol (Vitamina E natural) en combinación con 2 gramos de ácido ascórbico.
  • Para la prevención de un alza de la presión arterial en el embarazo (preeclampsia) en las mujeres con un alto riesgo: 400 IU de vitamina E con 1000 mg de vitamina C diarios.
Para obtener el mayor beneficio, es mejor tomar vitamina E que se ha hecho en el laboratorio (all-rac alfa-tocoferol) con la comida. La dosificación de la vitamina E se puede prestar a confusión. Las nuevas directrices muestran la ingesta diaria recomendada (RDA) y el nivel de ingesta máximo tolerable (UTL) para la vitamina E en miligramos. Sin embargo, la mayoría de los productos están todavía etiquetados en Unidades Internacionales (IUs).

Otros nombres

Volver al comienzo
Acétate d’Alpha Tocophérol, Acétate d’Alpha Tocophéryl, Acétate de D-Alpha-Tocophéryl, Acétate de DL-Alpha-Tocophéryl, Acétate de Tocophérol, Acétate de Tocophéryl, Acétate de Vitamine E, All Rac-Alpha-Tocopherol, All-Rac-Alpha-Tocophérol, Alpha-Tocophérol, Alpha Tocopherol Acetate, Alpha Tocopheryl Acetate, Alpha tocotrienol, Alpha tocotriénol, Alpha-tocopherol, Alpha-Tocophérol, Beta tocotrienol, Bêta-tocotriénol, Beta-tocopherol, Bêta-tocophérol, Concentré de Tocotriénol, D-Alpha Tocopherol, D-Alpha Tocophérol, D-Alpha Tocopheryl Succinate, D-Alpha Tocopheryl Acetate, D-Alpha Tocotrienol, D-Alpha Tocotriénol, D-Alpha-Tocopherol, D-Alpha-Tocophérol, D-Alpha-Tocopheryl Acetate, D-Alpha-Tocopheryl Acid Succinate, D-Alpha-Tocopheryl Succinate, D-Alpha-Tocopheryl, D-Alpha-Tocophéryl, D-Beta-Tocopherol, D-Bêta-Tocophérol, D-Delta-Tocopherol, D-Delta-Tocophérol, Delta Tocotrienol, Delta-Tocotriénol, Delta-tocopherol, Delta-tocophérol, D-Gamma Tocotrienol, D-Gamma-Tocotriénol, D-Gamma-Tocopherol, D-Gamma-Tocophérol, DL-Alpha-Tocopherol, DL-Alpha-Tocophérol, DL-Alpha-Tocopheryl Acetate, DL-Alpha-Tocopheryl, DL-Alpha-Tocophéryl, DL-Tocopherol, DL-Tocophérol, D-Tocopherol, D-Tocophérol, D-Tocopheryl Acetate, Fat-Soluble Vitamin, Gamma tocotrienol, Gamma-tocotriénol, Gamma-tocopherol, Gamma-tocophérol, Mixed Tocopherols, Mixed Tocotrienols, Palm Tocotrienols, Rice Tocotrienols, RRR-Alpha-Tocopherol, RRR-Alpha-Tocophérol, Succinate Acide de D-Alpha-Tocophéryl, Succinate Acide de Tocophéryl, Succinate de D-Alpha-Tocophéryl, Succinate de Tocophéryl, Succinate de Vitamine E, Tocopherol Acetate, Tocopherol, Tocophérol, Tocophérols Mixtes, Tocotriénols de Palme, Tocotriénols de Riz, Tocotriénols Mixtes, Tocopheryl Acetate, Tocopheryl Acid Succinate, Tocopheryl Succinate, Tocotrienol, Tocotriénol, Tocotrienol Concentrate, Tocotrienols, Tocotriénols, Vitamin E Acetate, Vitamin E Succinate, Vitamine E, Vitamine Liposoluble, Vitamine Soluble dans les Graisses.

Metodología

Volver al comienzo
Para saber más sobre cómo este artículo fue escrito, refiérase a la metodología metodología (http://www.nlm.nih.gov/medlineplus/spanish/druginfo/natural/methodology-sp.html) de la Base exhaustiva de datos de medicamentos naturales.

Referencias

Volver al comienzo
Para ver todas las referencias de la página de Vitamina E, por favor diríjase a http://www.nlm.nih.gov/medlineplus/spanish/druginfo/natural/954.html.
  1. Pryor, J. P. and Farell, C. F. Controlled clinical trial of vitamin E in Peyronie's disease. Prog Reprod Biol 1983;9:41-45.
  2. Junker, D., Steigleider, P., and Gattaz, W. F. Alpha-tocopherol in the treatment of tardive dyskinesia. Clin Neuropharm 1992;15:639B.
  3. Adler, L., Edson, R., Rotrosen, J., Lavori, P., Tracy, K., and Lohr, J. Vitamin E in the treatment of TD: the results of Department of Veterans Affairs Cooperative Study #394. Proceedings of New Clinical Drug Evaluation Unit Program 38th Annual Meeting 1998;
  4. Glass GV. Primary secondary and metanalysis of research. Educ Res 1976;5:8.
  5. Schmidt M, Meister P Baumann P. Treatment of tardive dyskinesias with vitamin E. European Psychiatry 1991;6:201-207.
  6. Schiller MS, Rudolph M Kim MH Thangavel M Rivera LM Kassner EG. Vitamin E and the ductus arteriosus (DA) in premature infants. Pediatric Research 1980;14:611.
  7. Rivas-Echeverria CA, Echeverria Y Molina L Novoa D. Synergic use of aspirin, fish oil and vitamins C and E for the prevention of preeclampsia. Hypertension in Pregnancy 2000;19(Suppl 1):30.
  8. Beazley D, Livingston J Kao L Sibai B. Vitamin c and e supplementation in women at high risk for preeclampsia: a doubleblind placebo controlled trial. American Journal of Obstetrics and Gynecology 2002;187(6 Pt 2):S216.
  9. Stevic Z, Nikolic A Blagojevic DP Saicic ZS Kocev NI Apostolski SA Spasic MB. A controlled trial of combination of methionine and antioxidants in ALS patients. Jugoslav Med Biohem 2001;20:223-228.
  10. Gupta MM, Chari S. Lipid peroxidation and antioxidant status in patients with diabetic retinopathy. Indian J Physiol Pharmacol 2005;49:192.
  1. Gurler B, Vural H Yilmaz N et al. The role of oxidative stress in diabetic retinopathy. Eye 2000;14:730-735.
  2. Zhu S, Mason J Shi Y Hu Y Li R Wang M et al. The interventional effect of folic acid on the development of gastric and other gastrointestinal cancers - clinical trial and follow-up for seven years. Chin J Gastroenterol 2002;7:73-78.
  3. Bonelli L, Camoriano A Ravelli P Missale G Bruzzi P Aste H. Reduction of the incidence of metachronous adenomas of the large bowel by means of antioxidants. Se-Te Press 1998;91-94.
  4. Weitzman, S. A., Lorell, B., Carey, R. W., Kaufman, S., and Stossel, T. P. Prospective study of tocopherol prophylaxis for anthracycline cardiac toxicity. Curr Ther Res 1980;28:682-686.
  5. Sklodowska M, Wasowicz W Gromadzinska J Miroslaw W Strzelczyk M Malczyk J Goch JK. Selenium and vitamin E concentrations in plasma and erythrocytes of angina pectoris patients. Trace Elements in Medicine 1991;8:113-117.
  6. Gaziano JM, Manson JE Ridker PM Buring JE Hennekens CH. Beta carotene therapy, for chronic stable angina. Circulation 1990;82(Suppl III):201.
  7. Ferlin MLS, Chuan LS Jorge SM Vannucchi H. Early anemia of prematurity. Nutrition Research 1998;18:1173.
  8. Roncucci L, Ponz de Leon M. Antioxidant vitamins or lactulose as chemopreventive agents for colorectal cancer. Food and Cancer Prevention 1993;147-150.
  9. Creagan ET, Moertel CG Schutt AJ Oconnell MJ. Vitamin-c (ascorbic-acid) therapy of pre-terminal cancer-patients. Proc Am Assoc Cancer Res 1979;20:355.
  10. Papila C, Papila I Bilir M Cagatay T Yanardag H et al. Effect of vitamin E supplementation on natural killer cell activity in patients with solid tumors. Journal of BU On 1999;4:435-437.
  11. Vlajinac H, Ilic M Sipetic S Marinkovic J Kocev N. A case-control study of diet and prostate cancer. Journal of B.U.On 2001;4:435-437.
  12. Wang, H., Li, R. X., and Wang, M. F. Effects of zinc and antioxidant on visual function of patients with age-related macular degeneration. Zhongguo Linchuant Kangfu 2004;8:1290-1291.
  13. Uygun A, Kadayifci A Bagci S et al. L-Carnitine therapy in non-alcoholic steatohepatitis. Turk J Gastroenterol 2000;11:196-201.
  14. Badcock NR, Parsons D, Staugas RE, Aldis JJE, and Couper RTL. Vitamin E, peroxidative and non-peroxidative free radical damage markers, and sample collection timing in children and adolescents with cystic fibrosis. Australian Journal of Nutrition & Dietetics (AUST J NUTR DIET) 2000;57:79-83.
  15. Harrington B, James K. Management of chemotherapy induced peripheral neuropathies with daily vitamin E. Commun Nurs Res 2010;43:604.
  16. Mitchinson, M. J., Stephens, N. G., Parsons, A., Bligh, E., Schofield, P. M., and Brown, M. J. Mortality in the CHAOS trial. Lancet 1-30-1999;353:381-382. View abstract.
  17. Delport, R., Ubbink, J. B., Human, J. A., Becker, P. J., Myburgh, D. P., and Vermaak, W. J. Antioxidant vitamins and coronary artery disease risk in South African males. Clin.Chim.Acta 1998;278:55-60. View abstract.
  18. Marniemi, J., Jarvisalo, J., Toikka, T., Raiha, I., Ahotupa, M., and Sourander, L. Blood vitamins, mineral elements and inflammation markers as risk factors of vascular and non-vascular disease mortality in an elderly population. Int.J.Epidemiol. 1998;27:799-807. View abstract.
  19. Sellers, T. A., Bazyk, A. E., Bostick, R. M., Kushi, L. H., Olson, J. E., Anderson, K. E., Lazovich, D., and Folsom, A. R. Diet and risk of colon cancer in a large prospective study of older women: an analysis stratified on family history (Iowa, United States). Cancer Causes Control 1998;9:357-367. View abstract.
  20. Barak, Y., Swartz, M., Shamir, E., Stein, D., and Weizman, A. Vitamin E (alpha-tocopherol) in the treatment of tardive dyskinesia: a statistical meta-analysis. Ann.Clin.Psychiatry 1998;10:101-105. View abstract.
  21. Favero, A., Parpinel, M., and Franceschi, S. Diet and risk of breast cancer: major findings from an Italian case-control study. Biomed.Pharmacother. 1998;52:109-115. View abstract.
  22. Davey, P. J., Schulz, M., Gliksman, M., Dobson, M., Aristides, M., and Stephens, N. G. Cost-effectiveness of vitamin E therapy in the treatment of patients with angiographically proven coronary narrowing (CHAOS trial). Cambridge Heart Antioxidant Study. Am.J.Cardiol. 8-15-1998;82:414-417. View abstract.
  23. Kumagai, Y., Pi, J. B., Lee, S., Sun, G. F., Yamanushi, T., Sagai, M., and Shimojo, N. Serum antioxidant vitamins and risk of lung and stomach cancers in Shenyang, China. Cancer Lett. 7-17-1998;129:145-149. View abstract.
  24. Launoy, G., Milan, C., Day, N. E., Pienkowski, M. P., Gignoux, M., and Faivre, J. Diet and squamous-cell cancer of the oesophagus: a French multicentre case-control study. Int.J.Cancer 3-30-1998;76:7-12. View abstract.
  25. Mortality in DATATOP: a multicenter trial in early Parkinson's disease. Parkinson Study Group. Ann.Neurol. 1998;43:318-325. View abstract.
  26. Mezzetti, M., La, Vecchia C., Decarli, A., Boyle, P., Talamini, R., and Franceschi, S. Population attributable risk for breast cancer: diet, nutrition, and physical exercise. J.Natl.Cancer Inst. 3-4-1998;90:389-394. View abstract.
  27. Andreone, P., Gramonzi, A., and Bernardi, M. Vitamin E for chronic hepatitis B. Ann.Intern.Med. 1-15-1998;128:156-157. View abstract.
  28. Tornwall, M., Virtamo, J., Haukka, J. K., Aro, A., Albanes, D., Edwards, B. K., and Huttunen, J. K. Effect of alpha-tocopherol (vitamin E) and beta-carotene supplementation on the incidence of intermittent claudication in male smokers. Arterioscler.Thromb.Vasc.Biol. 1997;17:3475-3480. View abstract.
  29. Clemens, M. R., Waladkhani, A. R., Bublitz, K., Ehninger, G., and Gey, K. F. Supplementation with antioxidants prior to bone marrow transplantation. Wien.Klin.Wochenschr. 10-17-1997;109:771-776. View abstract.
  30. Pacht, E. R., Diaz, P., Clanton, T., Hart, J., and Gadek, J. E. Serum vitamin E decreases in HIV-seropositive subjects over time. J.Lab Clin.Med. 1997;130:293-296. View abstract.
  31. Ruiz, Rejon F., Martin, Pena G., Lopez, Manglano C., Seijas, Martinez, V, and Ruiz, Galiana J. [Plasma levels of vitamins A and E and the risk of acute myocardial infarct]. Rev.Clin.Esp. 1997;197:411-416. View abstract.
  32. Bendich, A., Mallick, R., and Leader, S. Potential health economic benefits of vitamin supplementation. West J.Med. 1997;166:306-312. View abstract.
  33. Nomura, A. M., Ziegler, R. G., Stemmermann, G. N., Chyou, P. H., and Craft, N. E. Serum micronutrients and upper aerodigestive tract cancer. Cancer Epidemiol.Biomarkers Prev. 1997;6:407-412. View abstract.
  34. Dimery, I. W., Hong, W. K., Lee, J. J., Guillory-Perez, C., Pham, F., Fritsche, H. A., Jr., and Lippman, S. M. Phase I trial of alpha-tocopherol effects on 13-cis-retinoic acid toxicity. Ann.Oncol. 1997;8:85-89. View abstract.
  35. Vlajinac, H. D., Marinkovic, J. M., Ilic, M. D., and Kocev, N. I. Diet and prostate cancer: a case-control study. Eur.J.Cancer 1997;33:101-107. View abstract.
  36. Colditz, G. A., Manson, J. E., and Hankinson, S. E. The Nurses' Health Study: 20-year contribution to the understanding of health among women. J.Womens Health 1997;6:49-62. View abstract.
  37. Dorevitch, A., Kalian, M., Shlafman, M., and Lerner, V. Treatment of long-term tardive dyskinesia with vitamin E. Biol.Psychiatry 1-1-1997;41:114-116. View abstract.
  38. Azen, S. P., Qian, D., Mack, W. J., Sevanian, A., Selzer, R. H., Liu, C. R., Liu, C. H., and Hodis, H. N. Effect of supplementary antioxidant vitamin intake on carotid arterial wall intima-media thickness in a controlled clinical trial of cholesterol lowering. Circulation 11-15-1996;94:2369-2372. View abstract.
  39. Wagdi, P., Fluri, M., Aeschbacher, B., Fikrle, A., and Meier, B. Cardioprotection in patients undergoing chemo- and/or radiotherapy for neoplastic disease. A pilot study. Jpn.Heart J. 1996;37:353-359. View abstract.
  40. Esteve, J., Riboli, E., Pequignot, G., Terracini, B., Merletti, F., Crosignani, P., Ascunce, N., Zubiri, L., Blanchet, F., Raymond, L., Repetto, F., and Tuyns, A. J. Diet and cancers of the larynx and hypopharynx: the IARC multi-center study in southwestern Europe. Cancer Causes Control 1996;7:240-252. View abstract.
  41. Soares, K., McGrath, J., and Adams, C. Evidence and tardive dyskinesia. Lancet 6-15-1996;347:1696-1697. View abstract.
  42. Gerber, M., Astre, C., Segala, C., Saintot, M., Scali, J., Simony-Lafontaine, J., Grenier, J., and Pujol, H. Oxidant-antioxidant status alterations in cancer patients: relationship to tumor progression. J.Nutr. 1996;126(4 Suppl):1201S-1207S. View abstract.
  43. Singh, R. B., Niaz, M. A., Rastogi, S. S., and Rastogi, S. Usefulness of antioxidant vitamins in suspected acute myocardial infarction (the Indian experiment of infarct survival-3). Am.J.Cardiol. 2-1-1996;77:232-236. View abstract.
  44. Eichholzer, M., Stahelin, H. B., Gey, K. F., Ludin, E., and Bernasconi, F. Prediction of male cancer mortality by plasma levels of interacting vitamins: 17-year follow-up of the prospective Basel study. Int.J.Cancer 4-10-1996;66:145-150. View abstract.
  45. Wolk, A., Gridley, G., Niwa, S., Lindblad, P., McCredie, M., Mellemgaard, A., Mandel, J. S., Wahrendorf, J., McLaughlin, J. K., and Adami, H. O. International renal cell cancer study. VII. Role of diet. Int.J.Cancer 1-3-1996;65:67-73. View abstract.
  46. Donnan, P. T., Thomson, M., Fowkes, F. G., Prescott, R. J., and Housley, E. Diet as a risk factor for peripheral arterial disease in the general population: the Edinburgh Artery Study. Am.J.Clin.Nutr. 1993;57:917-921. View abstract.
  47. Lam, L. C., Chiu, H. F., and Hung, S. F. Vitamin E in the treatment of tardive dyskinesia: a replication study. J.Nerv.Ment.Dis. 1994;182:113-114. View abstract.
  48. Nguyen, T. T., Cox, C. S., Traber, D. L., Gasser, H., Redl, H., Schlag, G., and Herndon, D. N. Free radical activity and loss of plasma antioxidants, vitamin E, and sulfhydryl groups in patients with burns: the 1993 Moyer Award. J.Burn Care Rehabil. 1993;14:602-609. View abstract.
  49. Hense, H. W., Stender, M., Bors, W., and Keil, U. Lack of an association between serum vitamin E and myocardial infarction in a population with high vitamin E levels. Atherosclerosis 1993;103:21-28. View abstract.
  50. Peet, M., Laugharne, J., Rangarajan, N., and Reynolds, G. P. Tardive dyskinesia, lipid peroxidation, and sustained amelioration with vitamin E treatment. Int.Clin.Psychopharmacol. 1993;8:151-153. View abstract.
  51. Hansson, L. E., Nyren, O., Bergstrom, R., Wolk, A., Lindgren, A., Baron, J., and Adami, H. O. Nutrients and gastric cancer risk. A population-based case-control study in Sweden. Int.J.Cancer 6-1-1994;57:638-644. View abstract.
  52. Handelman, G. J., Epstein, W. L., Peerson, J., Spiegelman, D., Machlin, L. J., and Dratz, E. A. Human adipose alpha-tocopherol and gamma-tocopherol kinetics during and after 1 y of alpha-tocopherol supplementation. Am.J.Clin.Nutr. 1994;59:1025-1032. View abstract.
  53. Kirkpatrick, C. S., White, E., and Lee, J. A. Case-control study of malignant melanoma in Washington State. II. Diet, alcohol, and obesity. Am.J.Epidemiol. 5-1-1994;139:869-880. View abstract.
  54. Adler, L. A., Peselow, E., Duncan, E., Rosenthal, M., and Angrist, B. Vitamin E in tardive dyskinesia: time course of effect after placebo substitution. Psychopharmacol.Bull. 1993;29:371-374. View abstract.
  55. Adler, L. A., Peselow, E., Rotrosen, J., Duncan, E., Lee, M., Rosenthal, M., and Angrist, B. Vitamin E treatment of tardive dyskinesia. Am.J.Psychiatry 1993;150:1405-1407. View abstract.
  56. Tohgi, H., Abe, T., Nakanishi, M., Hamato, F., Sasaki, K., and Takahashi, S. Concentrations of alpha-tocopherol and its quinone derivative in cerebrospinal fluid from patients with vascular dementia of the Binswanger type and Alzheimer type dementia. Neurosci.Lett. 6-6-1994;174:73-76. View abstract.
  57. Akhtar, S., Jajor, T. R., and Kumar, S. Vitamin E in the treatment of tardive dyskinesia. J.Postgrad.Med. 1993;39:124-126. View abstract.
  58. Manzano, D., Aguirre, A., Gardeazabal, J., Eizaguirre, X., and Diaz Perez, J. L. Allergic contact dermatitis from tocopheryl acetate (vitamin E) and retinol palmitate (vitamin A) in a moisturizing cream. Contact Dermatitis 1994;31:324. View abstract.
  59. Lopez, I., Goudou, C., Ribrag, V., Sauvage, C., Hazebroucq, G., and Dreyfus, F. [Treatment of mucositis with vitamin E during administration of neutropenic antineoplastic agents]. Ann.Med.Interne (Paris) 1994;145:405-408. View abstract.
  60. Hunnisett, A., Davies, S., McLaren-Howard, J., Gravett, P., Finn, M., and Gueret-Wardle, D. Lipoperoxides as an index of free radical activity in bone marrow transplant recipients. Preliminary observations. Biol.Trace Elem.Res. 1995;47(1-3):125-132. View abstract.
  61. Torun, M., Akgul, S., and Sargin, H. Serum vitamin E level in patients with breast cancer. J.Clin.Pharm.Ther. 1995;20:173-178. View abstract.
  62. Zheng, W., Sellers, T. A., Doyle, T. J., Kushi, L. H., Potter, J. D., and Folsom, A. R. Retinol, antioxidant vitamins, and cancers of the upper digestive tract in a prospective cohort study of postmenopausal women. Am.J.Epidemiol. 11-1-1995;142:955-960. View abstract.
  63. Saldanha, R. L., Cepeda, E. E., and Poland, R. L. The effect of vitamin E prophylaxis on the incidence and severity of bronchopulmonary dysplasia. J.Pediatr. 1982;101:89-93. View abstract.
  64. Hittner, H. M., Godio, L. B., Rudolph, A. J., Adams, J. M., Garcia-Prats, J. A., Friedman, Z., Kautz, J. A., and Monaco, W. A. Retrolental fibroplasia: efficacy of vitamin E in a double-blind clinical study of preterm infants. N.Engl.J.Med. 12-3-1981;305:1365-1371. View abstract.
  65. Legha, S. S., Wang, Y. M., Mackay, B., Ewer, M., Hortobagyi, G. N., Benjamin, R. S., and Ali, M. K. Clinical and pharmacologic investigation of the effects of alpha-tocopherol on adriamycin cardiotoxicity. Ann.N.Y.Acad.Sci. 1982;393:411-418. View abstract.
  66. Chiswick, M. L., Wynn, J., and Toner, N. Vitamin E and intraventricular hemorrhage in the newborn. Ann.N.Y.Acad.Sci. 1982;393:109-120. View abstract.
  67. Jansson, L., Holmberg, L., Nilsson, B., and Johansson, B. Vitamin E requirements of preterm infants. Acta Paediatr.Scand. 1978;67:459-463. View abstract.
  68. Ehrenkranz, R. A., Ablow, R. C., and Warshaw, J. B. Effect of vitamin E on the development of oxygen-induced lung injury in neonates. Ann.N.Y.Acad.Sci. 1982;393:452-466. View abstract.
  69. Haeger, K. Long-term study of alpha-tocopherol in intermittent claudication. Ann.N.Y.Acad.Sci. 1982;393:369-375. View abstract.
  70. Wald, N. J., Boreham, J., Hayward, J. L., and Bulbrook, R. D. Plasma retinol, beta-carotene and vitamin E levels in relation to the future risk of breast cancer. Br.J.Cancer 1984;49:321-324. View abstract.
  71. London, R. S., Sundaram, G. S., Murphy, L., and Goldstein, P. J. Evaluation and treatment of breast symptoms in patients with the premenstrual syndrome. J.Reprod.Med. 1983;28:503-508. View abstract.
  72. Abraham, G. E. Nutritional factors in the etiology of the premenstrual tension syndromes. J.Reprod.Med. 1983;28:446-464. View abstract.
  73. Cruz, C. S., Wimberley, P. D., Johansen, K., and Friis-Hansen, B. The effect of vitamin E on erythrocyte hemolysis and lipid peroxidation in newborn premature infants. Acta Paediatr.Scand. 1983;72:823-826. View abstract.
  74. Lenzhofer, R., Ganzinger, U., Rameis, H., and Moser, K. Acute cardiac toxicity in patients after doxorubicin treatment and the effect of combined tocopherol and nifedipine pretreatment. J.Cancer Res.Clin.Oncol. 1983;106:143-147. View abstract.
  75. Stahelin, H. B., Rosel, F., Buess, E., and Brubacher, G. Cancer, vitamins, and plasma lipids: prospective Basel study. J.Natl.Cancer Inst. 1984;73:1463-1468. View abstract.
  76. Hittner, H. M., Speer, M. E., Rudolph, A. J., Blifeld, C., Chadda, P., Holbein, M. E., Godio, L. B., and Kretzer, F. L. Retrolental fibroplasia and vitamin E in the preterm infant--comparison of oral versus intramuscular:oral administration. Pediatrics 1984;73:238-249. View abstract.
  77. Willett, W. C., Polk, B. F., Underwood, B. A., Stampfer, M. J., Pressel, S., Rosner, B., Taylor, J. O., Schneider, K., and Hames, C. G. Relation of serum vitamins A and E and carotenoids to the risk of cancer. N.Engl.J.Med. 2-16-1984;310:430-434. View abstract.
  78. Sundstrom, H., Korpela, H., Viinikka, L., and Kauppila, A. Serum selenium and glutathione peroxidase, and plasma lipid peroxides in uterine, ovarian or vulvar cancer, and their responses to antioxidants in patients with ovarian cancer. Cancer Lett. 1984;24:1-10. View abstract.
  79. Whittaker, J. A. and Al-Ismail, S. A. Effect of digoxin and vitamin E in preventing cardiac damage caused by doxorubicin in acute myeloid leukaemia. Br.Med.J.(Clin.Res.Ed) 1-28-1984;288:283-284. View abstract.
  80. Chiswick, M. L., Johnson, M., Woodhall, C., Gowland, M., Davies, J., Toner, N., and Sims, D. G. Protective effect of vitamin E (DL-alpha-tocopherol) against intraventricular haemorrhage in premature babies. Br.Med.J.(Clin.Res.Ed) 7-9-1983;287:81-84. View abstract.
  81. London, R. S., Sundaram, G., Manimekalai, S., Murphy, L., Reynolds, M., and Goldstein, P. The effect of alpha-tocopherol on premenstrual symptomatology: a double-blind study. II. Endocrine correlates. J.Am.Coll.Nutr. 1984;3:351-356. View abstract.
  82. Saperstein, H., Rapaport, M., and Rietschel, R. L. Topical vitamin E as a cause of erythema multiforme-like eruption. Arch.Dermatol. 1984;120:906-908. View abstract.
  83. Finer, N. N., Schindler, R. F., Grant, G., Hill, G. B., and Peters, K. Effect of intramuscular vitamin E on frequency and severity of retrolental fibroplasia. A controlled trial. Lancet 5-15-1982;1:1087-1091. View abstract.
  84. WILLIAMS, H. T., Fenna, D., and MACBETH, R. A. Alpha tocopherol in the treatment of intermittent claudication. Surg.Gynecol.Obstet. 1971;132:662-666. View abstract.
  85. Graeber, J. E., Williams, M. L., and Oski, F. A. The use of intramuscular vitamin E in the premature infant. Optimum dose and iron interaction. J.Pediatr. 1977;90:282-284. View abstract.
  86. Melhorn, D. K. and Gross, S. Vitamin E-dependent anemia in the premature infant. II. Relationships between gestational age and absorption of vitamin E. J.Pediatr. 1971;79:581-588. View abstract.
  87. Gross, S. J. Vitamin E and neonatal bilirubinemia. Pediatrics 1979;64:321-323. View abstract.
  88. Molenaar, I., Hulstaert, C. E., and Vos, J. Membrane characteristics in vitamin E deficiency and the assessment of vitamin E status. Proc.Nutr.Soc. 1973;32:249-254. View abstract.
  89. Anderson, T. W. and Reid, D. B. A double-blind trial of vitamin E in angina pectoris. Am.J.Clin.Nutr. 1974;27:1174-1178. View abstract.
  90. Haeger, K. Long-time treatment of intermittent claudication with vitamin E. Am.J.Clin.Nutr. 1974;27:1179-1181. View abstract.
  91. Nomura, A. M., Stemmermann, G. N., Heilbrun, L. K., Salkeld, R. M., and Vuilleumier, J. P. Serum vitamin levels and the risk of cancer of specific sites in men of Japanese ancestry in Hawaii. Cancer Res. 1985;45:2369-2372. View abstract.
  92. Smith, D. W., Cohen, R. S., Vreman, H. J., Yeh, A., Sharron, S., and Stevenson, D. K. Bilirubin production after supplemental oral vitamin E therapy in preterm infants. J.Pediatr.Gastroenterol.Nutr. 1985;4:38-44. View abstract.
  93. Havens, C. Premenstrual syndrome. Tactics for intervention. Postgrad.Med. 5-15-1985;77:32-37. View abstract.
  94. McGinness, J. E., Grossie, B., Jr., Proctor, P. H., Benjamin, R. S., Gulati, O. P., and Hokanson, J. A. Effect of dose schedule of vitamin E and hydroxethylruticide on intestinal toxicity induced by adriamycin. Physiol Chem.Phys.Med.NMR 1986;18:17-24. View abstract.
  95. Menkes, M. S., Comstock, G. W., Vuilleumier, J. P., Helsing, K. J., Rider, A. A., and Brookmeyer, R. Serum beta-carotene, vitamins A and E, selenium, and the risk of lung cancer. N.Engl.J.Med. 11-13-1986;315:1250-1254. View abstract.
  96. Perez, J. E., Macchiavelli, M., Leone, B. A., Romero, A., Rabinovich, M. G., Goldar, D., and Vallejo, C. High-dose alpha-tocopherol as a preventive of doxorubicin-induced alopecia. Cancer Treat.Rep. 1986;70:1213-1214. View abstract.
  97. Schober, S. E., Comstock, G. W., Helsing, K. J., Salkeld, R. M., Morris, J. S., Rider, A. A., and Brookmeyer, R. Serologic precursors of cancer. I. Prediagnostic serum nutrients and colon cancer risk. Am.J.Epidemiol. 1987;126:1033-1041. View abstract.
  98. Wald, N. J., Thompson, S. G., Densem, J. W., Boreham, J., and Bailey, A. Serum vitamin E and subsequent risk of cancer. Br.J.Cancer 1987;56:69-72. View abstract.
  99. Phelps, D. L., Rosenbaum, A. L., Isenberg, S. J., Leake, R. D., and Dorey, F. J. Tocopherol efficacy and safety for preventing retinopathy of prematurity: a randomized, controlled, double-masked trial. Pediatrics 1987;79:489-500. View abstract.
  100. Martin-Jimenez, M., Diaz-Rubio, E., Gonzalez Larriba, J. L., and Sangro, B. Failure of high-dose tocopherol to prevent alopecia induced by doxorubicin. N.Engl.J.Med. 10-2-1986;315:894-895. View abstract.
  101. Knekt, P. Serum vitamin E level and risk of female cancers. Int.J.Epidemiol. 1988;17:281-286. View abstract.
  102. Russell, M. J., Thomas, B. S., and Bulbrook, R. D. A prospective study of the relationship between serum vitamins A and E and risk of breast cancer. Br.J.Cancer 1988;57:213-215. View abstract.
  103. Fischer, A. F., Inguillo, D., Martin, D. M., Ochikubo, C. G., Vreman, H. J., and Stevenson, D. K. Carboxyhemoglobin concentration as an index of bilirubin production in neonates with birth weights less than 1,500 grams: a randomized double-blind comparison of supplemental oral vitamin E and placebo. J.Pediatr.Gastroenterol.Nutr. 1987;6:748-751. View abstract.
  104. Knekt, P., Aromaa, A., Maatela, J., Aaran, R. K., Nikkari, T., Hakama, M., Hakulinen, T., Peto, R., Saxen, E., and Teppo, L. Serum vitamin E and risk of cancer among Finnish men during a 10-year follow-up. Am.J.Epidemiol. 1988;127:28-41. View abstract.
  105. Gross, S. J., Landaw, S. A., and Oski, F. A. Vitamin E and neonatal hemolysis. Pediatrics 1977;59 Suppl(6 Pt 2):995-997. View abstract.
  106. Knekt, P., Aromaa, A., Maatela, J., Alfthan, G., Aaran, R. K., Teppo, L., and Hakama, M. Serum vitamin E, serum selenium and the risk of gastrointestinal cancer. Int.J.Cancer 12-15-1988;42:846-850. View abstract.
  107. Sundstrom, H., Korpela, H., Sajanti, E., and Kauppila, A. Supplementation with selenium, vitamin E and their combination in gynaecological cancer during cytotoxic chemotherapy. Carcinogenesis 1989;10:273-278. View abstract.
  108. Ronnholm, K. A., Dostalova, L., and Siimes, M. A. Vitamin E supplementation in very-low-birth-weight infants: long-term follow-up at two different levels of vitamin E supplementation. Am.J.Clin.Nutr. 1989;49:121-126. View abstract.
  109. Lohr, J. B., Cadet, J. L., Lohr, M. A., Jeste, D. V., and Wyatt, R. J. Alpha-tocopherol in tardive dyskinesia. Lancet 4-18-1987;1:913-914. View abstract.
  110. Sinha, S., Davies, J., Toner, N., Bogle, S., and Chiswick, M. Vitamin E supplementation reduces frequency of periventricular haemorrhage in very preterm babies. Lancet 2-28-1987;1:466-471. View abstract.
  111. Rudolph, N., Schiller, M. S., and Wong, S. L. Vitamin E and selenium in preterm infants: lack of effect on clinical patency of ductus arteriosus. Int.J.Vitam.Nutr.Res. 1989;59:140-146. View abstract.
  112. Bell, E. F. Upper limit of vitamin E in infant formulas. J.Nutr. 1989;119(12 Suppl):1829-1831. View abstract.
  113. Johnson, L., Quinn, G. E., Abbasi, S., Otis, C., Goldstein, D., Sacks, L., Porat, R., Fong, E., Delivoria-Papadopoulos, M., Peckham, G., and . Effect of sustained pharmacologic vitamin E levels on incidence and severity of retinopathy of prematurity: a controlled clinical trial. J.Pediatr. 1989;114:827-838. View abstract.
  114. Gey, K. F. and Puska, P. Plasma vitamins E and A inversely correlated to mortality from ischemic heart disease in cross-cultural epidemiology. Ann.N.Y.Acad.Sci. 1989;570:268-282. View abstract.
  115. Effect of deprenyl on the progression of disability in early Parkinson's disease. The Parkinson Study Group. N.Engl.J.Med. 11-16-1989;321:1364-1371. View abstract.
  116. Stryker, W. S., Stampfer, M. J., Stein, E. A., Kaplan, L., Louis, T. A., Sober, A., and Willett, W. C. Diet, plasma levels of beta-carotene and alpha-tocopherol, and risk of malignant melanoma. Am.J.Epidemiol. 1990;131:597-611. View abstract.
  117. Farina, N., Isaac, M. G., Clark, A. R., Rusted, J., and Tabet, N. Vitamin E for Alzheimer's dementia and mild cognitive impairment. Cochrane.Database.Syst.Rev. 2012;11:CD002854. View abstract.
  118. Smits-Engelsman, B. C., Blank, R., van der Kaay, A. C., Mosterd-van der Meijs, R., Vlugt-van den Brand, E., Polatajko, H. J., and Wilson, P. H. Efficacy of interventions to improve motor performance in children with developmental coordination disorder: a combined systematic review and meta-analysis. Dev.Med.Child Neurol. 2013;55:229-237. View abstract.
  119. Jun, M., Venkataraman, V., Razavian, M., Cooper, B., Zoungas, S., Ninomiya, T., Webster, A. C., and Perkovic, V. Antioxidants for chronic kidney disease. Cochrane.Database.Syst.Rev. 2012;10:CD008176. View abstract.
  120. Vajro, P., Lenta, S., Pignata, C., Salerno, M., D'Aniello, R., De, Micco, I, Paolella, G., and Parenti, G. Therapeutic options in pediatric non alcoholic fatty liver disease: current status and future directions. Ital.J.Pediatr. 2012;38:55. View abstract.
  121. Wong, R. S. and Radhakrishnan, A. K. Tocotrienol research: past into present. Nutr.Rev. 2012;70:483-490. View abstract.
  122. Vardi, M., Blum, S., and Levy, A. P. Haptoglobin genotype and cardiovascular outcomes in diabetes mellitus - natural history of the disease and the effect of vitamin E treatment. Meta-analysis of the medical literature. Eur.J.Intern.Med. 2012;23:628-632. View abstract.
  123. Mahady, S. E., Wong, G., Craig, J. C., and George, J. Pioglitazone and vitamin E for nonalcoholic steatohepatitis: a cost utility analysis. Hepatology 2012;56:2172-2179. View abstract.
  124. Hatzimouratidis, K., Eardley, I., Giuliano, F., Hatzichristou, D., Moncada, I., Salonia, A., Vardi, Y., and Wespes, E. EAU guidelines on penile curvature. Eur.Urol. 2012;62:543-552. View abstract.
  125. Chalasani, N., Younossi, Z., Lavine, J. E., Diehl, A. M., Brunt, E. M., Cusi, K., Charlton, M., and Sanyal, A. J. The diagnosis and management of non-alcoholic fatty liver disease: Practice guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association. Am.J.Gastroenterol. 2012;107:811-826. View abstract.
  126. Jensen, M., Lindholm, A., and Hakkarainen, J. The vitamin E distribution in serum, liver, adipose and muscle tissues in the pig during depletion and repletion. Acta Vet.Scand. 1990;31:129-136. View abstract.
  127. Patel, C. J., Cullen, M. R., Ioannidis, J. P., and Butte, A. J. Systematic evaluation of environmental factors: persistent pollutants and nutrients correlated with serum lipid levels. Int.J.Epidemiol. 2012;41:828-843. View abstract.
  128. Musso, G., Cassader, M., Rosina, F., and Gambino, R. Impact of current treatments on liver disease, glucose metabolism and cardiovascular risk in non-alcoholic fatty liver disease (NAFLD): a systematic review and meta-analysis of randomised trials. Diabetologia 2012;55:885-904. View abstract.
  129. Nakayama, A., Alladin, K. P., Igbokwe, O., and White, J. D. Systematic review: generating evidence-based guidelines on the concurrent use of dietary antioxidants and chemotherapy or radiotherapy. Cancer Invest 2011;29:655-667. View abstract.
  130. Shyangdan, D., Clar, C., Ghouri, N., Henderson, R., Gurung, T., Preiss, D., Sattar, N., Fraser, A., and Waugh, N. Insulin sensitisers in the treatment of non-alcoholic fatty liver disease: a systematic review. Health Technol.Assess. 2011;15:1-110. View abstract.
  131. Macdonald, L. E., Brett, J., Kelton, D., Majowicz, S. E., Snedeker, K., and Sargeant, J. M. A systematic review and meta-analysis of the effects of pasteurization on milk vitamins, and evidence for raw milk consumption and other health-related outcomes. J.Food Prot. 2011;74:1814-1832. View abstract.
  132. Major, J. M., Yu, K., Wheeler, W., Zhang, H., Cornelis, M. C., Wright, M. E., Yeager, M., Snyder, K., Weinstein, S. J., Mondul, A., Eliassen, H., Purdue, M., Hazra, A., McCarty, C. A., Hendrickson, S., Virtamo, J., Hunter, D., Chanock, S., Kraft, P., and Albanes, D. Genome-wide association study identifies common variants associated with circulating vitamin E levels. Hum.Mol.Genet. 10-1-2011;20:3876-3883. View abstract.
  133. Chin, S. F., Ibahim, J., Makpol, S., Abdul Hamid, N. A., Abdul, Latiff A., Zakaria, Z., Mazlan, M., Mohd Yusof, Y. A., Abdul, Karim A., and Wan Ngah, W. Z. Tocotrienol Rich Fraction Supplementation Improved Lipid Profile and Oxidative Status in Healthy Older Adults: A Randomized Controlled Study. Nutr.Metab (Lond) 6-24-2011;8:42. View abstract.
  134. Winslow, B. T., Onysko, M. K., Stob, C. M., and Hazlewood, K. A. Treatment of Alzheimer disease. Am.Fam.Physician 6-15-2011;83:1403-1412. View abstract.
  135. Lavine, J. E., Schwimmer, J. B., Van Natta, M. L., Molleston, J. P., Murray, K. F., Rosenthal, P., Abrams, S. H., Scheimann, A. O., Sanyal, A. J., Chalasani, N., Tonascia, J., Unalp, A., Clark, J. M., Brunt, E. M., Kleiner, D. E., Hoofnagle, J. H., and Robuck, P. R. Effect of vitamin E or metformin for treatment of nonalcoholic fatty liver disease in children and adolescents: the TONIC randomized controlled trial. JAMA 4-27-2011;305:1659-1668. View abstract.
  136. Jilani, T. and Iqbal, M. P. Does vitamin E have a role in treatment and prevention of anemia? Pak.J.Pharm.Sci. 2011;24:237-242. View abstract.
  137. Lichtenberg, D. [Who is likely to gain from high dose supplementation of vitamin E?]. Harefuah 2011;150:37-40, 68. View abstract.
  138. Gray, B., Swick, J., and Ronnenberg, A. G. Vitamin E and adiponectin: proposed mechanism for vitamin E-induced improvement in insulin sensitivity. Nutr.Rev. 2011;69:155-161. View abstract.
  139. Wang, H., O'Reilly, E. J., Weisskopf, M. G., Logroscino, G., McCullough, M. L., Schatzkin, A., Kolonel, L. N., and Ascherio, A. Vitamin E intake and risk of amyotrophic lateral sclerosis: a pooled analysis of data from 5 prospective cohort studies. Am.J.Epidemiol. 3-15-2011;173:595-602. View abstract.
  140. Albers, J. W., Chaudhry, V., Cavaletti, G., and Donehower, R. C. Interventions for preventing neuropathy caused by cisplatin and related compounds. Cochrane.Database.Syst.Rev. 2011;:CD005228. View abstract.
  141. Soares-Weiser, K., Maayan, N., and McGrath, J. Vitamin E for neuroleptic-induced tardive dyskinesia. Cochrane.Database.Syst.Rev. 2011;:CD000209. View abstract.
  142. Bin, Q., Hu, X., Cao, Y., and Gao, F. The role of vitamin E (tocopherol) supplementation in the prevention of stroke. A meta-analysis of 13 randomised controlled trials. Thromb.Haemost. 2011;105:579-585. View abstract.
  143. Abner, E. L., Schmitt, F. A., Mendiondo, M. S., Marcum, J. L., and Kryscio, R. J. Vitamin E and All-cause Mortality: A Meta-Analysis. Curr.Aging Sci. 1-14-2011; View abstract.
  144. Wang, Q., Sun, Y., Ma, A., Li, Y., Han, X., and Liang, H. Effects of vitamin E on plasma lipid status and oxidative stress in Chinese women with metabolic syndrome. Int.J.Vitam.Nutr.Res. 2010;80:178-187. View abstract.
  145. Suksomboon, N., Poolsup, N., and Sinprasert, S. Effects of vitamin E supplementation on glycaemic control in type 2 diabetes: systematic review of randomized controlled trials. J.Clin.Pharm.Ther. 2011;36:53-63. View abstract.
  146. Trefan, L., Bunger, L., Bloom-Hansen, J., Rooke, J. A., Salmi, B., Larzul, C., Terlouw, C., and Doeschl-Wilson, A. Meta-analysis of the effects of dietary vitamin E supplementation on alpha-tocopherol concentration and lipid oxidation in pork. Meat.Sci. 2011;87:305-314. View abstract.
  147. O'Brien, J. T. and Burns, A. Clinical practice with anti-dementia drugs: a revised (second) consensus statement from the British Association for Psychopharmacology. J Psychopharmacol. 2011;25:997-1019. View abstract.
  148. Christen, W. G., Glynn, R. J., Sesso, H. D., Kurth, T., MacFadyen, J., Bubes, V., Buring, J. E., Manson, J. E., and Gaziano, J. M. Age-related cataract in a randomized trial of vitamins E and C in men. Arch.Ophthalmol. 2010;128:1397-1405. View abstract.
  149. Cario, W. R. [The use of vitamin E in childhood]. Kinderarztl.Prax. 1990;58:511-517. View abstract.
  150. Song, Y., Xu, Q., Park, Y., Hollenbeck, A., Schatzkin, A., and Chen, H. Multivitamins, individual vitamin and mineral supplements, and risk of diabetes among older U.S. adults. Diabetes Care 2011;34:108-114. View abstract.
  151. Greenough, A., Shaheen, S. O., Shennan, A., Seed, P. T., and Poston, L. Respiratory outcomes in early childhood following antenatal vitamin C and E supplementation. Thorax 2010;65:998-1003. View abstract.
  152. Traber, M. G., Leonard, S. W., Traber, D. L., Traber, L. D., Gallagher, J., Bobe, G., Jeschke, M. G., Finnerty, C. C., and Herndon, D. alpha-Tocopherol adipose tissue stores are depleted after burn injury in pediatric patients. Am.J.Clin.Nutr. 2010;92:1378-1384. View abstract.
  153. Gridley, G., McLaughlin, J. K., Block, G., Blot, W. J., Winn, D. M., Greenberg, R. S., Schoenberg, J. B., Preston-Martin, S., Austin, D. F., and Fraumeni, J. F., Jr. Diet and oral and pharyngeal cancer among blacks. Nutr.Cancer 1990;14(3-4):219-225. View abstract.
  154. Geldmacher, D. S., Fritsch, T., McClendon, M. J., and Landreth, G. A randomized pilot clinical trial of the safety of pioglitazone in treatment of patients with Alzheimer disease. Arch.Neurol. 2011;68:45-50. View abstract.
  155. Manny, T., Pettus, J., Hemal, A., Marks, M., and Mirzazadeh, M. Penile sclerosing lipogranulomas and disfigurement from use of "1Super Extenze" among Laotian immigrants. J.Sex Med. 2011;8:3505-3510. View abstract.
  156. Diafouka, F. and Gbassi, G. K. Deficiency of alpha-tocopherol in seminal fluid as a probable factor in low fertility in Cote d'Ivoire. Afr.J.Reprod.Health 2009;13:123-125. View abstract.
  157. Bakkeheim, E., Mowinckel, P., Carlsen, K. H., Burney, P., and Carlsen, K. C. Altered oxidative state in schoolchildren with asthma and allergic rhinitis. Pediatr.Allergy Immunol. 2011;22:178-185. View abstract.
  158. Li, S. C., Liu, Y. H., Liu, J. F., Chang, W. H., Chen, C. M., and Chen, C. Y. Almond consumption improved glycemic control and lipid profiles in patients with type 2 diabetes mellitus. Metabolism 2011;60:474-479. View abstract.
  159. Miyake, Y., Fukushima, W., Tanaka, K., Sasaki, S., Kiyohara, C., Tsuboi, Y., Yamada, T., Oeda, T., Miki, T., Kawamura, N., Sakae, N., Fukuyama, H., Hirota, Y., and Nagai, M. Dietary intake of antioxidant vitamins and risk of Parkinson's disease: a case-control study in Japan. Eur.J.Neurol. 2011;18:106-113. View abstract.
  160. Cortes-Gonzalez, J. R. and Glina, S. [Conservative treatment of Peyronie's disease: colchicine vs. colchicine plus vitamin E]. Actas Urol.Esp. 2010;34:444-449. View abstract.
  161. Di, Donato, I, Bianchi, S., and Federico, A. Ataxia with vitamin E deficiency: update of molecular diagnosis. Neurol.Sci. 2010;31:511-515. View abstract.
  162. Neupane, B., Walter, S. D., Krueger, P., Marrie, T., and Loeb, M. Predictors of inhospital mortality and re-hospitalization in older adults with community-acquired pneumonia: a prospective cohort study. BMC.Geriatr. 2010;10:22. View abstract.
  163. Okuda, M., Bando, N., Terao, J., Sasaki, S., Sugiyama, S., Kunitsugu, I., and Hobara, T. Association of serum carotenoids and tocopherols with atopic diseases in Japanese children and adolescents. Pediatr.Allergy Immunol. 2010;21(4 Pt 2):e705-e710. View abstract.
  164. Blum, S., Vardi, M., Brown, J. B., Russell, A., Milman, U., Shapira, C., Levy, N. S., Miller-Lotan, R., Asleh, R., and Levy, A. P. Vitamin E reduces cardiovascular disease in individuals with diabetes mellitus and the haptoglobin 2-2 genotype. Pharmacogenomics. 2010;11:675-684. View abstract.
  165. Buiatti, E., Palli, D., Bianchi, S., Decarli, A., Amadori, D., Avellini, C., Cipriani, F., Cocco, P., Giacosa, A., Lorenzini, L., and . A case-control study of gastric cancer and diet in Italy. III. Risk patterns by histologic type. Int.J.Cancer 5-30-1991;48:369-374. View abstract.
  166. Cordero, Z., Drogan, D., Weikert, C., and Boeing, H. Vitamin E and risk of cardiovascular diseases: a review of epidemiologic and clinical trial studies. Crit Rev.Food Sci.Nutr. 2010;50:420-440. View abstract.
  167. Blum, S., Vardi, M., Levy, N. S., Miller-Lotan, R., and Levy, A. P. The effect of vitamin E supplementation on cardiovascular risk in diabetic individuals with different haptoglobin phenotypes. Atherosclerosis 2010;211:25-27. View abstract.
  168. Christen, W. G., Glynn, R. J., Chew, E. Y., and Buring, J. E. Vitamin E and age-related macular degeneration in a randomized trial of women. Ophthalmology 2010;117:1163-1168. View abstract.
  169. Moyad, M. A. Conventional and alternative medical advice for cold and flu prevention: what should be recommended and what should be avoided? Urol.Nurs. 2009;29:455-458. View abstract.
  170. Capuron, L., Moranis, A., Combe, N., Cousson-Gelie, F., Fuchs, D., De Smedt-Peyrusse, V., Barberger-Gateau, P., and Laye, S. Vitamin E status and quality of life in the elderly: influence of inflammatory processes. Br.J.Nutr. 2009;102:1390-1394. View abstract.
  171. Haflah, N. H., Jaarin, K., Abdullah, S., and Omar, M. Palm vitamin E and glucosamine sulphate in the treatment of osteoarthritis of the knee. Saudi.Med J 2009;30:1432-1438. View abstract.
  172. Westergren, T. and Kalikstad, B. Dosage and formulation issues: oral vitamin E therapy in children. Eur.J.Clin.Pharmacol. 2010;66:109-118. View abstract.
  173. Elkashef, A. M., Ruskin, P. E., Bacher, N., and Barrett, D. Vitamin E in the treatment of tardive dyskinesia. Am.J.Psychiatry 1990;147:505-506. View abstract.
  174. Lloret, A., Badia, M. C., Mora, N. J., Pallardo, F. V., Alonso, M. D., and Vina, J. Vitamin E paradox in Alzheimer's disease: it does not prevent loss of cognition and may even be detrimental. J.Alzheimers.Dis. 2009;17:143-149. View abstract.
  175. Saremi, A. and Arora, R. Vitamin E and cardiovascular disease. Am.J.Ther. 2010;17:e56-e65. View abstract.
  176. Biglia, N., Sgandurra, P., Peano, E., Marenco, D., Moggio, G., Bounous, V., Tomasi, Cont N., Ponzone, R., and Sismondi, P. Non-hormonal treatment of hot flushes in breast cancer survivors: gabapentin vs. vitamin E. Climacteric. 2009;12:310-318. View abstract.
  177. Wagner, J. G., Harkema, J. R., Jiang, Q., Illek, B., Ames, B. N., and Peden, D. B. Gamma-tocopherol attenuates ozone-induced exacerbation of allergic rhinosinusitis in rats. Toxicol.Pathol. 2009;37:481-491. View abstract.
  178. Arnon, S., Regev, R. H., Bauer, S., Shainkin-Kestenbaum, R., Shiff, Y., Bental, Y., Dolfin, T., and Litmanovitz, I. Vitamin E levels during early iron supplementation in preterm infants. Am.J.Perinatol. 2009;26:387-392. View abstract.
  179. Berry, D., Wathen, J. K., and Newell, M. Bayesian model averaging in meta-analysis: vitamin E supplementation and mortality. Clin.Trials 2009;6:28-41. View abstract.
  180. Okamoto, K., Kihira, T., Kobashi, G., Washio, M., Sasaki, S., Yokoyama, T., Miyake, Y., Sakamoto, N., Inaba, Y., and Nagai, M. Fruit and vegetable intake and risk of amyotrophic lateral sclerosis in Japan. Neuroepidemiology 2009;32:251-256. View abstract.
  181. Vats, P., Singh, V. K., Singh, S. N., and Singh, S. B. Glutathione metabolism under high-altitude stress and effect of antioxidant supplementation. Aviat.Space Environ.Med. 2008;79:1106-1111. View abstract.
  182. Kamat, C. D., Gadal, S., Mhatre, M., Williamson, K. S., Pye, Q. N., and Hensley, K. Antioxidants in central nervous system diseases: preclinical promise and translational challenges. J.Alzheimers.Dis. 2008;15:473-493. View abstract.
  183. Karlson, E. W., Shadick, N. A., Cook, N. R., Buring, J. E., and Lee, I. M. Vitamin E in the primary prevention of rheumatoid arthritis: the Women's Health Study. Arthritis Rheum. 11-15-2008;59:1589-1595. View abstract.
  184. Sultana, N., Begum, N., Akhter, S., Begum, S., Quraishi, S. B., Ferdousi, S., and Ali, T. Role of vitamin E supplementation on serum levels of copper and zinc in hemolytic anemic patients with G6PD deficiency. Mymensingh.Med.J. 2008;17(2 Suppl):S84-S90. View abstract.
  185. Absorption of intramuscular vitamin E in premature babies. Italian Collaborative Group on Preterm Delivery. Dev.Pharmacol.Ther. 1991;16:13-21. View abstract.
  186. Clarke, M. W., Burnett, J. R., and Croft, K. D. Vitamin E in human health and disease. Crit Rev.Clin.Lab Sci. 2008;45:417-450. View abstract.
  187. Isaac, M. G., Quinn, R., and Tabet, N. Vitamin E for Alzheimer's disease and mild cognitive impairment. Cochrane.Database.Syst.Rev. 2008;:CD002854. View abstract.
  188. Nobili, V., Manco, M., Devito, R., Di, Ciommo, V, Comparcola, D., Sartorelli, M. R., Piemonte, F., Marcellini, M., and Angulo, P. Lifestyle intervention and antioxidant therapy in children with nonalcoholic fatty liver disease: a randomized, controlled trial. Hepatology 2008;48:119-128. View abstract.
  189. Antoniadi, G., Eleftheriadis, T., Liakopoulos, V., Kakasi, E., Kartsios, C., Passadakis, P., and Vargemezis, V. Effect of one-year oral alpha-tocopherol administration on the antioxidant defense system in hemodialysis patients. Ther.Apher.Dial. 2008;12:237-242. View abstract.
  190. Hamdy, N. M., Suwailem, S. M., and El-Mesallamy, H. O. Influence of vitamin E supplementation on endothelial complications in type 2 diabetes mellitus patients who underwent coronary artery bypass graft. J.Diabetes Complications 2009;23:167-173. View abstract.
  191. Green, D., Chambers, M. E., and Sugden, D. A. Does subtype of developmental coordination disorder count: is there a differential effect on outcome following intervention? Hum.Mov Sci. 2008;27:363-382. View abstract.
  192. Wang, C. L., Liang, L., Fu, J. F., Zou, C. C., Hong, F., Xue, J. Z., Lu, J. R., and Wu, X. M. Effect of lifestyle intervention on non-alcoholic fatty liver disease in Chinese obese children. World J.Gastroenterol. 3-14-2008;14:1598-1602. View abstract.
  193. Jilani, T., Moiz, B., and Iqbal, M. P. Vitamin E supplementation enhances hemoglobin and erythropoietin levels in mildly anemic adults. Acta Haematol. 2008;119:45-47. View abstract.
  194. Christen, W. G., Liu, S., Glynn, R. J., Gaziano, J. M., and Buring, J. E. Dietary carotenoids, vitamins C and E, and risk of cataract in women: a prospective study. Arch.Ophthalmol. 2008;126:102-109. View abstract.
  195. BODY, A. M., RATCLIFFE, A. H., and . Intermittent claudication; a clinical study. J.Bone Joint Surg.Br. 1949;31B:325-355. View abstract.
  196. Alkhenizan, A. and Hafez, K. The role of vitamin E in the prevention of cancer: a meta-analysis of randomized controlled trials. Ann.Saudi.Med. 2007;27:409-414. View abstract.
  197. Kunitomo, M. [Oxidative stress and atherosclerosis]. Yakugaku Zasshi 2007;127:1997-2014. View abstract.
  198. Milman, U., Blum, S., Shapira, C., Aronson, D., Miller-Lotan, R., Anbinder, Y., Alshiek, J., Bennett, L., Kostenko, M., Landau, M., Keidar, S., Levy, Y., Khemlin, A., Radan, A., and Levy, A. P. Vitamin E supplementation reduces cardiovascular events in a subgroup of middle-aged individuals with both type 2 diabetes mellitus and the haptoglobin 2-2 genotype: a prospective double-blinded clinical trial. Arterioscler.Thromb.Vasc.Biol. 2008;28:341-347. View abstract.
  199. Devaraj, S., Tang, R., Adams-Huet, B., Harris, A., Seenivasan, T., de Lemos, J. A., and Jialal, I. Effect of high-dose alpha-tocopherol supplementation on biomarkers of oxidative stress and inflammation and carotid atherosclerosis in patients with coronary artery disease. Am.J.Clin.Nutr. 2007;86:1392-1398. View abstract.
  200. Wagner, J. G., Jiang, Q., Harkema, J. R., Ames, B. N., Illek, B., Roubey, R. A., and Peden, D. B. Gamma-tocopherol prevents airway eosinophilia and mucous cell hyperplasia in experimentally induced allergic rhinitis and asthma. Clin.Exp.Allergy 2008;38:501-511. View abstract.
  201. Vignini, A., Nanetti, L., Moroni, C., Testa, R., Sirolla, C., Marra, M., Manfrini, S., Fumelli, D., Marcheselli, F., Mazzanti, L., and Rabini, R. A. A study on the action of vitamin E supplementation on plasminogen activator inhibitor type 1 and platelet nitric oxide production in type 2 diabetic patients. Nutr.Metab Cardiovasc.Dis. 2008;18:15-22. View abstract.
  202. Misirlioglu, C. H., Demirkasimoglu, T., Kucukplakci, B., Sanri, E., and Altundag, K. Pentoxifylline and alpha-tocopherol in prevention of radiation-induced lung toxicity in patients with lung cancer. Med.Oncol. 2007;24:308-311. View abstract.
  203. Hance, K. W., Rogers, C. J., Hursting, S. D., and Greiner, J. W. Combination of physical activity, nutrition, or other metabolic factors and vaccine response. Front Biosci. 2007;12:4997-5029. View abstract.
  204. Sung, L., Tomlinson, G. A., Greenberg, M. L., Koren, G., Judd, P., Ota, S., and Feldman, B. M. Serial controlled N-of-1 trials of topical vitamin E as prophylaxis for chemotherapy-induced oral mucositis in paediatric patients. Eur.J.Cancer 2007;43:1269-1275. View abstract.
  205. Christen, W. G., Manson, J. E., Glynn, R. J., Gaziano, J. M., Chew, E. Y., Buring, J. E., and Hennekens, C. H. Beta carotene supplementation and age-related maculopathy in a randomized trial of US physicians. Arch.Ophthalmol. 2007;125:333-339. View abstract.
  206. Ricciarelli, R., Argellati, F., Pronzato, M. A., and Domenicotti, C. Vitamin E and neurodegenerative diseases. Mol.Aspects Med. 2007;28(5-6):591-606. View abstract.
  207. Catalano, M., Born, G., and Peto, R. Prevention of serious vascular events by aspirin amongst patients with peripheral arterial disease: randomized, double-blind trial. J.Intern.Med. 2007;261:276-284. View abstract.
  208. Ito, Y., Suzuki, K., Ishii, J., Hishida, H., Tamakoshi, A., Hamajima, N., and Aoki, K. A population-based follow-up study on mortality from cancer or cardiovascular disease and serum carotenoids, retinol and tocopherols in Japanese inhabitants. Asian Pac.J.Cancer Prev. 2006;7:533-546. View abstract.
  209. Nobili, V., Manco, M., Devito, R., Ciampalini, P., Piemonte, F., and Marcellini, M. Effect of vitamin E on aminotransferase levels and insulin resistance in children with non-alcoholic fatty liver disease. Aliment.Pharmacol.Ther. 2006;24(11-12):1553-1561. View abstract.
  210. Dufour, J. F., Oneta, C. M., Gonvers, J. J., Bihl, F., Cerny, A., Cereda, J. M., Zala, J. F., Helbling, B., Steuerwald, M., and Zimmermann, A. Randomized placebo-controlled trial of ursodeoxycholic acid with vitamin e in nonalcoholic steatohepatitis. Clin.Gastroenterol.Hepatol. 2006;4:1537-1543. View abstract.
  211. Kang, J. H., Cook, N., Manson, J., Buring, J. E., and Grodstein, F. A randomized trial of vitamin E supplementation and cognitive function in women. Arch.Intern.Med. 12-11-2006;166:2462-2468. View abstract.
  212. Clifford, A. J., de Moura, F. F., Ho, C. C., Chuang, J. C., Follett, J., Fadel, J. G., and Novotny, J. A. A feasibility study quantifying in vivo human alpha-tocopherol metabolism. Am.J.Clin.Nutr. 2006;84:1430-1441. View abstract.
  213. Belfort, R., Harrison, S. A., Brown, K., Darland, C., Finch, J., Hardies, J., Balas, B., Gastaldelli, A., Tio, F., Pulcini, J., Berria, R., Ma, J. Z., Dwivedi, S., Havranek, R., Fincke, C., DeFronzo, R., Bannayan, G. A., Schenker, S., and Cusi, K. A placebo-controlled trial of pioglitazone in subjects with nonalcoholic steatohepatitis. N.Engl.J.Med. 11-30-2006;355:2297-2307. View abstract.
  214. Woollard, K. J., Rayment, S. J., Bevan, R., Shaw, J. A., Lunec, J., and Griffiths, H. R. Alpha-tocopherol supplementation does not affect monocyte endothelial adhesion or C-reactive protein levels but reduces soluble vascular adhesion molecule-1 in the plasma of healthy subjects. Redox.Rep. 2006;11:214-222. View abstract.
  215. Wolvers, D. A., van Herpen-Broekmans, W. M., Logman, M. H., van der Wielen, R. P., and Albers, R. Effect of a mixture of micronutrients, but not of bovine colostrum concentrate, on immune function parameters in healthy volunteers: a randomized placebo-controlled study. Nutr.J. 2006;5:28. View abstract.
  216. Wright, M. E., Lawson, K. A., Weinstein, S. J., Pietinen, P., Taylor, P. R., Virtamo, J., and Albanes, D. Higher baseline serum concentrations of vitamin E are associated with lower total and cause-specific mortality in the Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study. Am.J.Clin.Nutr. 2006;84:1200-1207. View abstract.
  217. Siekmeier, R., Steffen, C., and Marz, W. [Can antioxidants prevent atherosclerosis?]. Bundesgesundheitsblatt.Gesundheitsforschung.Gesundheitsschutz. 2006;49:1034-1049. View abstract.
  218. Robinson, I., de Serna, D. G., Gutierrez, A., and Schade, D. S. Vitamin E in humans: an explanation of clinical trial failure. Endocr.Pract. 2006;12:576-582. View abstract.
  219. Chande, N., Laidlaw, M., Adams, P., and Marotta, P. Yo Jyo Hen Shi Ko (YHK) improves transaminases in nonalcoholic steatohepatitis (NASH): a randomized pilot study. Dig Dis Sci 2006;51:1183-1189. View abstract.
  220. Magliano, D., McNeil, J., Branley, P., Shiel, L., Demos, L., Wolfe, R., Kotsopoulos, D., and McGrath, B. The Melbourne Atherosclerosis Vitamin E Trial (MAVET): a study of high dose vitamin E in smokers. Eur.J.Cardiovasc.Prev.Rehabil. 2006;13:341-347. View abstract.
  221. Bairati, I., Meyer, F., Jobin, E., Gelinas, M., Fortin, A., Nabid, A., Brochet, F., and Tetu, B. Antioxidant vitamins supplementation and mortality: a randomized trial in head and neck cancer patients. Int.J.Cancer 11-1-2006;119:2221-2224. View abstract.
  222. Read, R. W. Uveitis: advances in understanding of pathogenesis and treatment. Curr.Rheumatol.Rep. 2006;8:260-266. View abstract.
  223. Rimm, E. B., Giovannucci, E. L., Willett, W. C., Colditz, G. A., Ascherio, A., Rosner, B., and Stampfer, M. J. Prospective study of alcohol consumption and risk of coronary disease in men. Lancet 8-24-1991;338:464-468. View abstract.
  224. Wolfrath, S. C., Borenstein, A. R., Schwartz, S., Hauser, R. A., Sullivan, K. L., and Zesiewicz, T. A. Use of nutritional supplements in Parkinson's disease patients. Mov Disord. 2006;21:1098-1101. View abstract.
  225. Zelber-Sagi, S., Kessler, A., Brazowsky, E., Webb, M., Lurie, Y., Santo, M., Leshno, M., Blendis, L., Halpern, Z., and Oren, R. A double-blind randomized placebo-controlled trial of orlistat for the treatment of nonalcoholic fatty liver disease. Clin.Gastroenterol.Hepatol. 2006;4:639-644. View abstract.
  226. Argyriou, A. A., Chroni, E., Koutras, A., Iconomou, G., Papapetropoulos, S., Polychronopoulos, P., and Kalofonos, H. P. A randomized controlled trial evaluating the efficacy and safety of vitamin E supplementation for protection against cisplatin-induced peripheral neuropathy: final results. Support.Care Cancer 2006;14:1134-1140. View abstract.
  227. Murakami, Y., Nagai, A., Kawakami, T., Hino, K., Kitase, A., Hara, Y., Okuda, M., Okita, K., and Okita, M. Vitamin E and C supplementation prevents decrease of eicosapentaenoic acid in mononuclear cells in chronic hepatitis C patients during combination therapy of interferon alpha-2b and ribavirin. Nutrition 2006;22:114-122. View abstract.
  228. Montano Velazquez, B. B., Jauregui-Renaud, K., Banuelos Arias, Adel C., Ayala, J. C., Martinez, M. D., Campillo, Navarrete R., Rosalia, I. S., Salazar, Mdel R., Serrano, H. A., Mondragon, A. O., and Perez, R. L. Vitamin E effects on nasal symptoms and serum specific IgE levels in patients with perennial allergic rhinitis. Ann.Allergy Asthma Immunol. 2006;96:45-50. View abstract.
  229. Mas, E., Dupuy, A. M., Artero, S., Portet, F., Cristol, J. P., Ritchie, K., and Touchon, J. Functional Vitamin E deficiency in ApoE4 patients with Alzheimer's disease. Dement.Geriatr.Cogn Disord. 2006;21:198-204. View abstract.
  230. Nussenblatt, R. B., Kim, J., Thompson, D. J., Davis, M. D., Chew, E., Ferris, F. L., and Buggage, R. Vitamin E in the treatment of uveitis-associated macular edema. Am.J.Ophthalmol. 2006;141:193-194. View abstract.
  231. Edwards, T. Inflammation, pain, and chronic disease: an integrative approach to treatment and prevention. Altern.Ther.Health Med. 2005;11:20-27. View abstract.
  232. Pham, D. Q. and Plakogiannis, R. Vitamin E supplementation in Alzheimer's disease, Parkinson's disease, tardive dyskinesia, and cataract: Part 2. Ann.Pharmacother. 2005;39:2065-2072. View abstract.
  233. Ersoz, G., Gunsar, F., Karasu, Z., Akay, S., Batur, Y., and Akarca, U. S. Management of fatty liver disease with vitamin E and C compared to ursodeoxycholic acid treatment. Turk.J.Gastroenterol. 2005;16:124-128. View abstract.
  234. Buijsse, B., Feskens, E. J., Schlettwein-Gsell, D., Ferry, M., Kok, F. J., Kromhout, D., and de Groot, L. C. Plasma carotene and alpha-tocopherol in relation to 10-y all-cause and cause-specific mortality in European elderly: the Survey in Europe on Nutrition and the Elderly, a Concerted Action (SENECA). Am.J.Clin.Nutr. 2005;82:879-886. View abstract.
  235. Pham, D. Q. and Plakogiannis, R. Vitamin E supplementation in cardiovascular disease and cancer prevention: Part 1. Ann.Pharmacother. 2005;39:1870-1878. View abstract.
  236. Baliarsingh, S., Beg, Z. H., and Ahmad, J. The therapeutic impacts of tocotrienols in type 2 diabetic patients with hyperlipidemia. Atherosclerosis 2005;182:367-374. View abstract.
  237. Marras, C., Lang, A. E., Oakes, D., McDermott, M. P., Kieburtz, K., Shoulson, I., Tanner, C. M., and Fahn, S. High-dosage vitamin E supplementation and all-cause mortality. Ann.Intern.Med. 7-19-2005;143:152-153. View abstract.
  238. Ford, E. S., Ajani, U. A., and Mokdad, A. H. Brief communication: The prevalence of high intake of vitamin E from the use of supplements among U.S. adults. Ann.Intern.Med. 7-19-2005;143:116-120. View abstract.
  239. Bairati, I., Meyer, F., Gelinas, M., Fortin, A., Nabid, A., Brochet, F., Mercier, J. P., Tetu, B., Harel, F., Abdous, B., Vigneault, E., Vass, S., del, Vecchio P., and Roy, J. Randomized trial of antioxidant vitamins to prevent acute adverse effects of radiation therapy in head and neck cancer patients. J.Clin.Oncol. 8-20-2005;23:5805-5813. View abstract.
  240. Spivak, B., Schwartz, B., Radwan, M., and Weizman, A. alpha-Tocopherol treatment for tardive dyskinesia. J.Nerv.Ment.Dis. 1992;180:400-401. View abstract.
  241. Bugianesi, E., Gentilcore, E., Manini, R., Natale, S., Vanni, E., Villanova, N., David, E., Rizzetto, M., and Marchesini, G. A randomized controlled trial of metformin versus vitamin E or prescriptive diet in nonalcoholic fatty liver disease. Am.J.Gastroenterol. 2005;100:1082-1090. View abstract.
  242. Wadleigh, R. G., Redman, R. S., Graham, M. L., Krasnow, S. H., Anderson, A., and Cohen, M. H. Vitamin E in the treatment of chemotherapy-induced mucositis. Am.J.Med. 1992;92:481-484. View abstract.
  243. Meydani, S. N., Han, S. N., and Hamer, D. H. Vitamin E and respiratory infection in the elderly. Ann.N.Y.Acad.Sci. 2004;1031:214-222. View abstract.
  244. Wolf, G. The discovery of the antioxidant function of vitamin E: the contribution of Henry A. Mattill. J.Nutr. 2005;135:363-366. View abstract.
  245. Argyriou, A. A., Chroni, E., Koutras, A., Ellul, J., Papapetropoulos, S., Katsoulas, G., Iconomou, G., and Kalofonos, H. P. Vitamin E for prophylaxis against chemotherapy-induced neuropathy: a randomized controlled trial. Neurology 1-11-2005;64:26-31. View abstract.
  246. Sanyal, A. J., Mofrad, P. S., Contos, M. J., Sargeant, C., Luketic, V. A., Sterling, R. K., Stravitz, R. T., Shiffman, M. L., Clore, J., and Mills, A. S. A pilot study of vitamin E versus vitamin E and pioglitazone for the treatment of nonalcoholic steatohepatitis. Clin.Gastroenterol.Hepatol. 2004;2:1107-1115. View abstract.
  247. Rajasekhar, D., Srinivasa Rao, P. V., Latheef, S. A., Saibaba, K. S., and Subramanyam, G. Association of serum antioxidants and risk of coronary heart disease in South Indian population. Indian J.Med.Sci. 2004;58:465-471. View abstract.
  248. Jeanes, Y. M., Hall, W. L., Ellard, S., Lee, E., and Lodge, J. K. The absorption of vitamin E is influenced by the amount of fat in a meal and the food matrix. Br.J.Nutr. 2004;92:575-579. View abstract.
  249. Levy, A. P., Gerstein, H. C., Miller-Lotan, R., Ratner, R., McQueen, M., Lonn, E., and Pogue, J. The effect of vitamin E supplementation on cardiovascular risk in diabetic individuals with different haptoglobin phenotypes. Diabetes Care 2004;27:2767. View abstract.
  250. Schneider, M., Verges, B., Klein, A., Miller, E. R., Deckert, V., Desrumaux, C., Masson, D., Gambert, P., Brun, J. M., Fruchart-Najib, J., Blache, D., Witztum, J. L., and Lagrost, L. Alterations in plasma vitamin E distribution in type 2 diabetic patients with elevated plasma phospholipid transfer protein activity. Diabetes 2004;53:2633-2639. View abstract.
  251. Simon-Schnass, I. M. Nutrition at high altitude. J.Nutr. 1992;122(3 Suppl):778-781. View abstract.
  252. RATCLIFFE, A. H. Vitamin E in intermittent claudication. Lancet 12-17-1949;2:1128-1130. View abstract.
  253. Longnecker, M. P., Martin-Moreno, J. M., Knekt, P., Nomura, A. M., Schober, S. E., Stahelin, H. B., Wald, N. J., Gey, K. F., and Willett, W. C. Serum alpha-tocopherol concentration in relation to subsequent colorectal cancer: pooled data from five cohorts. J.Natl.Cancer Inst. 3-18-1992;84:430-435. View abstract.
  254. Rigalleau, V., Barbe, M., Garuz, F., Baillet-Blanco, L., Beauvieux, M. C., and Gin, H. Nutritional factors and diabetic foot: a role for vitamin E? Diabet.Med. 2004;21:951-952. View abstract.
  255. Shahar, E., Hassoun, G., and Pollack, S. Effect of vitamin E supplementation on the regular treatment of seasonal allergic rhinitis. Ann.Allergy Asthma Immunol. 2004;92:654-658. View abstract.
  256. Tornwall, M. E., Virtamo, J., Korhonen, P. A., Virtanen, M. J., Taylor, P. R., Albanes, D., and Huttunen, J. K. Effect of alpha-tocopherol and beta-carotene supplementation on coronary heart disease during the 6-year post-trial follow-up in the ATBC study. Eur.Heart J. 2004;25:1171-1178. View abstract.
  257. Hak, A. E., Ma, J., Powell, C. B., Campos, H., Gaziano, J. M., Willett, W. C., and Stampfer, M. J. Prospective study of plasma carotenoids and tocopherols in relation to risk of ischemic stroke. Stroke 2004;35:1584-1588. View abstract.
  258. Fahn, S. A pilot trial of high-dose alpha-tocopherol and ascorbate in early Parkinson's disease. Ann.Neurol. 1992;32 Suppl:S128-S132. View abstract.
  259. Mann, J. F., Lonn, E. M., Yi, Q., Gerstein, H. C., Hoogwerf, B. J., Pogue, J., Bosch, J., Dagenais, G. R., and Yusuf, S. Effects of vitamin E on cardiovascular outcomes in people with mild-to-moderate renal insufficiency: results of the HOPE study. Kidney Int. 2004;65:1375-1380. View abstract.
  260. Brion, L. P., Bell, E. F., Raghuveer, T. S., and Soghier, L. What is the appropriate intravenous dose of vitamin E for very-low-birth-weight infants? J.Perinatol. 2004;24:205-207. View abstract.
  261. Ferreira, P. R., Fleck, J. F., Diehl, A., Barletta, D., Braga-Filho, A., Barletta, A., and Ilha, L. Protective effect of alpha-tocopherol in head and neck cancer radiation-induced mucositis: a double-blind randomized trial. Head Neck 2004;26:313-321. View abstract.
  262. Lindor, K. D., Kowdley, K. V., Heathcote, E. J., Harrison, M. E., Jorgensen, R., Angulo, P., Lymp, J. F., Burgart, L., and Colin, P. Ursodeoxycholic acid for treatment of nonalcoholic steatohepatitis: results of a randomized trial. Hepatology 2004;39:770-778. View abstract.
  263. Uygun, A., Kadayifci, A., Isik, A. T., Ozgurtas, T., Deveci, S., Tuzun, A., Yesilova, Z., Gulsen, M., and Dagalp, K. Metformin in the treatment of patients with non-alcoholic steatohepatitis. Aliment.Pharmacol.Ther. 3-1-2004;19:537-544. View abstract.
  264. Tosukhowong, P., Sangwatanaroj, S., Jatuporn, S., Prapunwattana, P., Saengsiri, A., Rattanapruks, S., Srimahachota, S., Udayachalerm, W., and Tangkijvanich, P. The correlation between markers of oxidative stress and risk factors of coronary artery disease in Thai patients. Clin.Hemorheol.Microcirc. 2003;29(3-4):321-329. View abstract.
  265. Vajro, P., Mandato, C., Franzese, A., Ciccimarra, E., Lucariello, S., Savoia, M., Capuano, G., and Migliaro, F. Vitamin E treatment in pediatric obesity-related liver disease: a randomized study. J.Pediatr.Gastroenterol.Nutr. 2004;38:48-55. View abstract.
  266. Harrison, S. A., Torgerson, S., Hayashi, P., Ward, J., and Schenker, S. Vitamin E and vitamin C treatment improves fibrosis in patients with nonalcoholic steatohepatitis. Am.J.Gastroenterol. 2003;98:2485-2490. View abstract.
  267. Sacco, M., Pellegrini, F., Roncaglioni, M. C., Avanzini, F., Tognoni, G., and Nicolucci, A. Primary prevention of cardiovascular events with low-dose aspirin and vitamin E in type 2 diabetic patients: results of the Primary Prevention Project (PPP) trial. Diabetes Care 2003;26:3264-3272. View abstract.
  268. Fletcher, A. E., Breeze, E., and Shetty, P. S. Antioxidant vitamins and mortality in older persons: findings from the nutrition add-on study to the Medical Research Council Trial of Assessment and Management of Older People in the Community. Am.J.Clin.Nutr. 2003;78:999-1010. View abstract.
  269. Brion, L. P., Bell, E. F., and Raghuveer, T. S. Vitamin E supplementation for prevention of morbidity and mortality in preterm infants. Cochrane.Database.Syst.Rev. 2003;:CD003665. View abstract.
  270. BOYD, A. M. and MARKS, J. Treatment of intermittent claudication. A reappraisal of the value of alpha-tocopherol. Angiology 1963;14:198-208. View abstract.
  271. WILLIAMS, H. T., CLEIN, L. J., and MACBETH, R. A. Alpha-tocopherol in the treatment of intermittent claudication: a preliminary report. Can.Med.Assoc.J. 9-8-1962;87:538-541. View abstract.
  272. LIVINGSTONE, P. D. and JONES, C. Treatment of intermittent claudication with vitamin E. Lancet 9-20-1958;2:602-604. View abstract.
  273. Egan, M. F., Hyde, T. M., Albers, G. W., Elkashef, A., Alexander, R. C., Reeve, A., Blum, A., Saenz, R. E., and Wyatt, R. J. Treatment of tardive dyskinesia with vitamin E. Am.J.Psychiatry 1992;149:773-777. View abstract.
  274. Hunter, D. J., Colditz, G. A., Stampfer, M. J., Rosner, B., Willett, W. C., and Speizer, F. E. Diet and risk of basal cell carcinoma of the skin in a prospective cohort of women. Ann.Epidemiol. 1992;2:231-239. View abstract.
  275. Jaakkola, K., Lahteenmaki, P., Laakso, J., Harju, E., Tykka, H., and Mahlberg, K. Treatment with antioxidant and other nutrients in combination with chemotherapy and irradiation in patients with small-cell lung cancer. Anticancer Res. 1992;12:599-606. View abstract.
  276. HAMILTON, M., WILSON, G. M., ARMITAGE, P., and BOYD, J. T. The treatment of intermittent claudication with vitamin E. Lancet 2-21-1953;1:367-370. View abstract.
  277. Roed-Petersen, J. and Hjorth, N. Contact dermatitis from antioxidants. Br.J.Dermatol. 1976;94:233-241. View abstract.
  278. Pamuk, G. E. and Sonsuz, A. N-acetylcysteine in the treatment of non-alcoholic steatohepatitis. J.Gastroenterol.Hepatol. 2003;18:1220-1221. View abstract.
  279. Sung, L., Greenberg, M. L., Koren, G., Tomlinson, G. A., Tong, A., Malkin, D., and Feldman, B. M. Vitamin E: the evidence for multiple roles in cancer. Nutr.Cancer 2003;46:1-14. View abstract.
  280. Chan, J. C., Mahan, J. D., Trachtman, H., Scheinman, J., Flynn, J. T., Alon, U. S., Lande, M. B., Weiss, R. A., and Norkus, E. P. Vitamin E therapy in IgA nephropathy: a double-blind, placebo-controlled study. Pediatr.Nephrol. 2003;18:1015-1019. View abstract.
  281. Brion, L. P., Bell, E. F., and Raghuveer, T. S. Vitamin E supplementation for prevention of morbidity and mortality in preterm infants. Cochrane.Database.Syst.Rev. 2003;:CD003665. View abstract.
  282. Adler, L. A., Rotrosen, J., Edson, R., Lavori, P., Lohr, J., Hitzemann, R., Raisch, D., Caligiuri, M., and Tracy, K. Vitamin E treatment for tardive dyskinesia. Veterans Affairs Cooperative Study #394 Study Group. Arch.Gen.Psychiatry 1999;56:836-841. View abstract.
  283. Kugelmas, M., Hill, D. B., Vivian, B., Marsano, L., and McClain, C. J. Cytokines and NASH: a pilot study of the effects of lifestyle modification and vitamin E. Hepatology 2003;38:413-419. View abstract.
  284. Merat, S., Malekzadeh, R., Sohrabi, M. R., Sotoudeh, M., Rakhshani, N., Sohrabpour, A. A., and Naserimoghadam, S. Probucol in the treatment of non-alcoholic steatohepatitis: a double-blind randomized controlled study. J.Hepatol. 2003;38:414-418. View abstract.
  285. Prieto Castro, R. M., Leva Vallejo, M. E., Regueiro Lopez, J. C., Anglada Curado, F. J., Alvarez, Kindelan J., and Requena Tapia, M. J. Combined treatment with vitamin E and colchicine in the early stages of Peyronie's disease. BJU.Int. 2003;91:522-524. View abstract.
  286. Jialal, I. and Devaraj, S. Antioxidants and atherosclerosis: don't throw out the baby with the bath water. Circulation 2-25-2003;107:926-928. View abstract.
  287. Boshtam, M., Rafiei, M., Sadeghi, K., and Sarraf-Zadegan, N. Vitamin E can reduce blood pressure in mild hypertensives. Int.J.Vitam.Nutr.Res. 2002;72:309-314. View abstract.
  288. Fung, T. T., Spiegelman, D., Egan, K. M., Giovannucci, E., Hunter, D. J., and Willett, W. C. Vitamin and carotenoid intake and risk of squamous cell carcinoma of the skin. Int.J.Cancer 1-1-2003;103:110-115. View abstract.
  289. Ryglewicz, D., Rodo, M., Kunicki, P. K., Bednarska-Makaruk, M., Graban, A., Lojkowska, W., and Wehr, H. Plasma antioxidant activity and vascular dementia. J.Neurol.Sci. 11-15-2002;203-204:195-197. View abstract.
  290. Roberts, E. A. Steatohepatitis in children. Best.Pract.Res.Clin.Gastroenterol. 2002;16:749-765. View abstract.
  291. Sidani, M. and Campbell, J. Gynecology: select topics. Prim.Care 2002;29:297-321, vi. View abstract.
  292. Wijnen, M. H., Vader, H. L., Van Den Wall Bake AW, and Roumen, R. M. Can renal dysfunction after infra-renal aortic aneurysm repair be modified by multi-antioxidant supplementation? J.Cardiovasc.Surg.(Torino) 2002;43:483-488. View abstract.
  293. Radosavac, D., Graf, P., Polidori, M. C., Sies, H., and Stahl, W. Tocopherol metabolites 2, 5, 7, 8-tetramethyl-2-(2'-carboxyethyl)-6-hydroxychroman (alpha-CEHC) and 2, 7, 8-trimethyl-2-(2'-carboxyethyl)-6-hydroxychroman (gamma-CEHC) in human serum after a single dose of natural vitamin E. Eur.J.Nutr. 2002;41:119-124. View abstract.
  294. Muntwyler, J., Hennekens, C. H., Manson, J. E., Buring, J. E., and Gaziano, J. M. Vitamin supplement use in a low-risk population of US male physicians and subsequent cardiovascular mortality. Arch.Intern.Med. 7-8-2002;162:1472-1476. View abstract.
  295. Calle, E. E., Rodriguez, C., Jacobs, E. J., Almon, M. L., Chao, A., McCullough, M. L., Feigelson, H. S., and Thun, M. J. The American Cancer Society Cancer Prevention Study II Nutrition Cohort: rationale, study design, and baseline characteristics. Cancer 5-1-2002;94:2490-2501. View abstract.
  296. Fleischauer, A. T., Olson, S. H., Mignone, L., Simonsen, N., Caputo, T. A., and Harlap, S. Dietary antioxidants, supplements, and risk of epithelial ovarian cancer. Nutr.Cancer 2001;40:92-98. View abstract.
  297. Nojiri, S., Daida, H., Mokuno, H., Iwama, Y., Mae, K., Ushio, F., and Ueki, T. Association of serum antioxidant capacity with coronary artery disease in middle-aged men. Jpn.Heart J. 2001;42:677-690. View abstract.
  298. El-Sohemy, A., Baylin, A., Spiegelman, D., Ascherio, A., and Campos, H. Dietary and adipose tissue gamma-tocopherol and risk of myocardial infarction. Epidemiology 2002;13:216-223. View abstract.
  299. Ruiz, Rejon F., Martin-Pena, G., Granado, F., Ruiz-Galiana, J., Blanco, I., and Olmedilla, B. Plasma status of retinol, alpha- and gamma-tocopherols, and main carotenoids to first myocardial infarction: case control and follow-up study. Nutrition 2002;18:26-31. View abstract.
  300. Bidoli, E., La, Vecchia C., Talamini, R., Negri, E., Parpinel, M., Conti, E., Montella, M., Carbone, M. A., and Franceschi, S. Micronutrients and ovarian cancer: a case-control study in Italy. Ann.Oncol. 2001;12:1589-1593. View abstract.
  301. Jedrychowski, W., Steindorf, K., Popiela, T., Wahrendorf, J., Tobiasz-Adamczyk, B., Kulig, J., and Penar, A. Risk of colorectal cancer from alcohol consumption at lower vitamin intakes. A hospital-based case-control study in Poland. Rev.Environ.Health 2001;16:213-222. View abstract.
  302. Schatzkin, A., Subar, A. F., Thompson, F. E., Harlan, L. C., Tangrea, J., Hollenbeck, A. R., Hurwitz, P. E., Coyle, L., Schussler, N., Michaud, D. S., Freedman, L. S., Brown, C. C., Midthune, D., and Kipnis, V. Design and serendipity in establishing a large cohort with wide dietary intake distributions : the National Institutes of Health-American Association of Retired Persons Diet and Health Study. Am.J.Epidemiol. 12-15-2001;154:1119-1125. View abstract.
  303. Soares, K. V. and McGrath, J. J. Vitamin E for neuroleptic-induced tardive dyskinesia. Cochrane.Database.Syst.Rev. 2001;:CD000209. View abstract.
  304. Hasegawa, T., Yoneda, M., Nakamura, K., Makino, I., and Terano, A. Plasma transforming growth factor-beta1 level and efficacy of alpha-tocopherol in patients with non-alcoholic steatohepatitis: a pilot study. Aliment.Pharmacol.Ther. 2001;15:1667-1672. View abstract.
  305. Birkenstock, W. E., Louw, J. H., Terblanche, J., Immelman, E. J., Dent, D. M., and Baker, P. M. Smoking and other factors affecting the conservative management of peripheral vascular disease. S.Afr.Med.J. 7-5-1975;49:1129-1132. View abstract.
  306. Hayes, K., Pronczuk, A., and Perlman, D. Vitamin E in fortified cow milk uniquely enriches human plasma lipoproteins. Am.J.Clin.Nutr. 2001;74:211-218. View abstract.
  307. Shin, D. M., Khuri, F. R., Murphy, B., Garden, A. S., Clayman, G., Francisco, M., Liu, D., Glisson, B. S., Ginsberg, L., Papadimitrakopoulou, V., Myers, J., Morrison, W., Gillenwater, A., Ang, K. K., Lippman, S. M., Goepfert, H., and Hong, W. K. Combined interferon-alfa, 13-cis-retinoic acid, and alpha-tocopherol in locally advanced head and neck squamous cell carcinoma: novel bioadjuvant phase II trial. J.Clin.Oncol. 6-15-2001;19:3010-3017. View abstract.
  308. Bilgihan, K., Adiguzel, U., Sezer, C., Akyol, G., and Hasanreisoglu, B. Effects of topical vitamin E on keratocyte apoptosis after traditional photorefractive keratectomy. Ophthalmologica 2001;215:192-196. View abstract.
  309. Blanke, C. D., Stipanov, M., Morrow, J., Rothenberg, M., Chinery, R., Shyr, Y., Coffey, R., Johnson, D. H., Leach, S. D., and Beauchamp, R. D. A phase I study of vitamin E, 5-fluorouracil and leucovorin for advanced malignancies. Invest New Drugs 2001;19:21-27. View abstract.
  310. Palli, D., Russo, A., and Decarli, A. Dietary patterns, nutrient intake and gastric cancer in a high-risk area of Italy. Cancer Causes Control 2001;12:163-172. View abstract.
  311. Sieja, K. Protective role of selenium against the toxicity of multi-drug chemotherapy in patients with ovarian cancer. Pharmazie 2000;55:958-959. View abstract.
  312. de Waart, F. G., Schouten, E. G., Stalenhoef, A. F., and Kok, F. J. Serum carotenoids, alpha-tocopherol and mortality risk in a prospective study among Dutch elderly. Int.J.Epidemiol. 2001;30:136-143. View abstract.
  313. Tabet, N., Birks, J., and Grimley, Evans J. Vitamin E for Alzheimer's disease. Cochrane.Database.Syst.Rev. 2000;:CD002854. View abstract.
  314. Hirvonen, T., Virtamo, J., Korhonen, P., Albanes, D., and Pietinen, P. Intake of flavonoids, carotenoids, vitamins C and E, and risk of stroke in male smokers. Stroke 2000;31:2301-2306. View abstract.
  315. Feki, M., Souissi, M., Mokhtar, E., Hsairi, M., Kaabachi, N., Antebi, H., Alcindor, L. G., Mechmeche, R., and Mebazaa, A. Vitamin E and coronary heart disease in Tunisians. Clin.Chem. 2000;46:1401-1405. View abstract.
  316. Westheim, A. S., Brox, D., and Selv, O. A. [D-alpha tocopherol in intermittent claudication. A clinical study]. Tidsskr.Nor Laegeforen. 1-10-1975;95:13-15. View abstract.
  317. Meraji, S., Abuja, P. M., Hayn, M., Kostner, G. M., Morris, R., Oraii, S., Tatzber, F., Wonisch, W., Zechner, R., and Gey, K. F. Relationship between classic risk factors, plasma antioxidants and indicators of oxidant stress in angina pectoris (AP) in Tehran. Atherosclerosis 2000;150:403-412. View abstract.
  318. Cascinu, S., Ligi, M., Del, Ferro E., Foglietti, G., Cioccolini, P., Staccioli, M. P., Carnevali, A., Luigi Rocchi, M. B., Alessandroni, P., Giordani, P., Catalano, V., Polizzi, V., Agostinelli, R., Muretto, P., and Catalano, G. Effects of calcium and vitamin supplementation on colon cell proliferation in colorectal cancer. Cancer Invest 2000;18:411-416. View abstract.
  319. Franceschi, S., Bidoli, E., Negri, E., Zambon, P., Talamini, R., Ruol, A., Parpinel, M., Levi, F., Simonato, L., and La, Vecchia C. Role of macronutrients, vitamins and minerals in the aetiology of squamous-cell carcinoma of the oesophagus. Int.J.Cancer 6-1-2000;86:626-631. View abstract.
  320. Kleijnen, J. and Mackerras, D. Vitamin E for intermittent claudication. Cochrane.Database.Syst.Rev. 2000;:CD000987. View abstract.
  321. Battisti, C., Formichi, P., Tripodi, S. A., Vindigni, C., Roviello, F., and Federico, A. Vitamin E serum levels and gastric cancer: results from a cohort of patients in Tuscany, Italy. Cancer Lett. 4-3-2000;151:15-18. View abstract.
  322. Kolonel, L. N., Henderson, B. E., Hankin, J. H., Nomura, A. M., Wilkens, L. R., Pike, M. C., Stram, D. O., Monroe, K. R., Earle, M. E., and Nagamine, F. S. A multiethnic cohort in Hawaii and Los Angeles: baseline characteristics. Am.J.Epidemiol. 2-15-2000;151:346-357. View abstract.
  323. Ronco, A., De, Stefani E., Boffetta, P., Deneo-Pellegrini, H., Mendilaharsu, M., and Leborgne, F. Vegetables, fruits, and related nutrients and risk of breast cancer: a case-control study in Uruguay. Nutr.Cancer 1999;35:111-119. View abstract.
  324. Swain, R. A. and Kaplan-Machlis, B. Therapeutic uses of vitamin E in prevention of atherosclerosis. Altern.Med.Rev. 1999;4:414-423. View abstract.
  325. Lehtinen, M., Luostarinen, T., Youngman, L. D., Anttila, T., Dillner, J., Hakulinen, T., Koskela, P., Lenner, P., and Hallmans, G. Low levels of serum vitamins A and E in blood and subsequent risk for cervical cancer: interaction with HPV seropositivity. Nutr.Cancer 1999;34:229-234. View abstract.
  326. Vatassery, G. T., Bauer, T., and Dysken, M. High doses of vitamin E in the treatment of disorders of the central nervous system in the aged. Am.J.Clin.Nutr. 1999;70:793-801. View abstract.
  327. Woodson, K., Tangrea, J. A., Barrett, M. J., Virtamo, J., Taylor, P. R., and Albanes, D. Serum alpha-tocopherol and subsequent risk of lung cancer among male smokers. J Natl Cancer Inst. 10-20-1999;91:1738-1743. View abstract.
  328. Papadimitrakopoulou, V. A., Clayman, G. L., Shin, D. M., Myers, J. N., Gillenwater, A. M., Goepfert, H., El-Naggar, A. K., Lewin, J. S., Lippman, S. M., and Hong, W. K. Biochemoprevention for dysplastic lesions of the upper aerodigestive tract. Arch.Otolaryngol.Head Neck Surg. 1999;125:1083-1089. View abstract.
  329. Morrissey, P. A. and Sheehy, P. J. Optimal nutrition: vitamin E. Proc.Nutr.Soc. 1999;58:459-468. View abstract.
  330. Jansen, M. C., Bueno-de-Mesquita, H. B., Buzina, R., Fidanza, F., Menotti, A., Blackburn, H., Nissinen, A. M., Kok, F. J., and Kromhout, D. Dietary fiber and plant foods in relation to colorectal cancer mortality: the Seven Countries Study. Int.J.Cancer 4-12-1999;81:174-179. View abstract.
  331. Hu, J., La, Vecchia C., Negri, E., Chatenoud, L., Bosetti, C., Jia, X., Liu, R., Huang, G., Bi, D., and Wang, C. Diet and brain cancer in adults: a case-control study in northeast China. Int.J.Cancer 3-31-1999;81:20-23. View abstract.
  332. Javanbakht, M. H., Keshavarz, S. A., Djalali, M., Siassi, F., Eshraghian, M. R., Firooz, A., Seirafi, H., Ehsani, A. H., Chamari, M., and Mirshafiey, A. Randomized controlled trial using vitamins E and D supplementation in atopic dermatitis. J Dermatolog.Treat. 2011;22:144-150. View abstract.
  333. Matkovics, A. [Recent changes in concepts of antioxidant treatment]. Orv.Hetil. 4-23-2006;147:747-752. View abstract.
  334. Mayer-Davis, E. J., Bell, R. A., Reboussin, B. A., Rushing, J., Marshall, J. A., and Hamman, R. F. Antioxidant nutrient intake and diabetic retinopathy: the San Luis Valley Diabetes Study. Ophthalmology 1998;105:2264-2270. View abstract.
  335. Bobak, M., Brunner, E., Miller, N. J., Skodova, Z., and Marmot, M. Could antioxidants play a role in high rates of coronary heart disease in the Czech Republic? Eur.J Clin.Nutr 1998;52:632-636. View abstract.
  336. Willems, D., Dorchy, H., and Dufrasne, D. Serum antioxidant status and oxidized LDL in well-controlled young type 1 diabetic patients with and without subclinical complications. Atherosclerosis 1998;137 Suppl:S61-S64. View abstract.
  337. Kostner, K., Hornykewycz, S., Yang, P., Neunteufl, T., Glogar, D., Weidinger, F., Maurer, G., and Huber, K. Is oxidative stress causally linked to unstable angina pectoris? A study in 100 CAD patients and matched controls. Cardiovasc.Res 1997;36:330-336. View abstract.
  338. Evans, R. W., Shaten, B. J., Day, B. W., and Kuller, L. H. Prospective association between lipid soluble antioxidants and coronary heart disease in men. The Multiple Risk Factor Intervention Trial. Am.J Epidemiol. 1-15-1998;147:180-186. View abstract.
  339. Zhang, Z. F., Kurtz, R. C., Yu, G. P., Sun, M., Gargon, N., Karpeh, M., Jr., Fein, J. S., and Harlap, S. Adenocarcinomas of the esophagus and gastric cardia: the role of diet. Nutr Cancer 1997;27:298-309. View abstract.
  340. Tzonou, A., Lipworth, L., Garidou, A., Signorello, L. B., Lagiou, P., Hsieh, C., and Trichopoulos, D. Diet and risk of esophageal cancer by histologic type in a low-risk population. Int J Cancer 11-4-1996;68:300-304. View abstract.
  341. Sano, M., Ernesto, C., Klauber, M. R., Schafer, K., Woodbury, P., Thomas, R., Grundman, M., Growdon, J., and Thal, L. J. Rationale and design of a multicenter study of selegiline and alpha-tocopherol in the treatment of Alzheimer disease using novel clinical outcomes. Alzheimer's Disease Cooperative Study. Alzheimer Dis.Assoc.Disord. 1996;10:132-140. View abstract.
  342. Ohrvall, M., Sundlof, G., and Vessby, B. Gamma, but not alpha, tocopherol levels in serum are reduced in coronary heart disease patients. J Intern.Med 1996;239:111-117. View abstract.
  343. ter Riet, G., Kessels, A. G., and Knipschild, P. G. Randomized clinical trial of ascorbic acid in the treatment of pressure ulcers. J Clin.Epidemiol. 1995;48:1453-1460. View abstract.
  344. Takamatsu, S., Takamatsu, M., Satoh, K., Imaizumi, T., Yoshida, H., Hiramoto, M., Koyama, M., Ohgushi, Y., and Mizuno, S. Effects on health of dietary supplementation with 100 mg d-alpha-tocopheryl acetate, daily for 6 years. J Int Med Res 1995;23:342-357. View abstract.
  345. Rema, M., Mohan, V., Bhaskar, A., and Shanmugasundaram, K. R. Does oxidant stress play a role in diabetic retinopathy? Indian J Ophthalmol. 1995;43:17-21. View abstract.
  346. Kabat, G. C., Ng, S. K., and Wynder, E. L. Tobacco, alcohol intake, and diet in relation to adenocarcinoma of the esophagus and gastric cardia. Cancer Causes Control 1993;4:123-132. View abstract.
  347. Gey, K. F., Moser, U. K., Jordan, P., Stahelin, H. B., Eichholzer, M., and Ludin, E. Increased risk of cardiovascular disease at suboptimal plasma concentrations of essential antioxidants: an epidemiological update with special attention to carotene and vitamin C. Am.J Clin.Nutr 1993;57(5 Suppl):787S-797S. View abstract.
  348. Martinoli, L., Di, Felice M., Seghieri, G., Ciuti, M., De Giorgio, L. A., Fazzini, A., Gori, R., Anichini, R., and Franconi, F. Plasma retinol and alpha-tocopherol concentrations in insulin-dependent diabetes mellitus: their relationship to microvascular complications. Int J Vitam.Nutr Res 1993;63:87-92. View abstract.
  349. Bostick, R. M., Potter, J. D., McKenzie, D. R., Sellers, T. A., Kushi, L. H., Steinmetz, K. A., and Folsom, A. R. Reduced risk of colon cancer with high intake of vitamin E: the Iowa Women's Health Study. Cancer Res 9-15-1993;53:4230-4237. View abstract.
  350. Street, D. A., Comstock, G. W., Salkeld, R. M., Schuep, W., and Klag, M. J. Serum antioxidants and myocardial infarction. Are low levels of carotenoids and alpha-tocopherol risk factors for myocardial infarction? Circulation 1994;90:1154-1161. View abstract.
  351. Morris, D. L., Kritchevsky, S. B., and Davis, C. E. Serum carotenoids and coronary heart disease. The Lipid Research Clinics Coronary Primary Prevention Trial and Follow-up Study. JAMA 11-9-1994;272:1439-1441. View abstract.
  352. Kardinaal, A. F., Kok, F. J., Ringstad, J., Gomez-Aracena, J., Mazaev, V. P., Kohlmeier, L., Martin, B. C., Aro, A., Kark, J. D., Delgado-Rodriguez, M., and . Antioxidants in adipose tissue and risk of myocardial infarction: the EURAMIC Study. Lancet 12-4-1993;342:1379-1384. View abstract.
  353. Wilson, T. S., Datta, S. B., Murrell, J. S., and Andrews, C. T. Relation of vitamin C levels to mortality in a geriatric hospital: a study of the effect of vitamin C administration. Age Ageing 1973;2:163-171. View abstract.
  354. Ascorbic acid does not cure cancer. Nutr Rev 1985;43:146-147. View abstract.
  355. Kok, F. J., de Bruijn, A. M., Vermeeren, R., Hofman, A., van, Laar A., de, Bruin M., Hermus, R. J., and Valkenburg, H. A. Serum selenium, vitamin antioxidants, and cardiovascular mortality: a 9-year follow-up study in the Netherlands. Am.J Clin.Nutr 1987;45:462-468. View abstract.
  356. Enstrom, J. E., Kanim, L. E., and Breslow, L. The relationship between vitamin C intake, general health practices, and mortality in Alameda County, California. Am.J Public Health 1986;76:1124-1130. View abstract.
  357. Gey, K. F., Stahelin, H. B., Puska, P., and Evans, A. Relationship of plasma level of vitamin C to mortality from ischemic heart disease. Ann.N.Y Acad.Sci 1987;498:110-123. View abstract.
  358. Salonen, J. T., Salonen, R., Seppanen, K., Kantola, M., Parviainen, M., Alfthan, G., Maenpaa, P. H., Taskinen, E., and Rauramaa, R. Relationship of serum selenium and antioxidants to plasma lipoproteins, platelet aggregability and prevalent ischaemic heart disease in Eastern Finnish men. Atherosclerosis 1988;70(1-2):155-160. View abstract.
  359. Gillilan, R. E., Mondell, B., and Warbasse, J. R. Quantitative evaluation of vitamin E in the treatment of angina pectoris. Am.Heart J 1977;93:444-449. View abstract.
  360. Salonen, J. T., Salonen, R., Penttila, I., Herranen, J., Jauhiainen, M., Kantola, M., Lappetelainen, R., Maenpaa, P. H., Alfthan, G., and Puska, P. Serum fatty acids, apolipoproteins, selenium and vitamin antioxidants and the risk of death from coronary artery disease. Am.J Cardiol. 8-1-1985;56:226-231. View abstract.
  361. Ali, S. M. and Chakraborty, S. K. Role of plasma ascorbate in diabetic microangiopathy. Bangladesh Med Res Counc.Bull. 1989;15:47-59. View abstract.
  362. Hatwal, A., Gujral, A. S., Bhatia, R. P., Agrawal, J. K., and Bajpai, H. S. Association of hypomagnesemia with diabetic retinopathy. Acta Ophthalmol.(Copenh) 1989;67:714-716. View abstract.
  363. Erasmus, R. T., Olukoga, A. O., Alanamu, R. A., Adewoye, H. O., and Bojuwoye, B. Plasma magnesium and retinopathy in black African diabetics. Trop.Geogr.Med 1989;41:234-237. View abstract.
  364. Stringer, M. D., Gorog, P. G., Freeman, A., and Kakkar, V. V. Lipid peroxides and atherosclerosis. BMJ 2-4-1989;298:281-284. View abstract.
  365. Coombes, J. S. and Fassett, R. G. Antioxidant therapy in hemodialysis patients: a systematic review. Kidney Int 2012;81:233-246. View abstract.
  366. Li, G., Li, L., Yu, C., and Chen, L. Effect of vitamins C and E supplementation on Helicobacter pylori eradication: a meta-analysis. Br.J Nutr 2011;106:1632-1637. View abstract.
  367. Rossi, A. C. and Mullin, P. M. Prevention of pre-eclampsia with low-dose aspirin or vitamins C and E in women at high or low risk: a systematic review with meta-analysis. Eur.J Obstet.Gynecol.Reprod.Biol. 2011;158:9-16. View abstract.
  368. Conde-Agudelo, A., Romero, R., Kusanovic, J. P., and Hassan, S. S. Supplementation with vitamins C and E during pregnancy for the prevention of preeclampsia and other adverse maternal and perinatal outcomes: a systematic review and metaanalysis. Am J Obstet.Gynecol. 2011;204:503-512. View abstract.
  369. Cuerda, C., Luengo, L. M., Valero, M. A., Vidal, A., Burgos, R., Calvo, F. L., and Martinez, C. [Antioxidants and diabetes mellitus: review of the evidence]. Nutr Hosp. 2011;26:68-78. View abstract.
  370. Riemersma, R. A., Oliver, M., Elton, R. A., Alfthan, G., Vartiainen, E., Salo, M., Rubba, P., Mancini, M., Georgi, H., Vuilleumier, J. P., and . Plasma antioxidants and coronary heart disease: vitamins C and E, and selenium. Eur.J Clin.Nutr 1990;44:143-150. View abstract.
  371. McCance, D. R., Holmes, V. A., Maresh, M. J., Patterson, C. C., Walker, J. D., Pearson, D. W., and Young, I. S. Vitamins C and E for prevention of pre-eclampsia in women with type 1 diabetes (DAPIT): a randomised placebo-controlled trial. Lancet 7-24-2010;376:259-266. View abstract.
  372. Roberts, J. M., Myatt, L., Spong, C. Y., Thom, E. A., Hauth, J. C., Leveno, K. J., Pearson, G. D., Wapner, R. J., Varner, M. W., Thorp, J. M., Jr., Mercer, B. M., Peaceman, A. M., Ramin, S. M., Carpenter, M. W., Samuels, P., Sciscione, A., Harper, M., Smith, W. J., Saade, G., Sorokin, Y., and Anderson, G. B. Vitamins C and E to prevent complications of pregnancy-associated hypertension. N.Engl.J Med 4-8-2010;362:1282-1291. View abstract.
  373. Xu, H., Perez-Cuevas, R., Xiong, X., Reyes, H., Roy, C., Julien, P., Smith, G., von, Dadelszen P., Leduc, L., Audibert, F., Moutquin, J. M., Piedboeuf, B., Shatenstein, B., Parra-Cabrera, S., Choquette, P., Winsor, S., Wood, S., Benjamin, A., Walker, M., Helewa, M., Dube, J., Tawagi, G., Seaward, G., Ohlsson, A., Magee, L. A., Olatunbosun, F., Gratton, R., Shear, R., Demianczuk, N., Collet, J. P., Wei, S., and Fraser, W. D. An international trial of antioxidants in the prevention of preeclampsia (INTAPP). Am.J Obstet Gynecol. 2010;202:239. View abstract.
  374. Lee, C. T., Gayton, E. L., Beulens, J. W., Flanagan, D. W., and Adler, A. I. Micronutrients and diabetic retinopathy a systematic review. Ophthalmology 2010;117:71-78. View abstract.
  375. Gey, K. F., Puska, P., Jordan, P., and Moser, U. K. Inverse correlation between plasma vitamin E and mortality from ischemic heart disease in cross-cultural epidemiology. Am.J Clin.Nutr 1991;53(1 Suppl):326S-334S. View abstract.
  376. Rahimi, R., Nikfar, S., Rezaie, A., and Abdollahi, M. A meta-analysis on the efficacy and safety of combined vitamin C and E supplementation in preeclamptic women. Hypertens.Pregnancy. 2009;28:417-434. View abstract.
  377. Villar, J., Purwar, M., Merialdi, M., Zavaleta, N., Thi Nhu, Ngoc N., Anthony, J., De, Greeff A., Poston, L., and Shennan, A. World Health Organisation multicentre randomised trial of supplementation with vitamins C and E among pregnant women at high risk for pre-eclampsia in populations of low nutritional status from developing countries. BJOG. 2009;116:780-788. View abstract.
  378. Hemila, H. and Kaprio, J. Vitamin E supplementation may transiently increase tuberculosis risk in males who smoke heavily and have high dietary vitamin C intake. Br J Nutr 2008;100:896-902. View abstract.
  379. Spinnato, J. A., Freire, S., Pinto E Silva JL, Cunha Rudge, M. V., Martins-Costa, S., Koch, M. A., Goco, N., Santos, Cde B., Cecatti, J. G., Costa, R., Ramos, J. G., Moss, N., and Sibai, B. M. Antioxidant therapy to prevent preeclampsia: a randomized controlled trial. Obstet Gynecol. 2007;110:1311-1318. View abstract.
  380. Walter, R. M., Jr., Uriu-Hare, J. Y., Olin, K. L., Oster, M. H., Anawalt, B. D., Critchfield, J. W., and Keen, C. L. Copper, zinc, manganese, and magnesium status and complications of diabetes mellitus. Diabetes Care 1991;14:1050-1056. View abstract.
  381. Sharma, A., Dabla, S., Agrawal, R. P., Barjatya, H., Kochar, D. K., and Kothari, R. P. Serum magnesium: an early predictor of course and complications of diabetes mellitus. J Indian Med Assoc. 2007;105:16, 18, 20. View abstract.
  382. Bader, N., Bosy-Westphal, A., Koch, A., Rimbach, G., Weimann, A., Poulsen, H. E., and Muller, M. J. Effect of hyperbaric oxygen and vitamin C and E supplementation on biomarkers of oxidative stress in healthy men. Br J Nutr 2007;98:826-833. View abstract.
  383. Polyzos, N. P., Mauri, D., Tsappi, M., Tzioras, S., Kamposioras, K., Cortinovis, I., and Casazza, G. Combined vitamin C and E supplementation during pregnancy for preeclampsia prevention: a systematic review. Obstet Gynecol.Surv. 2007;62:202-206. View abstract.
  384. Riemersma, R. A., Wood, D. A., Macintyre, C. C., Elton, R. A., Gey, K. F., and Oliver, M. F. Risk of angina pectoris and plasma concentrations of vitamins A, C, and E and carotene. Lancet 1-5-1991;337:1-5. View abstract.
  385. Rumbold, A. R., Crowther, C. A., Haslam, R. R., Dekker, G. A., and Robinson, J. S. Vitamins C and E and the risks of preeclampsia and perinatal complications. N.Engl.J Med 4-27-2006;354:1796-1806. View abstract.
  386. Poston, L., Briley, A. L., Seed, P. T., Kelly, F. J., and Shennan, A. H. Vitamin C and vitamin E in pregnant women at risk for pre-eclampsia (VIP trial): randomised placebo-controlled trial. Lancet 4-8-2006;367:1145-1154. View abstract.
  387. Clarke, M. W., Ward, N. C., Wu, J. H., Hodgson, J. M., Puddey, I. B., and Croft, K. D. Supplementation with mixed tocopherols increases serum and blood cell gamma-tocopherol but does not alter biomarkers of platelet activation in subjects with type 2 diabetes. Am.J Clin.Nutr 2006;83:95-102. View abstract.
  388. Boothby, L. A. and Doering, P. L. Vitamin C and vitamin E for Alzheimer's disease. Ann.Pharmacother. 2005;39:2073-2080. View abstract.
  389. Czernichow, S., Bertrais, S., Blacher, J., Galan, P., Briancon, S., Favier, A., Safar, M., and Hercberg, S. Effect of supplementation with antioxidants upon long-term risk of hypertension in the SU.VI.MAX study: association with plasma antioxidant levels. J Hypertens. 2005;23:2013-2018. View abstract.
  390. Nouraie, M., Pietinen, P., Kamangar, F., Dawsey, S. M., Abnet, C. C., Albanes, D., Virtamo, J., and Taylor, P. R. Fruits, vegetables, and antioxidants and risk of gastric cancer among male smokers. Cancer Epidemiol.Biomarkers Prev. 2005;14:2087-2092. View abstract.
  391. Limburg, P. J., Wei, W., Ahnen, D. J., Qiao, Y., Hawk, E. T., Wang, G., Giffen, C. A., Wang, G., Roth, M. J., Lu, N., Korn, E. L., Ma, Y., Caldwell, K. L., Dong, Z., Taylor, P. R., and Dawsey, S. M. Randomized, placebo-controlled, esophageal squamous cell cancer chemoprevention trial of selenomethionine and celecoxib. Gastroenterology 2005;129:863-873. View abstract.
  392. Rumbold, A. and Crowther, C. A. Vitamin E supplementation in pregnancy. Cochrane.Database.Syst.Rev 2005;:CD004069. View abstract.
  393. Maxwell, C. J., Hicks, M. S., Hogan, D. B., Basran, J., and Ebly, E. M. Supplemental use of antioxidant vitamins and subsequent risk of cognitive decline and dementia. Dement.Geriatr.Cogn Disord. 2005;20:45-51. View abstract.
  394. Beazley, D., Ahokas, R., Livingston, J., Griggs, M., and Sibai, B. M. Vitamin C and E supplementation in women at high risk for preeclampsia: a double-blind, placebo-controlled trial. Am.J Obstet Gynecol. 2005;192:520-521. View abstract.
  395. Tam, L. S., Li, E. K., Leung, V. Y., Griffith, J. F., Benzie, I. F., Lim, P. L., Whitney, B., Lee, V. W., Lee, K. K., Thomas, G. N., and Tomlinson, B. Effects of vitamins C and E on oxidative stress markers and endothelial function in patients with systemic lupus erythematosus: a double blind, placebo controlled pilot study. J Rheumatol. 2005;32:275-282. View abstract.
  396. Pathak, A. K., Bhutani, M., Guleria, R., Bal, S., Mohan, A., Mohanti, B. K., Sharma, A., Pathak, R., Bhardwaj, N. K., Prasad, K. N., and Kochupillai, V. Chemotherapy alone vs. chemotherapy plus high dose multiple antioxidants in patients with advanced non small cell lung cancer. J Am.Coll.Nutr 2005;24:16-21. View abstract.
  397. Mooney, L. A., Madsen, A. M., Tang, D., Orjuela, M. A., Tsai, W. Y., Garduno, E. R., and Perera, F. P. Antioxidant vitamin supplementation reduces benzo(a)pyrene-DNA adducts and potential cancer risk in female smokers. Cancer Epidemiol.Biomarkers Prev. 2005;14:237-242. View abstract.
  398. Marras, C., McDermott, M. P., Rochon, P. A., Tanner, C. M., Naglie, G., Rudolph, A., and Lang, A. E. Survival in Parkinson disease: thirteen-year follow-up of the DATATOP cohort. Neurology 1-11-2005;64:87-93. View abstract.
  399. Manders, M., de Groot, L. C., van Staveren, W. A., Wouters-Wesseling, W., Mulders, A. J., Schols, J. M., and Hoefnagels, W. H. Effectiveness of nutritional supplements on cognitive functioning in elderly persons: a systematic review. J Gerontol.A Biol.Sci Med Sci 2004;59:1041-1049. View abstract.
  400. Graf, M., Ecker, D., Horowski, R., Kramer, B., Riederer, P., Gerlach, M., Hager, C., Ludolph, A. C., Becker, G., Osterhage, J., Jost, W. H., Schrank, B., Stein, C., Kostopulos, P., Lubik, S., Wekwerth, K., Dengler, R., Troeger, M., Wuerz, A., Hoge, A., Schrader, C., Schimke, N., Krampfl, K., Petri, S., Zierz, S., Eger, K., Neudecker, S., Traufeller, K., Sievert, M., Neundorfer, B., and Hecht, M. High dose vitamin E therapy in amyotrophic lateral sclerosis as add-on therapy to riluzole: results of a placebo-controlled double-blind study. J Neural Transm. 2005;112:649-660. View abstract.
  401. Manuel, Y. Keenoy, Vinckx, M., Vertommen, J., Van, Gaal L., and De, Leeuw, I. Impact of Vitamin E supplementation on lipoprotein peroxidation and composition in Type 1 diabetic patients treated with Atorvastatin. Atherosclerosis 2004;175:369-376. View abstract.
  402. Clemons, T. E., Kurinij, N., and Sperduto, R. D. Associations of mortality with ocular disorders and an intervention of high-dose antioxidants and zinc in the Age-Related Eye Disease Study: AREDS Report No. 13. Arch.Ophthalmol. 2004;122:716-726. View abstract.
  403. Laurin, D., Masaki, K. H., Foley, D. J., White, L. R., and Launer, L. J. Midlife dietary intake of antioxidants and risk of late-life incident dementia: the Honolulu-Asia Aging Study. Am.J.Epidemiol. 5-15-2004;159:959-967. View abstract.
  404. Millen, A. E., Klein, R., Folsom, A. R., Stevens, J., Palta, M., and Mares, J. A. Relation between intake of vitamins C and E and risk of diabetic retinopathy in the Atherosclerosis Risk in Communities Study. Am.J Clin.Nutr 2004;79:865-873. View abstract.
  405. McNeil, J. J., Robman, L., Tikellis, G., Sinclair, M. I., McCarty, C. A., and Taylor, H. R. Vitamin E supplementation and cataract: randomized controlled trial. Ophthalmology 2004;111:75-84. View abstract.
  406. Hofstad, B., Vatn, M., Hoff, G., Larsen, S., and Osnes, M. Growth of colorectal polyps: design of a prospective, randomized, placebo-controlled intervention study in patients with colorectal polyps. Eur.J Cancer Prev. 1992;1:415-422. View abstract.
  407. Sinclair, A. J., Girling, A. J., Gray, L., Lunec, J., and Barnett, A. H. An investigation of the relationship between free radical activity and vitamin C metabolism in elderly diabetic subjects with retinopathy. Gerontology 1992;38:268-274. View abstract.
  408. Millen, A. E., Gruber, M., Klein, R., Klein, B. E., Palta, M., and Mares, J. A. Relations of serum ascorbic acid and alpha-tocopherol to diabetic retinopathy in the Third National Health and Nutrition Examination Survey. Am.J Epidemiol. 8-1-2003;158:225-233. View abstract.
  409. Grodstein, F., Chen, J., and Willett, W. C. High-dose antioxidant supplements and cognitive function in community-dwelling elderly women. Am.J Clin.Nutr 2003;77:975-984. View abstract.
  410. Collins, E. G., Edwin, Langbein W., Orebaugh, C., Bammert, C., Hanson, K., Reda, D., Edwards, L. C., and Littooy, F. N. PoleStriding exercise and vitamin E for management of peripheral vascular disease. Med Sci Sports Exerc. 2003;35:384-393. View abstract.
  411. Bollschweiler, E., Wolfgarten, E., Nowroth, T., Rosendahl, U., Monig, S. P., and Holscher, A. H. Vitamin intake and risk of subtypes of esophageal cancer in Germany. J Cancer Res Clin Oncol 2002;128:575-580. View abstract.
  412. Chen, H., Tucker, K. L., Graubard, B. I., Heineman, E. F., Markin, R. S., Potischman, N. A., Russell, R. M., Weisenburger, D. D., and Ward, M. H. Nutrient intakes and adenocarcinoma of the esophagus and distal stomach. Nutr Cancer 2002;42:33-40. View abstract.
  413. White, K. L., Chalmers, D. M., Martin, I. G., Everett, S. M., Neville, P. M., Naylor, G., Sutcliffe, A. E., Dixon, M. F., Turner, P. C., and Schorah, C. J. Dietary antioxidants and DNA damage in patients on long-term acid-suppression therapy: a randomized controlled study. Br J Nutr 2002;88:265-271. View abstract.
  414. Taylor, H. R., Tikellis, G., Robman, L. D., McCarty, C. A., and McNeil, J. J. Vitamin E supplementation and macular degeneration: randomised controlled trial. BMJ 7-6-2002;325:11. View abstract.
  415. Morris, M. C., Evans, D. A., Bienias, J. L., Tangney, C. C., Bennett, D. A., Aggarwal, N., Wilson, R. S., and Scherr, P. A. Dietary intake of antioxidant nutrients and the risk of incident Alzheimer disease in a biracial community study. JAMA 6-26-2002;287:3230-3237. View abstract.
  416. Engelhart, M. J., Geerlings, M. I., Ruitenberg, A., van Swieten, J. C., Hofman, A., Witteman, J. C., and Breteler, M. M. Dietary intake of antioxidants and risk of Alzheimer disease. JAMA 6-26-2002;287:3223-3229. View abstract.
  417. Asplund, K. Antioxidant vitamins in the prevention of cardiovascular disease: a systematic review. J Intern.Med 2002;251:372-392. View abstract.
  418. Li, W., Zhu, Y., Yan, X., Zhang, Q., Li, X., Ni, Z., Shen, Z., Yao, H., and Zhu, J. [The prevention of primary liver cancer by selenium in high risk populations]. Zhonghua Yu Fang Yi.Xue.Za Zhi. 2000;34:336-338. View abstract.
  419. de Waart, F. G., Kok, F. J., Smilde, T. J., Hijmans, A., Wollersheim, H., and Stalenhoef, A. F. Effect of glutathione S-transferase M1 genotype on progression of atherosclerosis in lifelong male smokers. Atherosclerosis 2001;158:227-231. View abstract.
  420. Desnuelle, C., Dib, M., Garrel, C., and Favier, A. A double-blind, placebo-controlled randomized clinical trial of alpha-tocopherol (vitamin E) in the treatment of amyotrophic lateral sclerosis. ALS riluzole-tocopherol Study Group. Amyotroph.Lateral.Scler.Other Motor Neuron Disord. 2001;2:9-18. View abstract.
  421. Kontush, A., Mann, U., Arlt, S., Ujeyl, A., Luhrs, C., Muller-Thomsen, T., and Beisiegel, U. Influence of vitamin E and C supplementation on lipoprotein oxidation in patients with Alzheimer's disease. Free Radic.Biol.Med 8-1-2001;31:345-354. View abstract.
  422. Terry, P., Lagergren, J., Ye, W., Nyren, O., and Wolk, A. Antioxidants and cancers of the esophagus and gastric cardia. Int J Cancer 9-1-2000;87:750-754. View abstract.
  423. Huang, H. Y., Helzlsouer, K. J., and Appel, L. J. The effects of vitamin C and vitamin E on oxidative DNA damage: results from a randomized controlled trial. Cancer Epidemiol.Biomarkers Prev. 2000;9:647-652. View abstract.
  424. Cheng, K. K., Sharp, L., McKinney, P. A., Logan, R. F., Chilvers, C. E., Cook-Mozaffari, P., Ahmed, A., and Day, N. E. A case-control study of oesophageal adenocarcinoma in women: a preventable disease. Br J Cancer 2000;83:127-132. View abstract.
  425. Ekstrom, A. M., Serafini, M., Nyren, O., Hansson, L. E., Ye, W., and Wolk, A. Dietary antioxidant intake and the risk of cardia cancer and noncardia cancer of the intestinal and diffuse types: a population-based case-control study in Sweden. Int J Cancer 7-1-2000;87:133-140. View abstract.
  426. Baron, J. A., Beach, M., Mandel, J. S., van Stolk, R. U., Haile, R. W., Sandler, R. S., Rothstein, R., Summers, R. W., Snover, D. C., Beck, G. J., Frankl, H., Pearson, L., Bond, J. H., and Greenberg, E. R. Calcium supplements and colorectal adenomas. Polyp Prevention Study Group. Ann.N.Y Acad.Sci 1999;889:138-145. View abstract.
  427. Garrett, S. K., McNeil, J. J., Silagy, C., Sinclair, M., Thomas, A. P., Robman, L. P., McCarty, C. A., Tikellis, G., and Taylor, H. R. Methodology of the VECAT study: vitamin E intervention in cataract and age-related maculopathy. Ophthalmic Epidemiol. 1999;6:195-208. View abstract.
  428. Marchioli, R. Antioxidant vitamins and prevention of cardiovascular disease: laboratory, epidemiological and clinical trial data. Pharmacol.Res 1999;40:227-238. View abstract.
  429. de Valk, H. W., Hardus, P. L., van Rijn, H. J., and Erkelens, D. W. Plasma magnesium concentration and progression of retinopathy. Diabetes Care 1999;22:864-865. View abstract.
  430. Myung, S. K., Ju, W., Cho, B., Oh, S. W., Park, S. M., Koo, B. K., and Park, B. J. Efficacy of vitamin and antioxidant supplements in prevention of cardiovascular disease: systematic review and meta-analysis of randomised controlled trials. BMJ 2013;346:f10. View abstract.
  431. Dror, D. K. and Allen, L. H. Interventions with vitamins B6, B12 and C in pregnancy. Paediatr.Perinat.Epidemiol. 2012;26 Suppl 1:55-74. View abstract.
  432. DeMaio, S. J., King, S. B., III, Lembo, N. J., Roubin, G. S., Hearn, J. A., Bhagavan, H. N., and Sgoutas, D. S. Vitamin E supplementation, plasma lipids and incidence of restenosis after percutaneous transluminal coronary angioplasty (PTCA). J Am.Coll.Nutr 1992;11:68-73. View abstract.
  433. Zureik, M., Galan, P., Bertrais, S., Mennen, L., Czernichow, S., Blacher, J., Ducimetiere, P., and Hercberg, S. Effects of long-term daily low-dose supplementation with antioxidant vitamins and minerals on structure and function of large arteries. Arterioscler.Thromb.Vasc.Biol. 2004;24:1485-1491. View abstract.
  434. Hodis, H. N., Mack, W. J., LaBree, L., Mahrer, P. R., Sevanian, A., Liu, C. R., Liu, C. H., Hwang, J., Selzer, R. H., and Azen, S. P. Alpha-tocopherol supplementation in healthy individuals reduces low-density lipoprotein oxidation but not atherosclerosis: the Vitamin E Atherosclerosis Prevention Study (VEAPS). Circulation 9-17-2002;106:1453-1459. View abstract.
  435. Fang, J. C., Kinlay, S., Beltrame, J., Hikiti, H., Wainstein, M., Behrendt, D., Suh, J., Frei, B., Mudge, G. H., Selwyn, A. P., and Ganz, P. Effect of vitamins C and E on progression of transplant-associated arteriosclerosis: a randomised trial. Lancet 3-30-2002;359:1108-1113. View abstract.
  436. von, Herbay A., Stahl, W., Niederau, C., and Sies, H. Vitamin E improves the aminotransferase status of patients suffering from viral hepatitis C: a randomized, double-blind, placebo-controlled study. Free Radic.Res 1997;27:599-605. View abstract.
  437. Moon, T. E., Levine, N., Cartmel, B., Bangert, J. L., Rodney, S., Dong, Q., Peng, Y. M., and Alberts, D. S. Effect of retinol in preventing squamous cell skin cancer in moderate-risk subjects: a randomized, double-blind, controlled trial. Southwest Skin Cancer Prevention Study Group. Cancer Epidemiol Biomarkers Prev. 1997;6:949-956. View abstract.
  438. Yu, S. Y., Zhu, Y. J., and Li, W. G. Protective role of selenium against hepatitis B virus and primary liver cancer in Qidong. Biol Trace Elem.Res 1997;56:117-124. View abstract.
  439. Hogarth, M. B., Marshall, P., Lovat, L. B., Palmer, A. J., Frost, C. G., Fletcher, A. E., Nicholl, C. G., and Bulpitt, C. J. Nutritional supplementation in elderly medical in-patients: a double-blind placebo-controlled trial. Age Ageing 1996;25:453-457. View abstract.
  440. Verhoeven, D. T., Assen, N., Goldbohm, R. A., Dorant, E., van, 't, V, Sturmans, F., Hermus, R. J., and Van den Brandt, P. A. Vitamins C and E, retinol, beta-carotene and dietary fibre in relation to breast cancer risk: a prospective cohort study. Br.J Cancer 1997;75:149-155. View abstract.
  441. Negri, E., La, Vecchia C., Franceschi, S., D'Avanzo, B., Talamini, R., Parpinel, M., Ferraroni, M., Filiberti, R., Montella, M., Falcini, F., Conti, E., and Decarli, A. Intake of selected micronutrients and the risk of breast cancer. Int J Cancer 1-17-1996;65:140-144. View abstract.
  442. Butcher, G. P., Rhodes, J. M., Walker, R., Krasner, N., and Jackson, M. J. The effect of antioxidant supplementation on a serum marker of free radical activity and abnormal serum biochemistry in alcoholic patients admitted for detoxification. J Hepatol. 1993;19:105-109. View abstract.
  443. de la Maza, M. P., Petermann, M., Bunout, D., and Hirsch, S. Effects of long-term vitamin E supplementation in alcoholic cirrhotics. J Am Coll Nutr 1995;14:192-196. View abstract.
  444. Pike, J. and Chandra, R. K. Effect of vitamin and trace element supplementation on immune indices in healthy elderly. Int J Vitam Nutr Res 1995;65:117-121. View abstract.
  445. Verreault, R., Chu, J., Mandelson, M., and Shy, K. A case-control study of diet and invasive cervical cancer. Int J Cancer 6-15-1989;43:1050-1054. View abstract.
  446. Agte, V. and Tarwadi, K. The importance of nutrition in the prevention of ocular disease with special reference to cataract. Ophthalmic Res 2010;44:166-172. View abstract.
  447. Ferrucci, L., Perry, J. R., Matteini, A., Perola, M., Tanaka, T., Silander, K., Rice, N., Melzer, D., Murray, A., Cluett, C., Fried, L. P., Albanes, D., Corsi, A. M., Cherubini, A., Guralnik, J., Bandinelli, S., Singleton, A., Virtamo, J., Walston, J., Semba, R. D., and Frayling, T. M. Common variation in the beta-carotene 15,15'-monooxygenase 1 gene affects circulating levels of carotenoids: a genome-wide association study. Am J Hum Genet 2009;84:123-133. View abstract.
  448. Penn, N. D., Purkins, L., Kelleher, J., Heatley, R. V., Mascie-Taylor, B. H., and Belfield, P. W. The effect of dietary supplementation with vitamins A, C and E on cell-mediated immune function in elderly long-stay patients: a randomized controlled trial. Age Ageing 1991;20:169-174. View abstract.
  449. Maraini, G., Williams, S. L., Sperduto, R. D., Ferris, F., Milton, R. C., Clemons, T. E., Rosmini, F., and Ferrigno, L. A randomized, double-masked, placebo-controlled clinical trial of multivitamin supplementation for age-related lens opacities. Clinical trial of nutritional supplements and age-related cataract report no. 3. Ophthalmology 2008;115:599-607. View abstract.
  450. Gabbay, E., Zigmond, E., Pappo, O., Hemed, N., Rowe, M., Zabrecky, G., Cohen, R., and Ilan, Y. Antioxidant therapy for chronic hepatitis C after failure of interferon: results of phase II randomized, double-blind placebo controlled clinical trial. World J Gastroenterol 10-28-2007;13:5317-5323. View abstract.
  451. Canter, P. H., Wider, B., and Ernst, E. The antioxidant vitamins A, C, E and selenium in the treatment of arthritis: a systematic review of randomized clinical trials. Rheumatology.(Oxford) 2007;46:1223-1233. View abstract.
  452. Hino, K., Murakami, Y., Nagai, A., Kitase, A., Hara, Y., Furutani, T., Ren, F., Yamaguchi, Y., Yutoku, K., Yamashita, S., Okuda, M., Okita, M., and Okita, K. Alpha-tocopherol [corrected] and ascorbic acid attenuates the ribavirin [corrected] induced decrease of eicosapentaenoic acid in erythrocyte membrane in chronic hepatitis C patients. J Gastroenterol Hepatol. 2006;21:1269-1275. View abstract.
  453. Avenell, A., Campbell, M. K., Cook, J. A., Hannaford, P. C., Kilonzo, M. M., McNeill, G., Milne, A. C., Ramsay, C. R., Seymour, D. G., Stephen, A. I., and Vale, L. D. Effect of multivitamin and multimineral supplements on morbidity from infections in older people (MAVIS trial): pragmatic, randomised, double blind, placebo controlled trial. BMJ 8-6-2005;331:324-329. View abstract.
  454. Saeian, K., Bajaj, J. S., Franco, J., Knox, J. F., Daniel, J., Peine, C., McKee, D., Varma, R. R., and Ho, S. High-dose vitamin E supplementation does not diminish ribavirin-associated haemolysis in hepatitis C treatment with combination standard alpha-interferon and ribavirin. Aliment.Pharmacol.Ther 11-15-2004;20:1189-1193. View abstract.
  455. Takagi, H., Kakizaki, S., Sohara, N., Sato, K., Tsukioka, G., Tago, Y., Konaka, K., Kabeya, K., Kaneko, M., Takayama, H., Hashimoto, Y., Yamada, T., Takahashi, H., Shimojo, H., Nagamine, T., and Mori, M. Pilot clinical trial of the use of alpha-tocopherol for the prevention of hepatocellular carcinoma in patients with liver cirrhosis. Int J Vitam Nutr Res 2003;73:411-415. View abstract.
  456. Murphy, S., West, K. P., Jr., Greenough, W. B., III, Cherot, E., Katz, J., and Clement, L. Impact of vitamin A supplementation on the incidence of infection in elderly nursing-home residents: a randomized controlled trial. Age Ageing 1992;21:435-439. View abstract.
  457. Mezey, E., Potter, J. J., Rennie-Tankersley, L., Caballeria, J., and Pares, A. A randomized placebo controlled trial of vitamin E for alcoholic hepatitis. J Hepatol. 2004;40:40-46. View abstract.
  458. Gueguen, S., Pirollet, P., Leroy, P., Guilland, J. C., Arnaud, J., Paille, F., Siest, G., Visvikis, S., Hercberg, S., and Herbeth, B. Changes in serum retinol, alpha-tocopherol, vitamin C, carotenoids, xinc and selenium after micronutrient supplementation during alcohol rehabilitation. J.Am.Coll.Nutr. 2003;22:303-310. View abstract.
  459. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet 7-6-2002;360:7-22. View abstract.
  460. Moorman, P. G., Ricciuti, M. F., Millikan, R. C., and Newman, B. Vitamin supplement use and breast cancer in a North Carolina population. Public Health Nutr 2001;4:821-827. View abstract.
  461. Ideo, G., Bellobuono, A., Tempini, S., Mondazzi, L., Airoldi, A., Benetti, G., Bissoli, F., Cestari, C., Colombo, E., Del, Poggio P., Fracassetti, O., Lazzaroni, S., Marelli, A., Paris, B., Prada, A., Rainer, E., and Roffi, L. Antioxidant drugs combined with alpha-interferon in chronic hepatitis C not responsive to alpha-interferon alone: a randomized, multicentre study. Eur J Gastroenterol Hepatol. 1999;11:1203-1207. View abstract.
  462. Look, M. P., Gerard, A., Rao, G. S., Sudhop, T., Fischer, H. P., Sauerbruch, T., and Spengler, U. Interferon/antioxidant combination therapy for chronic hepatitis C--a controlled pilot trial. Antiviral Res 1999;43:113-122. View abstract.
  463. Bohlke, K., Spiegelman, D., Trichopoulou, A., Katsouyanni, K., and Trichopoulos, D. Vitamins A, C and E and the risk of breast cancer: results from a case-control study in Greece. Br.J Cancer 1999;79:23-29. View abstract.
  464. Gaby, A. R. Natural approaches to epilepsy. Altern.Med Rev. 2007;12:9-24. View abstract.
  465. Fairris, G. M., Perkins, P. J., Lloyd, B., Hinks, L., and Clayton, B. E. The effect on atopic dermatitis of supplementation with selenium and vitamin E. Acta Derm.Venereol. 1989;69:359-362. View abstract.
  466. Yu, S. Y., Zhu, Y. J., Li, W. G., Huang, Q. S., Huang, C. Z., Zhang, Q. N., and Hou, C. A preliminary report on the intervention trials of primary liver cancer in high-risk populations with nutritional supplementation of selenium in China. Biol.Trace Elem.Res. 1991;29:289-294. View abstract.
  467. Singh, U., Otvos, J., Dasgupta, A., de Lemos, J. A., Devaraj, S., and Jialal, I. High-dose alpha-tocopherol therapy does not affect HDL subfractions in patients with coronary artery disease on statin therapy. Clin Chem 2007;53:525-528. View abstract.
  468. Groenbaek, K., Friis, H., Hansen, M., Ring-Larsen, H., and Krarup, H. B. The effect of antioxidant supplementation on hepatitis C viral load, transaminases and oxidative status: a randomized trial among chronic hepatitis C virus-infected patients. Eur J Gastroenterol Hepatol 2006;18:985-989. View abstract.
  469. Rayman, M., Thompson, A., Warren-Perry, M., Galassini, R., Catterick, J., Hall, E., Lawrence, D., and Bliss, J. Impact of selenium on mood and quality of life: a randomized, controlled trial. Biol Psychiatry 1-15-2006;59:147-154. View abstract.
  470. Allsup, S. J., Shenkin, A., Gosney, M. A., Taylor, S., Taylor, W., Hammond, M., and Zambon, M. C. Can a short period of micronutrient supplementation in older institutionalized people improve response to influenza vaccine? A randomized, controlled trial. J Am.Geriatr.Soc. 2004;52:20-24. View abstract.
  471. Chao, W. H., Askew, E. W., Roberts, D. E., Wood, S. M., and Perkins, J. B. Oxidative stress in humans during work at moderate altitude. J Nutr. 1999;129:2009-2012. View abstract.
  472. Pfeiffer, J. M., Askew, E. W., Roberts, D. E., Wood, S. M., Benson, J. E., Johnson, S. C., and Freedman, M. S. Effect of antioxidant supplementation on urine and blood markers of oxidative stress during extended moderate-altitude training. Wilderness.Environ.Med 1999;10:66-74. View abstract.
  473. Munoz, N., Wahrendorf, J., Bang, L. J., Crespi, M., Thurnham, D. I., Day, N. E., Ji, Z. H., Grassi, A., Yan, L. W., Lin, L. G., and . No effect of riboflavine, retinol, and zinc on prevalence of precancerous lesions of oesophagus. Randomised double-blind intervention study in high-risk population of China. Lancet 7-20-1985;2:111-114. View abstract.
  474. Odigwe, C. C., Smedslund, G., Ejemot-Nwadiaro, R. I., Anyanechi, C. C., and Krawinkel, M. B. Supplementary vitamin E, selenium, cysteine and riboflavin for preventing kwashiorkor in preschool children in developing countries. Cochrane.Database.Syst.Rev. 2010;:CD008147. View abstract.
  475. Ciliberto, H., Ciliberto, M., Briend, A., Ashorn, P., Bier, D., and Manary, M. Antioxidant supplementation for the prevention of kwashiorkor in Malawian children: randomised, double blind, placebo controlled trial. BMJ 5-14-2005;330:1109. View abstract.
  476. Law, M. R. and Morris, J. K. By how much does fruit and vegetable consumption reduce the risk of ischaemic heart disease? Eur J Clin Nutr 1998;52:549-556. View abstract.
  477. Bath-Hextall, F. J., Jenkinson, C., Humphreys, R., and Williams, H. C. Dietary supplements for established atopic eczema. Cochrane.Database.Syst.Rev. 2012;2:CD005205. View abstract.
  478. Trikalinos, T. A., Moorthy, D., Chung, M., Yu, W. W., Lee, J., Lichtenstein, A. H., and Lau, J. Concordance of randomized and nonrandomized studies was unrelated to translational patterns of two nutrient-disease associations. J.Clin.Epidemiol. 2012;65:16-29. View abstract.
  479. Rosselli, J. L., Thacker, S. M., Karpinski, J. P., and Petkewicz, K. A. Treatment of IgA nephropathy: an update. Ann.Pharmacother. 2011;45:1284-1296. View abstract.
  480. Gogos, C. A., Ginopoulos, P., Salsa, B., Apostolidou, E., Zoumbos, N. C., and Kalfarentzos, F. Dietary omega-3 polyunsaturated fatty acids plus vitamin E restore immunodeficiency and prolong survival for severely ill patients with generalized malignancy: a randomized control trial. Cancer 1-15-1998;82:395-402. View abstract.
  481. Cahill, R. J., O'Sullivan, K. R., Mathias, P. M., Beattie, S., Hamilton, H., and O'Morain, C. Effects of vitamin antioxidant supplementation on cell kinetics of patients with adenomatous polyps. Gut 1993;34:963-967. View abstract.
  482. Lamm, D. L., Riggs, D. R., Shriver, J. S., vanGilder, P. F., Rach, J. F., and DeHaven, J. I. Megadose vitamins in bladder cancer: a double-blind clinical trial. J Urol 1994;151:21-26. View abstract.
  483. Taylor, P. R., Li, B., Dawsey, S. M., Li, J. Y., Yang, C. S., Guo, W., and Blot, W. J. Prevention of esophageal cancer: the nutrition intervention trials in Linxian, China. Linxian Nutrition Intervention Trials Study Group. Cancer Res 4-1-1994;54(7 Suppl):2029s-2031s. View abstract.
  484. Li, B., Taylor, P. R., Li, J. Y., Dawsey, S. M., Wang, W., Tangrea, J. A., Liu, B. Q., Ershow, A. G., Zheng, S. F., Fraumeni, J. F., Jr., and . Linxian nutrition intervention trials. Design, methods, participant characteristics, and compliance. Ann Epidemiol. 1993;3:577-585. View abstract.
  485. Blot, W. J., Li, J. Y., Taylor, P. R., Guo, W., Dawsey, S. M., and Li, B. The Linxian trials: mortality rates by vitamin-mineral intervention group. Am J Clin Nutr 1995;62(6 Suppl):1424S-1426S. View abstract.
  486. Bussey, H. J., DeCosse, J. J., Deschner, E. E., Eyers, A. A., Lesser, M. L., Morson, B. C., Ritchie, S. M., Thomson, J. P., and Wadsworth, J. A randomized trial of ascorbic acid in polyposis coli. Cancer 10-1-1982;50:1434-1439. View abstract.
  487. Poulter, J. M., White, W. F., and Dickerson, J. W. Ascorbic acid supplementation and five year survival rates in women with early breast cancer. Acta Vitaminol.Enzymol. 1984;6:175-182. View abstract.
  488. Virtamo, J., Edwards, B. K., Virtanen, M., Taylor, P. R., Malila, N., Albanes, D., Huttunen, J. K., Hartman, A. M., Hietanen, P., Maenpaa, H., Koss, L., Nordling, S., and Heinonen, O. P. Effects of supplemental alpha-tocopherol and beta-carotene on urinary tract cancer: incidence and mortality in a controlled trial (Finland). Cancer Causes Control 2000;11:933-939. View abstract.
  489. Blot, W. J. Preventing cancer by disrupting progression of precancerous lesions. J Natl.Cancer Inst. 12-6-2000;92:1868-1869. View abstract.
  490. Albanes, D., Malila, N., Taylor, P. R., Huttunen, J. K., Virtamo, J., Edwards, B. K., Rautalahti, M., Hartman, A. M., Barrett, M. J., Pietinen, P., Hartman, T. J., Sipponen, P., Lewin, K., Teerenhovi, L., Hietanen, P., Tangrea, J. A., Virtanen, M., and Heinonen, O. P. Effects of supplemental alpha-tocopherol and beta-carotene on colorectal cancer: results from a controlled trial (Finland). Cancer Causes Control 2000;11:197-205. View abstract.
  491. Stewart, S., Prince, M., Bassendine, M., Hudson, M., James, O., Jones, D., Record, C., and Day, C. P. A randomized trial of antioxidant therapy alone or with corticosteroids in acute alcoholic hepatitis. J Hepatol. 2007;47:277-283. View abstract.
  492. Dorgan, J. F., Sowell, A., Swanson, C. A., Potischman, N., Miller, R., Schussler, N., and Stephenson, H. E., Jr. Relationships of serum carotenoids, retinol, alpha-tocopherol, and selenium with breast cancer risk: results from a prospective study in Columbia, Missouri (United States). Cancer Causes Control 1998;9:89-97. View abstract.
  493. Nomura, A. M., Stemmermann, G. N., Lee, J., and Craft, N. E. Serum micronutrients and prostate cancer in Japanese Americans in Hawaii. Cancer Epidemiol.Biomarkers Prev. 1997;6:487-491. View abstract.
  494. Helzlsouer, K. J., Alberg, A. J., Norkus, E. P., Morris, J. S., Hoffman, S. C., and Comstock, G. W. Prospective study of serum micronutrients and ovarian cancer. J Natl.Cancer Inst. 1-3-1996;88:32-37. View abstract.
  495. Voorrips, L. E., Goldbohm, R. A., Brants, H. A., van Poppel, G. A., Sturmans, F., Hermus, R. J., and van den Brandt, P. A. A prospective cohort study on antioxidant and folate intake and male lung cancer risk. Cancer Epidemiol.Biomarkers Prev. 2000;9:357-365. View abstract.
  496. Piermarocchi, S., Saviano, S., Parisi, V., Tedeschi, M., Panozzo, G., Scarpa, G., Boschi, G., and Lo, Giudice G. Carotenoids in Age-related Maculopathy Italian Study (CARMIS): two-year results of a randomized study. Eur.J.Ophthalmol. 2012;22:216-225. View abstract.
  497. Bartlett, H. E. and Eperjesi, F. Effect of lutein and antioxidant dietary supplementation on contrast sensitivity in age-related macular disease: a randomized controlled trial. Eur.J.Clin.Nutr. 2007;61:1121-1127. View abstract.
  498. Morris, C. R. and Agin, M. C. Syndrome of allergy, apraxia, and malabsorption: characterization of a neurodevelopmental phenotype that responds to omega 3 and vitamin E supplementation. Altern.Ther Health Med. 2009;15:34-43. View abstract.
  499. Socha, P., Horvath, A., Vajro, P., Dziechciarz, P., Dhawan, A., and Szajewska, H. Pharmacological interventions for nonalcoholic fatty liver disease in adults and in children: a systematic review. J Pediatr.Gastroenterol.Nutr. 2009;48:587-596. View abstract.
  500. Safarinejad, M. R., Hosseini, S. Y., and Kolahi, A. A. Comparison of vitamin E and propionyl-L-carnitine, separately or in combination, in patients with early chronic Peyronie's disease: a double-blind, placebo controlled, randomized study. J Urol. 2007;178(4 Pt 1):1398-1403. View abstract.
  501. Li, H., Li, H. Q., Wang, Y., Xu, H. X., Fan, W. T., Wang, M. L., Sun, P. H., and Xie, X. Y. An intervention study to prevent gastric cancer by micro-selenium and large dose of allitridum. Chin Med.J.(Engl.) 2004;117:1155-1160. View abstract.
  502. Ponz de, Leon M. and Roncucci, L. Chemoprevention of colorectal tumors: role of lactulose and of other agents. Scand J Gastroenterol Suppl 1997;222:72-75. View abstract.
  503. Mark, S. D., Wang, W., Fraumeni, J. F., Jr., Li, J. Y., Taylor, P. R., Wang, G. Q., Guo, W., Dawsey, S. M., Li, B., and Blot, W. J. Lowered risks of hypertension and cerebrovascular disease after vitamin/mineral supplementation: the Linxian Nutrition Intervention Trial. Am.J.Epidemiol. 4-1-1996;143:658-664. View abstract.
  504. Perez, L., Heim, L., Sherzai, A., Jaceldo-Siegl, K., and Sherzai, A. Nutrition and vascular dementia. J.Nutr.Health Aging 2012;16:319-324. View abstract.
  505. Marik, P. E. and Flemmer, M. Do dietary supplements have beneficial health effects in industrialized nations: what is the evidence? JPEN J.Parenter.Enteral Nutr. 2012;36:159-168. View abstract.
  506. Morris, M. C. Nutritional determinants of cognitive aging and dementia. Proc.Nutr.Soc. 2012;71:1-13. View abstract.
  507. Lazzeroni, M., Gandini, S., Puntoni, M., Bonanni, B., Gennari, A., and Decensi, A. The science behind vitamins and natural compounds for breast cancer prevention. Getting the most prevention out of it. Breast 2011;20 Suppl 3:S36-S41. View abstract.
  508. Debreceni, B. and Debreceni, L. Why do homocysteine-lowering B vitamin and antioxidant E vitamin supplementations appear to be ineffective in the prevention of cardiovascular diseases? Cardiovasc.Ther. 2012;30:227-233. View abstract.
  509. Zhang, S. M., Cook, N. R., Albert, C. M., Gaziano, J. M., Buring, J. E., and Manson, J. E. Effect of combined folic acid, vitamin B6, and vitamin B12 on cancer risk in women: a randomized trial. JAMA 11-5-2008;300:2012-2021. View abstract.
  510. Jaszewski, R., Misra, S., Tobi, M., Ullah, N., Naumoff, J. A., Kucuk, O., Levi, E., Axelrod, B. N., Patel, B. B., and Majumdar, A. P. Folic acid supplementation inhibits recurrence of colorectal adenomas: a randomized chemoprevention trial. World J Gastroenterol 7-28-2008;14:4492-4498. View abstract.
  511. Logan, R. F., Grainge, M. J., Shepherd, V. C., Armitage, N. C., and Muir, K. R. Aspirin and folic acid for the prevention of recurrent colorectal adenomas. Gastroenterology 2008;134:29-38. View abstract.
  512. Cole, B. F., Baron, J. A., Sandler, R. S., Haile, R. W., Ahnen, D. J., Bresalier, R. S., McKeown-Eyssen, G., Summers, R. W., Rothstein, R. I., Burke, C. A., Snover, D. C., Church, T. R., Allen, J. I., Robertson, D. J., Beck, G. J., Bond, J. H., Byers, T., Mandel, J. S., Mott, L. A., Pearson, L. H., Barry, E. L., Rees, J. R., Marcon, N., Saibil, F., Ueland, P. M., and Greenberg, E. R. Folic acid for the prevention of colorectal adenomas: a randomized clinical trial. JAMA 6-6-2007;297:2351-2359. View abstract.
  513. Lonn, E., Yusuf, S., Arnold, M. J., Sheridan, P., Pogue, J., Micks, M., McQueen, M. J., Probstfield, J., Fodor, G., Held, C., and Genest, J., Jr. Homocysteine lowering with folic acid and B vitamins in vascular disease. N.Engl.J Med 4-13-2006;354:1567-1577. View abstract.
  514. Lonn, E., Held, C., Arnold, J. M., Probstfield, J., McQueen, M., Micks, M., Pogue, J., Sheridan, P., Bosch, J., Genest, J., and Yusuf, S. Rationale, design and baseline characteristics of a large, simple, randomized trial of combined folic acid and vitamins B6 and B12 in high-risk patients: the Heart Outcomes Prevention Evaluation (HOPE)-2 trial. Can.J Cardiol 2006;22:47-53. View abstract.
  515. Ranganathan, L. N. and Ramaratnam, S. Vitamins for epilepsy. Cochrane.Database.Syst.Rev 2005;:CD004304. View abstract.
  516. Johnson, S. R. Premenstrual syndrome therapy. Clin Obstet.Gynecol. 1998;41:405-421. View abstract.
  517. Baldinger, R., Katzberg, H. D., and Weber, M. Treatment for cramps in amyotrophic lateral sclerosis/motor neuron disease. Cochrane.Database.Syst.Rev. 2012;4:CD004157. View abstract.
  518. Yaffe, K., Clemons, T. E., McBee, W. L., and Lindblad, A. S. Impact of antioxidants, zinc, and copper on cognition in the elderly: a randomized, controlled trial. Neurology 11-9-2004;63:1705-1707. View abstract.
  519. Lockwood, K., Moesgaard, S., Hanioka, T., and Folkers, K. Apparent partial remission of breast cancer in 'high risk' patients supplemented with nutritional antioxidants, essential fatty acids and coenzyme Q10. Mol.Aspects Med 1994;15 Suppl:s231-s240. View abstract.
  520. Sieswerda, E., van Dalen, E. C., Postma, A., Cheuk, D. K., Caron, H. N., and Kremer, L. C. Medical interventions for treating anthracycline-induced symptomatic and asymptomatic cardiotoxicity during and after treatment for childhood cancer. Cochrane Database Syst.Rev. 2011;:CD008011. View abstract.
  521. Patel, B. P. and Hamadeh, M. J. Nutritional and exercise-based interventions in the treatment of amyotrophic lateral sclerosis. Clin Nutr. 2009;28:604-617. View abstract.
  522. Witte, K. K., Nikitin, N. P., Parker, A. C., von Haehling, S., Volk, H. D., Anker, S. D., Clark, A. L., and Cleland, J. G. The effect of micronutrient supplementation on quality-of-life and left ventricular function in elderly patients with chronic heart failure. Eur Heart J 2005;26:2238-2244. View abstract.
  523. Thomas, M. G., Thomson, J. P., and Williamson, R. C. Oral calcium inhibits rectal epithelial proliferation in familial adenomatous polyposis. Br.J Surg. 1993;80:499-501. View abstract.
  524. Whelan, A. M., Jurgens, T. M., and Naylor, H. Herbs, vitamins and minerals in the treatment of premenstrual syndrome: a systematic review. Can.J.Clin.Pharmacol. 2009;16:e407-e429. View abstract.
  525. Hofstad, B., Almendingen, K., Vatn, M., Andersen, S. N., Owen, R. W., Larsen, S., and Osnes, M. Growth and recurrence of colorectal polyps: a double-blind 3-year intervention with calcium and antioxidants. Digestion 1998;59:148-156. View abstract.
  526. Richer, S. Multicenter ophthalmic and nutritional age-related macular degeneration study--part 2: antioxidant intervention and conclusions. J.Am.Optom.Assoc. 1996;67:30-49. View abstract.
  527. Rapola, J. M., Virtamo, J., Haukka, J. K., Heinonen, O. P., Albanes, D., Taylor, P. R., and Huttunen, J. K. Effect of vitamin E and beta carotene on the incidence of angina pectoris. A randomized, double-blind, controlled trial. JAMA 3-6-1996;275:693-698. View abstract.
  528. Li, J. Y., Taylor, P. R., Li, B., Dawsey, S., Wang, G. Q., Ershow, A. G., Guo, W., Liu, S. F., Yang, C. S., Shen, Q., and . Nutrition intervention trials in Linxian, China: multiple vitamin/mineral supplementation, cancer incidence, and disease-specific mortality among adults with esophageal dysplasia. J.Natl.Cancer Inst. 9-15-1993;85:1492-1498. View abstract.
  529. No author. The alpha-tocopherol, beta-carotene lung cancer prevention study: design, methods, participant characteristics, and compliance. The ATBC Cancer Prevention Study Group. Ann.Epidemiol. 1994;4:1-10. View abstract.
  530. MacLennan, R., Macrae, F., Bain, C., Battistutta, D., Chapuis, P., Gratten, H., Lambert, J., Newland, R. C., Ngu, M., Russell, A., and . Randomized trial of intake of fat, fiber, and beta carotene to prevent colorectal adenomas. The Australian Polyp Prevention Project. J.Natl.Cancer Inst. 12-6-1995;87:1760-1766. View abstract.
  531. Evans, J. R. and Lawrenson, J. G. Antioxidant vitamin and mineral supplements for slowing the progression of age-related macular degeneration. Cochrane.Database.Syst.Rev. 2012;11:CD000254. View abstract.
  532. Cortes-Jofre, M., Rueda, J. R., Corsini-Munoz, G., Fonseca-Cortes, C., Caraballoso, M., and Bonfill, Cosp, X. Drugs for preventing lung cancer in healthy people. Cochrane.Database.Syst.Rev. 2012;10:CD002141. View abstract.
  533. Mathew, M. C., Ervin, A. M., Tao, J., and Davis, R. M. Antioxidant vitamin supplementation for preventing and slowing the progression of age-related cataract. Cochrane.Database.Syst.Rev. 2012;6:CD004567. View abstract.
  534. Evans, J. R. and Lawrenson, J. G. Antioxidant vitamin and mineral supplements for preventing age-related macular degeneration. Cochrane.Database.Syst.Rev. 2012;6:CD000253. View abstract.
  535. Bjelakovic, G., Nikolova, D., Gluud, L. L., Simonetti, R. G., and Gluud, C. Antioxidant supplements for prevention of mortality in healthy participants and patients with various diseases. Cochrane.Database.Syst.Rev. 2012;3:CD007176. View abstract.
  536. Galli, F., Battistoni, A., Gambari, R., Pompella, A., Bragonzi, A., Pilolli, F., Iuliano, L., Piroddi, M., Dechecchi, M. C., and Cabrini, G. Oxidative stress and antioxidant therapy in cystic fibrosis. Biochim.Biophys.Acta 2012;1822:690-713. View abstract.
  537. Lahner, E., Persechino, S., and Annibale, B. Micronutrients (Other than iron) and Helicobacter pylori infection: a systematic review. Helicobacter. 2012;17:1-15. View abstract.
  538. Greenberg, E. R., Baron, J. A., Stukel, T. A., Stevens, M. M., Mandel, J. S., Spencer, S. K., Elias, P. M., Lowe, N., Nierenberg, D. W., Bayrd, G., and . A clinical trial of beta carotene to prevent basal-cell and squamous-cell cancers of the skin. The Skin Cancer Prevention Study Group. N.Engl.J.Med. 9-20-1990;323:789-795. View abstract.
  539. Fulan, H., Changxing, J., Baina, W. Y., Wencui, Z., Chunqing, L., Fan, W., Dandan, L., Dianjun, S., Tong, W., Da, P., and Yashuang, Z. Retinol, vitamins A, C, and E and breast cancer risk: a meta-analysis and meta-regression. Cancer Causes Control 2011;22:1383-1396. View abstract.
  540. Myung, S. K., Ju, W., Kim, S. C., and Kim, H. Vitamin or antioxidant intake (or serum level) and risk of cervical neoplasm: a meta-analysis. BJOG. 2011;118:1285-1291. View abstract.
  541. Bjelakovic, G., Gluud, L. L., Nikolova, D., Bjelakovic, M., Nagorni, A., and Gluud, C. Antioxidant supplements for liver diseases. Cochrane.Database.Syst.Rev. 2011;:CD007749. View abstract.
  542. Stratton, J. and Godwin, M. The effect of supplemental vitamins and minerals on the development of prostate cancer: a systematic review and meta-analysis. Fam.Pract. 2011;28:243-252. View abstract.
  543. Cooper, K., Squires, H., Carroll, C., Papaioannou, D., Booth, A., Logan, R. F., Maguire, C., Hind, D., and Tappenden, P. Chemoprevention of colorectal cancer: systematic review and economic evaluation. Health Technol.Assess. 2010;14:1-206. View abstract.
  544. Papaioannou, D., Cooper, K. L., Carroll, C., Hind, D., Squires, H., Tappenden, P., and Logan, R. F. Antioxidants in the chemoprevention of colorectal cancer and colorectal adenomas in the general population: a systematic review and meta-analysis. Colorectal Dis. 2011;13:1085-1099. View abstract.
  545. Hercberg, S., Kesse-Guyot, E., Druesne-Pecollo, N., Touvier, M., Favier, A., Latino-Martel, P., Briancon, S., and Galan, P. Incidence of cancers, ischemic cardiovascular diseases and mortality during 5-year follow-up after stopping antioxidant vitamins and minerals supplements: a postintervention follow-up in the SU.VI.MAX Study. Int.J.Cancer 10-15-2010;127:1875-1881. View abstract.
  546. Song, Y., Cook, N. R., Albert, C. M., Van, Denburgh M., and Manson, J. E. Effects of vitamins C and E and beta-carotene on the risk of type 2 diabetes in women at high risk of cardiovascular disease: a randomized controlled trial. Am.J.Clin.Nutr. 2009;90:429-437. View abstract.
  547. Allen, S., Britton, J. R., and Leonardi-Bee, J. A. Association between antioxidant vitamins and asthma outcome measures: systematic review and meta-analysis. Thorax 2009;64:610-619. View abstract.
  548. Garbagnati, F., Cairella, G., De, Martino A., Multari, M., Scognamiglio, U., Venturiero, V., and Paolucci, S. Is antioxidant and n-3 supplementation able to improve functional status in poststroke patients? Results from the Nutristroke Trial. Cerebrovasc.Dis. 2009;27:375-383. View abstract.
  549. Bjelakovic, G., Nikolova, D., Simonetti, R. G., and Gluud, C. Systematic review: primary and secondary prevention of gastrointestinal cancers with antioxidant supplements. Aliment.Pharmacol.Ther. 9-15-2008;28:689-703. View abstract.
  550. Lin, J., Cook, N. R., Albert, C., Zaharris, E., Gaziano, J. M., Van, Denburgh M., Buring, J. E., and Manson, J. E. Vitamins C and E and beta carotene supplementation and cancer risk: a randomized controlled trial. J.Natl.Cancer Inst. 1-7-2009;101:14-23. View abstract.
  551. Sesso, H. D., Buring, J. E., Christen, W. G., Kurth, T., Belanger, C., MacFadyen, J., Bubes, V., Manson, J. E., Glynn, R. J., and Gaziano, J. M. Vitamins E and C in the prevention of cardiovascular disease in men: the Physicians' Health Study II randomized controlled trial. JAMA 11-12-2008;300:2123-2133. View abstract.
  552. Bjelakovic, G., Nikolova, D., Gluud, L. L., Simonetti, R. G., and Gluud, C. Antioxidant supplements for prevention of mortality in healthy participants and patients with various diseases. Cochrane.Database.Syst.Rev. 2008;:CD007176. View abstract.
  553. Gao, J., Gao, X., Li, W., Zhu, Y., and Thompson, P. J. Observational studies on the effect of dietary antioxidants on asthma: a meta-analysis. Respirology. 2008;13:528-536. View abstract.
  554. Evans, J. R. and Henshaw, K. Antioxidant vitamin and mineral supplements for preventing age-related macular degeneration. Cochrane.Database.Syst.Rev. 2008;:CD000253. View abstract.
  555. Christen, W. G., Glynn, R. J., Chew, E. Y., and Buring, J. E. Vitamin E and age-related cataract in a randomized trial of women. Ophthalmology 2008;115:822-829. View abstract.
  556. Grieger, J. A., Nowson, C. A., Jarman, H. F., Malon, R., and Ackland, L. M. Multivitamin supplementation improves nutritional status and bone quality in aged care residents. Eur.J.Clin.Nutr. 2009;63:558-565. View abstract.
  557. Cook, N. R., Albert, C. M., Gaziano, J. M., Zaharris, E., MacFadyen, J., Danielson, E., Buring, J. E., and Manson, J. E. A randomized factorial trial of vitamins C and E and beta carotene in the secondary prevention of cardiovascular events in women: results from the Women's Antioxidant Cardiovascular Study. Arch.Intern.Med. 8-13-2007;167:1610-1618. View abstract.
  558. Kubo, A. and Corley, D. A. Meta-analysis of antioxidant intake and the risk of esophageal and gastric cardia adenocarcinoma. Am.J.Gastroenterol. 2007;102:2323-2330. View abstract.
  559. Liu, B. A., McGeer, A., McArthur, M. A., Simor, A. E., Aghdassi, E., Davis, L., and Allard, J. P. Effect of multivitamin and mineral supplementation on episodes of infection in nursing home residents: a randomized, placebo-controlled study. J.Am.Geriatr.Soc. 2007;55:35-42. View abstract.
  560. Plummer, M., Vivas, J., Lopez, G., Bravo, J. C., Peraza, S., Carillo, E., Cano, E., Castro, D., Andrade, O., Sanchez, V., Garcia, R., Buiatti, E., Aebischer, C., Franceschi, S., Oliver, W., and Munoz, N. Chemoprevention of precancerous gastric lesions with antioxidant vitamin supplementation: a randomized trial in a high-risk population. J.Natl.Cancer Inst. 1-17-2007;99:137-146. View abstract.
  561. Kamangar, F., Qiao, Y. L., Yu, B., Sun, X. D., Abnet, C. C., Fan, J. H., Mark, S. D., Zhao, P., Dawsey, S. M., and Taylor, P. R. Lung cancer chemoprevention: a randomized, double-blind trial in Linxian, China. Cancer Epidemiol.Biomarkers Prev. 2006;15:1562-1564. View abstract.
  562. Huang, H. Y., Caballero, B., Chang, S., Alberg, A. J., Semba, R. D., Schneyer, C. R., Wilson, R. F., Cheng, T. Y., Vassy, J., Prokopowicz, G., Barnes, G. J., and Bass, E. B. The efficacy and safety of multivitamin and mineral supplement use to prevent cancer and chronic disease in adults: a systematic review for a National Institutes of Health state-of-the-science conference. Ann.Intern.Med. 9-5-2006;145:372-385. View abstract.
  563. Coulter, I. D., Hardy, M. L., Morton, S. C., Hilton, L. G., Tu, W., Valentine, D., and Shekelle, P. G. Antioxidants vitamin C and vitamin e for the prevention and treatment of cancer. J Gen.Intern Med 2006;21:735-744. View abstract.
  564. Gritz, D. C., Srinivasan, M., Smith, S. D., Kim, U., Lietman, T. M., Wilkins, J. H., Priyadharshini, B., John, R. K., Aravind, S., Prajna, N. V., Duraisami, Thulasiraj R., and Whitcher, J. P. The Antioxidants in Prevention of Cataracts Study: effects of antioxidant supplements on cataract progression in South India. Br J Ophthalmol. 2006;90:847-851. View abstract.
  565. Goodman, G. E., Thornquist, M. D., Balmes, J., Cullen, M. R., Meyskens, F. L., Jr., Omenn, G. S., Valanis, B., and Williams, J. H., Jr. The Beta-Carotene and Retinol Efficacy Trial: incidence of lung cancer and cardiovascular disease mortality during 6-year follow-up after stopping beta-carotene and retinol supplements. J.Natl.Cancer Inst. 12-1-2004;96:1743-1750. View abstract.
  566. Tornwall, M. E., Virtamo, J., Korhonen, P. A., Virtanen, M. J., Albanes, D., and Huttunen, J. K. Postintervention effect of alpha tocopherol and beta carotene on different strokes: a 6-year follow-up of the Alpha Tocopherol, Beta Carotene Cancer Prevention Study. Stroke 2004;35:1908-1913. View abstract.
  567. Chandra, R. K. Effect of vitamin and trace-element supplementation on immune responses and infection in elderly subjects. Lancet 11-7-1992;340:1124-1127. View abstract.
  568. Sasazuki, S., Sasaki, S., Tsubono, Y., Okubo, S., Hayashi, M., Kakizoe, T., and Tsugane, S. The effect of 5-year vitamin C supplementation on serum pepsinogen level and Helicobacter pylori infection. Cancer Sci. 2003;94:378-382. View abstract.
  569. Baron, J. A., Cole, B. F., Mott, L., Haile, R., Grau, M., Church, T. R., Beck, G. J., and Greenberg, E. R. Neoplastic and antineoplastic effects of beta-carotene on colorectal adenoma recurrence: results of a randomized trial. J.Natl.Cancer Inst. 5-21-2003;95:717-722. View abstract.
  570. Zhu, S., Mason, J., Shi, Y., Hu, Y., Li, R., Wahg, M., Zhou, Y., Jin, G., Xie, Y., Wu, G., Xia, D., Qian, Z., Sohg, H., Zhang, L., Russell, R., and Xiao, S. The effect of folic acid on the development of stomach and other gastrointestinal cancers. Chin Med.J.(Engl.) 2003;116:15-19. View abstract.
  571. Prince, M. I., Mitchison, H. C., Ashley, D., Burke, D. A., Edwards, N., Bramble, M. G., James, O. F., and Jones, D. E. Oral antioxidant supplementation for fatigue associated with primary biliary cirrhosis: results of a multicentre, randomized, placebo-controlled, cross-over trial. Aliment.Pharmacol.Ther. 2003;17:137-143. View abstract.
  572. Malila, N., Taylor, P. R., Virtanen, M. J., Korhonen, P., Huttunen, J. K., Albanes, D., and Virtamo, J. Effects of alpha-tocopherol and beta-carotene supplementation on gastric cancer incidence in male smokers (ATBC Study, Finland). Cancer Causes Control 2002;13:617-623. View abstract.
  573. No author. MRC/BHF Heart Protection Study of antioxidant vitamin supplementation in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet 7-6-2002;360:23-33. View abstract.
  574. Schmidt, M. C., Askew, E. W., Roberts, D. E., Prior, R. L., Ensign, W. Y., Jr., and Hesslink, R. E., Jr. Oxidative stress in humans training in a cold, moderate altitude environment and their response to a phytochemical antioxidant supplement. Wilderness.Environ.Med. 2002;13:94-105. View abstract.
  575. Malila, N., Virtamo, J., Virtanen, M., Pietinen, P., Albanes, D., and Teppo, L. Dietary and serum alpha-tocopherol, beta-carotene and retinol, and risk for colorectal cancer in male smokers. Eur.J.Clin.Nutr. 2002;56:615-621. View abstract.
  576. You, W. C., Chang, Y. S., Heinrich, J., Ma, J. L., Liu, W. D., Zhang, L., Brown, L. M., Yang, C. S., Gail, M. H., Fraumeni, J. F., Jr., and Xu, G. W. An intervention trial to inhibit the progression of precancerous gastric lesions: compliance, serum micronutrients and S-allyl cysteine levels, and toxicity. Eur.J.Cancer Prev. 2001;10:257-263. View abstract.
  577. Jacobson, J. S., Begg, M. D., Wang, L. W., Wang, Q., Agarwal, M., Norkus, E., Singh, V. N., Young, T. L., Yang, D., and Santella, R. M. Effects of a 6-month vitamin intervention on DNA damage in heavy smokers. Cancer Epidemiol.Biomarkers Prev. 2000;9:1303-1311. View abstract.
  578. Rosenbaum, C. C., O'Mathuna, D. P., Chavez, M., and Shields, K. Antioxidants and antiinflammatory dietary supplements for osteoarthritis and rheumatoid arthritis. Altern.Ther.Health Med. 2010;16:32-40. View abstract.
  579. Flora, S. J. Arsenic-induced oxidative stress and its reversibility. Free Radic.Biol.Med 7-15-2011;51:257-281. View abstract.
  580. Dysken MW, Sano M, Asthana S, et al. Effect of vitamin E and memantine on functional decline in Alzheimer disease: the TEAM-AD VA cooperative randomized trial. JAMA 2014;311:33-44. View abstract.
  581. Klein EA, Thompson IM Jr, Tangen CM, et al. Vitamin E and the risk of prostate cancer: the Selenium and Vitamin E Cancer Prevention Trial (SELECT). JAMA 2011;306:1549-56. View abstract.
  582. Sanyal AJ, Chalasani N, Kowdley KV, et al. Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis. N Engl J Med 2010;362:1675-85. View abstract.
  583. Smedts HP, de Vries JH, Rakhshandehroo M, et al. High maternal vitamin E intake by diet or supplements is associated with congenital heart defects in the offspring. BJOG 2009;116:416-23. View abstract.
  584. Hayden KM, Welsh-Bohmer KA, Wengreen HJ, et al; Cache County Investigators. Risk of mortality with vitamin E supplements: the Cache County study. Am L Med 2007;120:180-4. View abstract.
  585. Gaziano JM, Glynn RJ, Christen WG, et al. Vitamins E and C in the prevention of prostate total cancer in men: the physicians' health study II randomised controlled trial. JAMA 2009;301:52-62. View abstract.
  586. Lippmann SM, Klein EA, Goodman PJ, et al. Effect of selenium and vitamin E on risk of prostate cancer and other cancers: the selenium and vitamin E cancer prevention trial (SELECT). JAMA 2009;301:39-51. View abstract.
  587. Lappe JM, Travers-Gustafson D, Davies KM, et al. Vitamin D and calcium supplementation reduces cancer risk: results of a randomized trial. Am J Clin Nutr 2007;85:1586-91. View abstract.
  588. Lawson KA, Wright ME, Subar A, et al. Multivitamin use and risk of prostate cancer in the National Institutes of Health-AARP Diet and Health Study. J Natl Cancer Inst 2007;99:754-64. View abstract.
  589. Bjelakovic G, Nikolova D, Gluud LL, et al. Mortality in randomized trials of antioxidant supplements for primary and secondary prevention: systematic review and meta-analysis. JAMA 2007;297:842-57. View abstract.
  590. Kompauer I, Heinrich J, Wolfram G, Linseisen J. Association of carotenoids, tocopherols, and vitamin C in plasma with allergic rhinitis and allergic sensitization in adults. Public Health Nutr 2006;9:472-9. View abstract.
  591. Devereux G, Turner SW, Craig LC, et al. Low maternal vitamin E intake during pregnancy is associated with asthma in 5-year-old children. Am J Respir Crit Care Med 2006;174:499-507. View abstract.
  592. Aberg F, Appelkvist EL, Broijersen A, et al. Gemfibrozil-induced decrease in serum ubiquinone and alpha- and gamma-tocopherol levels in men with combined hyperlipidaemia. Eur J Clin Invest 1998;28:235-42. View abstract.
  593. Schurks M, Glynn RJ, Rist PM, et al. Effects of vitamin E on stroke subtypes: meta-analysis of randomized controlled trials. BMJ 2010;341: c5702. doi: 10.1136/bmj.c5702. View abstract.
  594. You WC, Brown LM, Zhang L, et al. Randomized double-blind factorial trial of three treatments to reduce the prevalence of precancerous gastric lesions. J Natl Cancer Inst 2006;98:974-83. View abstract.
  595. Ziaei S, Zakeri M, Kazemnejad A. A randomised controlled trial of vitamin E in the treatment of primary dysmenorrhoea. BJOG 2005;112:466-9. View abstract.
  596. Wactawski-Wende J, Kotchen JM, Anderson GL. Calcium plus vitamin D supplementation and the risk of colorectal cancer. N Engl J Med 2006;354:684-96. View abstract.
  597. van Leeuwen R, Boekhoorn S, Vingerling JR, et al. Dietary intake of antioxidants and risk of age-related macular degeneration. JAMA 2005;294:3101-7. View abstract.
  598. Meyer F, Galan P, Douville P, et al. Antioxidant vitamin and mineral supplementation and prostate cancer prevention in the SU.VI.MAX trial. Int J Cancer 2005;116:182-6. View abstract.
  599. Dagnelie PC, Schuurman AG, Goldbohm RA, Van den Brandt PA. Diet, anthropometric measures and prostate cancer risk: a review of prospective cohort and intervention studies. BJU Int 2004;93:1139-50. View abstract.
  600. Kirsh VA, Hayes RB, Mayne ST, et al. Supplemental and dietary vitamin E, beta-carotene, and vitamin C intakes and prostate cancer risk. J Natl Cancer Inst 2006;98:245-54. View abstract.
  601. Hercberg S, Galan P, Preziosi P, et al. The SU.VI.MAX Study: a randomized, placebo-controlled trial of the health effects of antioxidant vitamins and minerals. Arch Intern Med 2004;164:2335-42. View abstract.
  602. Knekt P, Ritz J, Pereira MA, et al. Antioxidant vitamins and coronary heart disease risk: a pooled analysis of 9 cohorts. Am J Clin Nutr 2004;80:1508-20. View abstract.
  603. Conklin KA. Cancer chemotherapy and antioxidants. J Nutr 2004;134:3201S-3204S. View abstract.
  604. Prasad KN. Rationale for using high-dose multiple dietary antioxidants as an adjunct to radiation therapy and chemotherapy. J Nutr 2004;134:3182S-3S. View abstract.
  605. Block G, Jensen C, Dietrich M, et al. Plasma C-reactive protein concentrations in active and passive smokers: influence of antioxidant supplementation. J Am Coll Nutr 2004;23:141-7. View abstract.
  606. Cho E, Seddon JM, Rosner B, et al. Prospective study of intake of fruits, vegetables, vitamins, and carotenoids and risk of age-related maculopathy. Arch Ophthalmol 2004;122:883-92. View abstract.
  607. Cesari M, Pahor M, Bartali B, et al. Antioxidants and physical performance in elderly persons: the Invecchiare in Chianti (InCHIANTI) study. Am J Clin Nutr 2004;79:289-94. View abstract.
  608. Adams LA, Angulo P. Vitamins E and C for the treatment of NASH: duplication of results but lack of demonstration of efficacy. Am J Gastroenterol 2003;98:2348-50. View abstract.
  609. Montonen J, Knekt P, Jarvinen R, Reunanen A. Dietary antioxidant intake and risk of type 2 diabetes. Diabetes Care 2004;27:362-6. View abstract.
  610. Brigelius-Flohe R, Kelly FJ, Salonen JT, et al. The European perspective on vitamin E: current knowledge and future research. Am J Clin Nutr 2002;76:703-16.. View abstract.
  611. Schneider C. Chemistry and biology of vitamin E. Mol Nutr Food Res 2005;49:7-30.. View abstract.
  612. Jiang Q, Wong J, Fyrst H, et al. gamma-Tocopherol or combinations of vitamin E forms induce cell death in human prostate cancer cells by interrupting sphingolipid synthesis. Proc Natl Acad Sci U S A 2004;101:17825-30.. View abstract.
  613. Blatt DH, Pryor WA, Mata JE, Rodriguez-Proteau R. Re-evaluation of the relative potency of synthetic and natural alpha-tocopherol: experimental and clinical observations. J Nutr Biochem 2004;15:380-95.. View abstract.
  614. Wagner KH, Kamal-Eldin A, Elmadfa I. Gamma-tocopherol--an underestimated vitamin? Ann Nutr Metab 2004;48:169-88.. View abstract.
  615. Brigelius-Flohe R. Vitamin E and drug metabolism. Biochem Biophys Res Commun 2003;305:737-40. View abstract.
  616. Landes N, Pfluger P, Kluth D, et al. Vitamin E activates gene expression via the pregnane X receptor. Biochem Pharmacol 2003;65:269-73. . View abstract.
  617. Kaempf-Rotzoll DE, Traber MG, Arai H. Vitamin E and transfer proteins. Curr Opin Lipidol 2003;14:249-54.. View abstract.
  618. Jain SK, McVie R, Jaramillo JJ, et al. Effect of modest vitamin E supplementation on blood glycated hemoglobin and triglyceride levels and red cell indices in type I diabetic patients. J Am Coll Nutr 1996;15:458-61. . View abstract.
  619. Gomez-Perez FJ, Valles-Sanchez VE, Lopez-Alvarenga JC, et al. Vitamin E modifies neither fructosamine nor HbA1c levels in poorly controlled diabetes. Rev Invest Clin 1996;48:421-4. . View abstract.
  620. Corrada M, Kawas C. Reduced risk of Alzheimer's disease with high folate Intake: The Baltimore Longitudinal Study of Aging. Alzheimers Dement 2005;1:11-18. View abstract.
  621. Huang HY, Appel LJ, Croft KD, et al. Effects of vitamin C and vitamin E on in vivo lipid peroxidation: results of a randomized controlled trial. Am J Clin Nutr 2002;76:549-55. View abstract.
  622. Kraemer K, Koch W, Hoppe PP. Is all-rac-alpha-tocopherol different from RRR-alpha-tocopherol regarding cardiovascular efficacy? A meta-analysis of clinical trials. Ann N Y Acad Sci 2004;1031:435-8. View abstract.
  623. Lee IM, Cook NR, Gaziano JM, et al. Vitamin E in the primary prevention of cardiovascular disease and cancer: The Women's Health Study: A randomized controlled trial. JAMA 2005;294:56-65. View abstract.
  624. Wluka AE, Stuckey S, Brand C, Cicuttini FM. Supplementary vitamin E does not affect the loss of cartilage volume in knee osteoarthritis: A 2 year double blind randomized placebo controlled study. J Rheumatol 2002;29:2585-91. View abstract.
  625. Petersen RC, Thomas RG, Grundman M, et al. Vitamin E and donepezil for the treatment of mild cognitive impairment. N Engl J Med 2005;352:2379-88. View abstract.
  626. Bairati I, Meyer F, Gelinas M, et al. A randomized trial of antioxidant vitamins to prevent second primary cancers in head and neck cancer patients. J Natl Cancer Inst 2005;97:481-8. View abstract.
  627. Weinstein SJ, Wright ME, Pietinen P, King I, Tan C, Taylor PR, Virtamo J, Albanes D. Serum alpha-tocopherol and gamma-tocopherol in relation to prostate cancer risk in a prospective study. J Natl Cancer Inst 2005;97:396-9. View abstract.
  628. Lonn E, Bosch J, Yusuf S, et al. HOPE and HOPE-TOO Trial Investigators. Effects of long-term vitamin E supplementation on cardiovascular events and cancer: a randomized controlled trial. JAMA 2005;293:1338-47. View abstract.
  629. Cook NR, Le IM, Manson JE, et al. Effects of beta-carotene supplementation on cancer incidence by baseline characteristics in the Physicians' Health Study (United States). Cancer Causes Control 2000;11:617-26. View abstract.
  630. Hartman TJ, Dorgan JF, Woodson K, et al. Effects of long-term alpha-tocopherol supplementation on serum hormones in older men. Prostate 2001;46:33-8. View abstract.
  631. Thompson TA, Wilding G. Androgen antagonist activity by the antioxidant moiety of vitamin E, 2,2,5,7,8-pentamethyl-6-chromanol in human prostate carcinoma cells. Mol Cancer Ther 2003;2:797-803. View abstract.
  632. Goodman GE, Schaffer S, Omenn GS, et al. The association between lung and prostate cancer risk, and serum micronutrients: results and lessons learned from beta-carotene and retinol efficacy trial. Cancer Epidemiol Biomarkers Prev 2003;12:518-26. View abstract.
  633. Rodriguez C, Jacobs EJ, Mondul AM, et al. Vitamin E supplements and risk of prostate cancer in U.S. men. Cancer Epidemiol Biomarkers Prev 2004;13:378-82. View abstract.
  634. Dagnelie PC, Schuurman AG, Goldbohm RA, Van den Brandt PA. Diet, anthropometric measures and prostate cancer risk: a review of prospective cohort and intervention studies. BJU Int 2004;93:1139-50. View abstract.
  635. Vega-Lopez S, Kaul N, Devaraj S, et al. Supplementation with omega3 polyunsaturated fatty acids and all-rac alpha-tocopherol alone and in combination failed to exert an anti-inflammatory effect in human volunteers. Metabolism 2004;53:236-40. View abstract.
  636. Huang HY, Appel LJ. Supplementation of diets with alpha-tocopherol reduces serum concentrations of gamma- and delta-tocopherol in humans. J Nutr 2003;133:3137-40. View abstract.
  637. Abudu N, Miller JJ, Attaelmannan M, Levinson SS. Vitamins in human arteriosclerosis with emphasis on vitamin C and vitamin E. Clin Chim Acta 2004;339:11-25. View abstract.
  638. Jiang Q, Christen S, Shigenaga MK, Ames BN. gamma-tocopherol, the major form of vitamin E in the US diet, deserves more attention. Am J Clin Nutr 2001;74:714-22. View abstract.
  639. Shekelle PG, Morton SC, Jungvig LK, et al. Effect of supplemental vitamin E for the prevention and treatment of cardiovascular disease. J Gen Intern Med 2004;19:380-9. View abstract.
  640. Eidelman RS, Hollar D, Hebert PR, et al. Randomized trials of vitamin E in the treatment and prevention of cardiovascular disease. Arch Intern Med 2004;164:1552-6. View abstract.
  641. Miller ER 3rd, Pastor-Barriuso R, Dalal D, et al. Meta-analysis: High-dosage vitamin E supplementation may increase all-cause mortality. Ann Intern Med 2005;142:60520-53. View abstract.
  642. Bjelakovic G, Nikolova D, Simonetti RG, Gluud C. Antioxidant supplements for prevention of gastrointestinal cancers: a systematic review and meta-analysis. Lancet 2004;364:1219-28. View abstract.
  643. Kris-Etherton PM, Lichtenstein AH, Howard BV, et al. AHA Science Advisory: Antioxidant vitamin supplements and cardiovascular disease. Circulation 2004;110:637-41. View abstract.
  644. Meydani SN, Leka LS, Fine BC, et al. Vitamin E and respiratory tract infections in elderly nursing home residents. JAMA 2004;292:828-36. View abstract.
  645. Booth SL, Golly I, Sacheck JM, et al. Effect of vitamin E supplementation on vitamin K status in adults with normal coagulation status. Am J Clin Nutr 2004;80:143-8. View abstract.
  646. Brodkin RH, Bleiberg J. Sensitivity to topically applied vitamin E. Arch Dermatol 1965;92:76-7. View abstract.
  647. Kennedy DD, Tucker KL, Ladas ED, et al. Low antioxidant vitamin intakes are associated with increases in adverse effects of chemotherapy in children with acute lymphoblastic leukemia. Am J Clin Nutr 2004;79:1029-36. View abstract.
  648. Richer S, Stiles W, Statkute L, et al. Double-masked, placebo-controlled, randomized trial of lutein and antioxidant supplementation in the intervention of atrophic age-related macular degermation: the Veterans LAST study (Lutein Antioxidant Supplement Trial). Optometry 2004;75:216-30. View abstract.
  649. Ladas EJ, Jacobson JS, Kennedy DD, et al. Antioxidants and cancer therapy: a systematic review. J Clin Oncol 2004;22:517-28. View abstract.
  650. Weijl NI, Hopman GD, Wipkink-Bakker A, et al. Cisplatin combination chemotherapy induces a fall in plasma antioxidants of cancer patients. Ann Oncol 1998;9:1331-7. View abstract.
  651. Yoshida H, Ishikawa T, Ayaori M, et al. Beneficial effect of gemfibrozil on the chemical composition and oxidative susceptibility of low density lipoprotein: a randomized, double-blind, placebo-controlled study. Atherosclerosis 1998;139:179-87. View abstract.
  652. Steiner M. Vitamin E, a modifier of platelet function: rationale and use in cardiovascular and cerebrovascular disease. Nutr Rev 1999;57:306-9. View abstract.
  653. Freedman JE, Farhat JH, Loscalzo J, Keaney JF. Alpha-tocopherol inhibits aggregation of human platelets by a protein kinase C-dependent mechanism. Circulation 1996;94:2434-40. View abstract.
  654. Jandak J, Steiner M, Richardson PD. Alpha-tocopherol, an effective inhibitor of platelet adhesion. Blood 1989;73:141-9. View abstract.
  655. Stampfer MJ, Jakubowski JA, Faigel D, et al. Vitamin E supplementation effect on human platelet function, arachidonic acid metabolism, and plasma prostacyclin levels. Am J Clin Nutr 1988;47:700-6. View abstract.
  656. Celestini A, Pulcinelli FM, Pignatelli P, et al. Vitamin E potentiates the antiplatelet activity of aspirin in collagen-stimulated platelets. Haematologica 2002;87:420-6. View abstract.
  657. Steiner M, Glantz M, Lekos A. Vitamin E plus aspirin compared with aspirin alone in patients with transient ischemic attacks. Am J Clin Nutr 1995;62:1381s-4s. View abstract.
  658. Schrogie JJ. Coagulopathy and fat-soluble vitamins (letter). JAMA 1975;232:19. View abstract.
  659. Higashi A, Tamari H, Ikeda T, et al. Serum vitamin E concentration in patients with severe multiple handicaps treated with anticonvulsants. Pediatr Pharmacol 1980;1:129-34. View abstract.
  660. Higashi A, Ikeda T, Matsukura M, Matsuda I. Serum zinc and vitamin E concentrations in handicapped children treated with anticonvulsants. Devel Pharmacol Ther 1982;5:109-13. View abstract.
  661. Ogunmekan AO. Plasma vitamin E (alpha-tocopherol) levels in normal children and in epileptic children with and without anticonvulsant drug therapy. Trop Geog Med 1985;37:175-7. View abstract.
  662. Kataoka K, Kanamori N, Oishi M, et al. Vitamin E status in pediatric patients receiving antiepileptic drugs. Devel Pharmacol Ther 1989;14:96-101. View abstract.
  663. Ogunmekan AO. Relationship between age and vitamin E level in epileptic children and normal children. Am J Clin Nutr 1979;32:2269-71. View abstract.
  664. Bredie SJ, de Bruin TW, Demacker PN, et al. Comparison of gemfibrozil versus simvastatin in familial combined hyperlipidemia and effects on apolipoprotein-B-containing lipoproteins, low-density lipoprotein subfraction profile, and low-density lipoprotein oxidizability. Am J Cardiol 1995;75:348-53. View abstract.
  665. Melhorn DK, Gross S. Relationships between iron-dextran and vitamin E in iron deficiency anemia in children. J Lab Clin Med 1969;74:789-802. View abstract.
  666. Giugliano D, Marfella R. Antioxidants and nitrate tolerance (letter). Circulation 1998;98:1350-1. View abstract.
  667. Cheung MC, Zhao XQ, Chait A, et al. Antioxidant supplements block the response of HDL to simvastatin-niacin therapy in patients with coronary artery disease and low HDL. Arterioscler Thromb Vasc Biol 2001;21:1320-6. View abstract.
  668. Dowd P, Zheng ZB. On the mechanism of the anticlotting action of vitamin E quinone. Proc Natl Acad Sci U S A 1995;92:8171-5. View abstract.
  669. Klatte ET, Scharre DW, Nagaraja HN, et al. Combination therapy of donepezil and vitamin E in Alzheimer disease. Alzheimer Dis Assoc Disord 2003;17:113-6. View abstract.
  670. Zandi PP, Anthony JC, Khachaturian AS, et al. Reduced risk of Alzheimer disease in users of antioxidant vitamin supplements: the Cache County Study. Arch Neurol 2004;61:82-8. View abstract.
  671. Age-Related Eye Disease Study Research Group. Potential public health impact of age-related eye disease study results: AREDS report no. 11. Arch Ophthalmol 2003;121:1621-4. View abstract.
  672. Virtamo J, Pietinen P, Huttunen JK, et al. Incidence of cancer and mortality following alpha-tocopherol and beta-carotene supplementation: a postintervention follow-up. JAMA 2003;290:476-85.. View abstract.
  673. Carlsson CM, Papcke-Benson K, Carnes M, et al. Health-related quality of life and long-term therapy with pravastatin and tocopherol (vitamin E) in older adults. Drugs Aging 2002;19:793-805. . View abstract.
  674. Stein JH, Carlsson CM, Papcke-Benson K, et al. The effects of lipid-lowering and antioxidant vitamin therapies on flow-mediated vasodilation of the brachial artery in older adults with hypercholesterolemia. J Am Coll Cardiol 2001;38:1806-13.. View abstract.
  675. Wan XS, Zhou Z, Kennedy AR, Kopelovich L. In vitro evaluation of chemopreventive agents using cultured human prostate epithelial cells. Oncol Rep 2003;10:2009-14. View abstract.
  676. Karagas MR, Greenberg ER, Nierenberg D, et al. Risk of squamous cell carcinoma of the skin in relation to plasma selenium, alpha-tocopherol, beta-carotene, and retinol: a nested case-control study. Cancer Epidemiol Biomarkers Prev 1997;6:25-9.. View abstract.
  677. Enstrom JE, Kanim LE, Klein MA. Vitamin C intake and mortality among a sample of the United States population. Epidemiology 1992;3:194-202.. View abstract.
  678. Tardif JC. Probucol and multivitamins in the prevention of restenosis after coronary angioplasty. N Engl J Med 1997;337:365-372.. View abstract.
  679. Waters DD, Alderman EL, Hsia J, et al. Effects of hormone replacement therapy and antioxidant vitamin supplements on coronary atherosclerosis in postmenopausal women: A randomized controlled trial. JAMA 2002;288:2432-40.. View abstract.
  680. Chylack LT, Brown NP, Bron A, et al. The Roche European American Cataract Trial (REACT): A randomized clinical trial to investigate the efficacy of an oral antioxidant micronutrient mixture to slow progression of age-related cataract. Ophthalmic Epidemiol 2002;9:49-80.. View abstract.
  681. Negri E, Franceschi S, Bosetti C, et al. Selected micronutrients and oral and pharyngeal cancer. Int J Cancer 2000;86:122-7.. View abstract.
  682. Hodis HN, Mack WJ, LaBree L, et al. Serial coronary angiographic evidence that antioxidant vitamin intake reduces progression of coronary artery atherosclerosis. JAMA 1995;273:1849-54.. View abstract.
  683. Kritchevsky SB, Shimakawa T, Tell GS, et al. Dietary antioxidants and carotid artery wall thickness. The ARIC Study. Atherosclerosis Risk in Communities Study. Circulation 1995;92:2142-50.. View abstract.
  684. Sahyoun NR, Jacques PF, Russell RM. Carotenoids, vitamins C and E, and mortality in an elderly population. Am J Epidemiol 1996;144:501-11.. View abstract.
  685. Graat JM, Schouten EG, Kok FJ. Effect of daily vitamin E and multivitamin-mineral supplementation on acute respiratory tract infections in elderly persons: a randomized controlled trial. JAMA 2002;288:715-21. View abstract.
  686. Sjostrom L, Rissanen A, Andersen T, et al. Randomised placebo-controlled trial of orlistat for weight loss and prevention of weight regain in obese patients. Lancet 1998;352:167-73.. View abstract.
  687. Davidson MH, Hauptman J, DiGirolamo M, et al. Weight control and risk factor reduction in obese subjects treated for 2 years with orlistat. JAMA 1999;281:235-42. View abstract.
  688. Glueck CJ, Tsang RC, Fallat RW, Scheel D. Plasma vitamin A and E levels in children with familial type II hyperlipoproteinemia during therapy with diet and cholestyramine resin. Pediatrics 1974;54:51-5.. View abstract.
  689. Schade RWB, van't Laar A, Majoor CLH, Jansen AP. A comparative study of the effects of cholestyramine and neomycin in the treatment of type II hyperlipoproteinemia. Acta Med Scand 1976;199:175-80.. View abstract.
  690. Willett WC, Stampfer MJ, Underwood BA, et al. Vitamins A, E and carotene: effects of supplementation on their plasma levels. Am J Clin Nutr 1983;38:559-66.. View abstract.
  691. Bendich A, Langseth L. Safety of vitamin A. Am J Clin Nutr 1989;49:358-71.. View abstract.
  692. Bauernfeind JC, Newmark H, Brin M. Vitamins A and E nutrition via intramuscular or oral route. Am J Clin Nutr 1974;27:234-53.. View abstract.
  693. DiPalma JR, Ritchie DM. Vitamin Toxicity. Annu Rev Pharmacol Toxicol 1977;17:133-48.. View abstract.
  694. Hathcock JN, Hattan DG, Jenkins MY, et al. Evaluation of vitamin A toxicity. Am J Clin Nutr 1990;52:183-202.. View abstract.
  695. Salonen RM, Nyyssonen K, Kaikkonen J, et al. Six-year effect of combined vitamin C and E supplementation on atherosclerotic progression: the Antioxidant Supplementation in Atherosclerosis Prevention (ASAP) Study. Circulation 2003;107:947-53.. View abstract.
  696. Fryer MJ. Vitamin E as a protective antioxidant in progressive renal failure. Nephrology 2000;5:1-7.
  697. Sokol RJ, Johnson KE, Karrer FM, et al. Improvement of cyclosporin absorption in children after liver transplantation by means of water-soluble vitamin E. Lancet 1991;338:212-4.. View abstract.
  698. Traber MG, Schiano TD, Steephen AC, et al. Efficacy of water-soluble vitamin E in the treatment of vitamin E malabsorption in short-bowel syndrome. Am J Clin Nutr 1994;59:1270-4.. View abstract.
  699. Pace A, Savarese A, Picardo M, et al. Neuroprotective effect of vitamin E supplementation in patients treated with cisplatin chemotherapy. J Clin Oncol 2003;21:927-31.. View abstract.
  700. Vivekananthan DP, Penn MS, Sapp SK, et al. Use of antioxidant vitamins for the prevention of cardiovascular disease: meta-analysis of randomised trials. Lancet 2003;361:2017-23.. View abstract.
  701. Liu M, Wallmon A, Olsson-Mortlock C, et al. Mixed tocopherols inhibit platelet aggregation in humans: potential mechanisms. Am J Clin Nutr 2003;77:700-6. View abstract.
  702. Delanian S, Porcher R, Balla-Mekias S, Lefaix JL. Randomized, placebo-controlled trial of combined pentoxifylline and tocopherol for regression of superficial radiation-induced fibrosis. J Clin Oncol 2003;21:2545-50.. View abstract.
  703. Pathak A, Roth P, Piscitelli J, Johnson L. Effects of vitamin E supplementation during erythropoietin treatment of the anaemia of prematurity. Arch Dis Child Fetal Neonatal Ed 2003;88:F324-8. View abstract.
  704. Ziaei S, Faghihzadeh S, Sohrabvand F, et al. A randomised placebo-controlled trial to determine the effect of vitamin E in treatment of primary dysmenorrhoea. BJOG 2001;108:1181-3.. View abstract.
  705. Engler MM, Engler MB, Malloy MJ, et al. Antioxidant Vitamins C and E Improve Endothelial Function in Children With Hyperlipidemia: Endothelial Assessment of Risk from Lipids in Youth (EARLY) Trial. Circulation 2003;108:1059-63.. View abstract.
  706. Helzlsouer KJ, Huang HY, Alberg AJ, et al. Association between alpha-tocopherol, gamma-tocopherol, selenium, and subsequent prostate cancer. J Natl Cancer Inst 2000;92:2018-23.. View abstract.
  707. Kim MK, Ahn SH, Lee-Kim. Relationship of serum alpha-tocopherol, carotenoids and retinol with the risk of breast cancer. Nutr Res 2001;21:797-809.
  708. Luchsinger JA, Tang M, Shea S, Mayeux R. Antioxidant vitamin intake and risk of Alzheimer disease. Arch Neurol 2003;60:203-8.. View abstract.
  709. Klipstein-Grobusch K, den Breeijen JH, Grobbee DE, et al. Dietary antioxidants and peripheral arterial disease: the Rotterdam study. Am J Epidemiol 2001;154:145-9.. View abstract.
  710. Jacobs EJ, Henion AK, Briggs PJ, et al. Vitamin C and vitamin E supplement use and bladder cancer mortality in a large cohort of US men and women. Am J Epidemiol 2002;156:1002-10.. View abstract.
  711. Mayne ST, Risch HA, Dubrow R, et al. Nutrient intake and risk of subtypes of esophageal and gastric cancer. Cancer Epidemiol Biomarkers Prev 2001;10:1055-62.. View abstract.
  712. Duffield-Lillico AJ, Reid ME, et al. Baseline characteristics and the effect of selenium supplementation on cancer incidence in a randomized clinical trial: a summary report of the Nutritional Prevention of Cancer Trial. Cancer Epidemiol Biomarkers Prev 2002;11:630-9.. View abstract.
  713. McDuffie JR, Calis KA, Booth SL, et al. Effects of orlistat on fat-soluble vitamins in obese adolescents. Pharmacotherapy 2002;22:814-22.. View abstract.
  714. Hak AE, Stampfer MJ, Campos H, et al. Plasma carotenoids and tocopherols and risk of myocardial infarction in a low-risk population of US male physicians. Circulation 2003;108:802-7.. View abstract.
  715. Girodon F, Lombard M, Galan P, et al. Effect of micronutrient supplementation on infection in institutionalized elderly subjects: a controlled trial. Ann Nutr Metab 1997;41:98-107. View abstract.
  716. Kumar B, Cole WC, Prasad KN. Alpha tocopheryl succinate, retinoic acid and polar carotenoids enhanced the growth-inhibitory effect of a cholesterol-lowering drug on immortalized and transformed nerve cells in culture. J Am Coll Nutr 2001;20:628-36. View abstract.
  717. Watkins ML, Erickson JD, Thun MJ, et al. Multivitamin use and mortality in a large prospective study. Am J Epidemiol 2000;152:149-62.. View abstract.
  718. Keli SO, Hertog MG, Feskens EJ, Kromhout D. Dietary flavonoids, antioxidant vitamins, and incidence of stroke: the Zutphen study. Arch Intern Med 1996;156:637-42. View abstract.
  719. Knekt P, Reunanen A, Jarvinen R, et al. Antioxidant vitamin intake and coronary mortality in a longitudinal population study. Am J Epidemiol 1994;139:1180-9. View abstract.
  720. Bonithon-Kopp C, Kronborg O, Giacosa A, et al. Calcium and fibre supplementation in prevention of colorectal adenoma recurrence: a randomised intervention trial. European Cancer Prevention Organisation Study Group. Lancet 2000;356:1300-6. View abstract.
  721. Yochum LA, Folsom AR, Kushi LH. Intake of antioxidant vitamins and risk of death from stroke in postmenopausal women. Am J Clin Nutr 2000;72:476-83.. View abstract.
  722. Brown BG, Zhao XQ, Chait A. Simvastatin and niacin, antioxidant vitamins, or the combination for the prevention of coronary disease. N Engl J Med 2001;345:1583-93. View abstract.
  723. Todd S, Woodward M, Tunstall-Pedoe H, Bolton-Smith C. Dietary antioxidant vitamins and fiber in the etiology of cardiovascular disease and all-causes mortality: results from the Scottish Heart Health Study. Am J Epidemiol 1999;150:1073-80. View abstract.
  724. Age-Related Eye Disease Study Research Group. A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E and beta carotene for age-related cataract and vision loss: AREDS report no. 9. Arch Ophthalmol 2001;119:1439-52. View abstract.
  725. Age-Related Eye Disease Study Research Group. A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss. AREDS report no. 8. Arch Ophthalmol 2001;119:1417-36. View abstract.
  726. Food and Nutrition Board, Institute of Medicine. Dietary Reference Intakes for Vitamin A, Vitamin K, Arsenic, Boron, Chromium, Copper, Iodine, Iron, Manganese, Molybdenum, Nickel, Silicon, Vanadium, and Zinc. Washington, DC: National Academy Press, 2002. Available at: www.nap.edu/books/0309072794/html/.
  727. Bendich A. The potential for dietary supplements to reduce premenstrual syndrome (PMS) symptoms. J Am Coll Nutrition 2000;19:3-12. View abstract.
  728. Girodon F, Galan P, Monget AL, et al. Impact of trace elements and vitamin supplementation on immunity and infections in institutionalized elderly patients: a randomized, controlled trial. MIN. VIT. AOX. geriatric network. Arch Intern Med 1999;159:748-54. View abstract.
  729. Iuliano L, Micheletta F, Maranghi M, et al. Bioavailability of vitamin E as function of food intake in healthy subjects: effects on plasma peroxide-scavenging activity and cholesterol-oxidation products. Arterioscler Thromb Vasc Biol 2001;21:E34-7. View abstract.
  730. Vitamin E and heart disease. Pharmacist's Letter / Prescriber's Letter 2000;16:160307.
  731. Roodenburg AJ, Leenen R, van het Hof KH, et al. Amount of fat in the diet affects bioavailability of lutein esters but not of alpha-carotene, beta-carotene, and vitamin E in humans. Am J Clin Nutr 2000;71:1187-93. View abstract.
  732. Caspi O, Greenfield RH, Gurgevich S. Case report in integrative medicine: a 24-year-old male with medically intractable seizures. Int Med 1998;1:173-6.
  733. Kligman AM. Topical treatments for photoaged skin. Separating the reality from the hype. Postgrad Med 1997;102:115-26. View abstract.
  734. Keller KL, Fenske NA. Uses of vitamins A, C, and E and related compounds in dermatology: A review. J Am Acad Dermatol 1998;39:611-25. View abstract.
  735. Troisi RJ, Willett WC, Weiss ST, et al. A prospective study of diet and adult-onset asthma. Am J Respir Crit Care Med 1995;151:1401-8. View abstract.
  736. Blumenthal RD, Lew W, Reising A, et al. Antioxidant vitamins reduce normal tissue toxicity induced by radio-immunotherapy. Int J Cancer 2000;86:276-80. View abstract.
  737. McAlindon TE, Jacques P, Zhang Y, et al. Do antioxidant micronutrients protect against the development and progression of knee osteoarthritis? Arthritis Rheum 1996;39:648-56. View abstract.
  738. Stordy BJ. Dark adaptation, motor skills, docosahexaenoic acid, and dyslexia. Am J Clin Nutr 2000;71:323S-6S. View abstract.
  739. Fogarty A, Lewis S, Weiss S, Britton J. Dietary vitamin E, IgE concentrations, and atopy. Lancet 2000;356:1573-4. View abstract.
  740. Brand C, Snaddon J, Bailey M, Cicuttini F. Vitamin E is ineffective for symptomatic relief of knee osteoarthritis: a six month double blind, randomised, placebo controlled study. Ann Rheum Dis 2001;60:946-9. View abstract.
  741. Palumbo G, Avanzini F, Alli C, et al. Effects of vitamin E on clinic and ambulatory blood pressure in treated hypertensive patients. Collaborative Group of the Primary Prevention Project (PPP)--Hypertension study. Am J Hypertens 2000;13:564-7. View abstract.
  742. Ohnishi ST, Ohnishi T, Ogunmola GB. Sickle cell anemia: a potential nutritional approach for a molecular disease. Nutrition 2000;16:330-8. View abstract.
  743. Sperduto RD, Hu TS, Milton RC, et al. The Linxian cataract studies. Two nutrition intervention trials. Arch Ophthalmol 1993;111:1246-53. View abstract.
  744. Food and Nutrition Board, Institute of Medicine. Dietary Reference Intakes for Vitamin C, Vitamin E, Selenium, and Carotenoids. Washington, DC: National Academy Press, 2000. Available at: http://www.nap.edu/books/0309069351/html/.
  745. Creagan ET, Moertel CG, O'Fallon JR, et al. Failure of high-dose vitamin C (ascorbic acid) therapy to benefit patients with advanced cancer. A controlled trial. N Engl J Med 1979;301:687-90. View abstract.
  746. Moertel CG, Fleming TR, Creagan ET, et al. High-dose vitamin C versus placebo in the treatment of patients with advanced cancer who have had no prior chemotherapy. A randomized double-blind comparison. N Engl J Med 1985;312:137-41. View abstract.
  747. Mares-Perlman JA, Brady WE, Klein BE, et al. Serum carotenoids and tocopherols and severity of nuclear and cortical opacities. Invest Ophthalmol Vis Sci 1995;36:276-88. View abstract.
  748. Liede KE, Haukka JK, Saxen LM, Heinonen OP. Increased tendency towards gingival bleeding caused by joint effect of alpha-tocopherol supplementation and acetylsalicylic acid. Ann Med 1998;30:542-6. View abstract.
  749. Tornwall ME, Virtamo J, Haukka JK, et al. The effect of alpha-tocopherol and beta-carotene supplementation on symptoms and progression of intermittent claudication in a controlled trial. Atherosclerosis 1999;147:193-7. View abstract.
  750. van Rooij J, Schwartzenberg SG, Mulder PG, Baarsma SG. Oral vitamins C and E as additional treatment in patients with acute anterior uveitis: a randomised double masked study in 145 patients. Br J Ophthalmol 1999;83:1277-82. View abstract.
  751. Paolisso G, Di Maro G, Galzerano D, et al. Pharmacological doses of vitamin E and insulin action in elderly subjects. Am J Clin Nutr 1994;59:1291-6. View abstract.
  752. Paolisso G, D'Amore A, Giugliano D, et al. Pharmacologic doses of vitamin E improve insulin action in healthy subjects and non-insulin-dependent diabetic patients. Am J Clin Nutr 1993;57:650-6. View abstract.
  753. Bursell SE, Clermont AC, Aiello LP, et al. High-dose vitamin E supplementation normalizes retinal blood flow and creatinine clearance in patients with type 1 diabetes. Diabetes Care 1999;22:1245-51. View abstract.
  754. Tutuncu NB, Bayraktar M, Varli K. Reversal of defective nerve conduction with vitamin E supplementation in type 2 diabetes: a preliminary study. Diabetes Care 1998;21:1915-8. View abstract.
  755. Edmonds SE, Winyard PG, Guo R, et al. Putative analgesic activity of repeated oral doses of vitamin E in the treatment of rheumatoid arthritis. Results of a prospective placebo controlled double blind trial. Ann Rheum Dis 1997;56:649-55. View abstract.
  756. Jenkins M, Alexander JW, MacMillan BG, et al. Failure of topical steroids and vitamin E to reduce postoperative scar formation following reconstructive surgery. J Burn Care Rehabil 1986;7:309-12. View abstract.
  757. Baumann LS, Spencer JS. The effects of topical vitamin E on the cosmetic appearance of scars. Dermatol Surg 1999;25:311-5. View abstract.
  758. London RS, Sundaram GS, Murphy L, Goldstein PJ. The effect of alpha-tocopherol on premenstrual symptomatology: a double-blind study. J Am Coll Nutr 1983;2:115-22. View abstract.
  759. London RS, Murphy L, Kitlowski KE, Reynolds MA. Efficacy of alpha-tocopherol in the treatment of the premenstrual syndrome. J Reprod Med 1987;32:400-4. View abstract.
  760. Gulmezoglu AM, Hofmeyr GJ, Oosthuisen MM. Antioxidants in the treatment of severe pre-eclampsia: an explanatory randomised controlled trial. Br J Obstet Gynaecol 1997;104:689-96. View abstract.
  761. Eberlein-Konig B, Placzek M, Przybilla B. Protective effect against sunburn of combined systemic ascorbic acid (vitamin C) and d-alpha-tocopherol (vitamin E). J Am Acad Dermatol 1998;38:45-8. View abstract.
  762. Fuchs J, Kern H. Modulation of UV-light-induced skin inflammation by D-alpha-tocopherol and L-ascorbic acid: a clinical study using solar simulated radiation. Free Radic Biol Med 1998;25:1006-12. View abstract.
  763. Dreher F, Denig N, Gabard B, et al. Effect of topical antioxidants on UV-induced erythema formation when administered after exposure. Dermatol 1999;198:52-5. View abstract.
  764. Dreher F, Gabard B, Schwindt DA, Maibach HI. Topical melatonin in combination with vitamins E and C protects skin from ultraviolet-induced erythema: a human study in vivo. Br J Dermatol 1998;139:332-9. View abstract.
  765. de Rijk MC, Breteler MM, den Breeijen JH, et al. Dietary antioxidants and Parkinson disease. The Rotterdam Study. Arch Neurol 1997;54:762-5. View abstract.
  766. Parkinson Study Group. Impact of deprenyl and tocopherol treatment on Parkinson's disease in DATATOP patients requiring levodopa. Ann Neurol 1996;39:37-45. View abstract.
  767. Kieburtz K, McDermott M, Como P, et al. The effect of deprenyl and tocopherol on cognitive performance in early untreated Parkinson's disease. Parkinson Study Group. Neurology 1994;44:1756-9. View abstract.
  768. The Parkinson Study Group. Effects of tocopherol and deprenyl on the progression of disability in early Parkinson's disease. N Engl J Med 1993;328:176-83. View abstract.
  769. Benner SE, Winn RJ, Lippman SM, et al. Regression of oral leukoplakia with alpha-tocopherol: a community clinical oncology program chemoprevention study. J Natl Cancer Inst 1993;85:44-7. View abstract.
  770. Watanabe H, Kakihana M, Ohtsuka S, Sugishita Y. Randomized, double-blind, placebo-controlled study of supplemental vitamin E on attenuation of the development of nitrate tolerance. Circulation 1997;96:2545-50. View abstract.
  771. Orndahl G, Grimby G, Grimby A, et al. Functional deterioration and selenium-vitamin E treatment in myotonic dystrophy. A placebo-controlled study. J Intern Med 1994;235:205-10. View abstract.
  772. Fenichel GM, Brooke MH, Griggs RC, et al. Clinical investigation in Duchenne muscular dystrophy: penicillamine and vitamin E. Muscle Nerve 1988;11:1164-8. View abstract.
  773. Connolly PS, Shirley EA, Wasson JH, Nierenberg DW. Treatment of nocturnal leg cramps. A crossover trial of quinine vs vitamin E. Arch Intern Med 1992;152:1877-80. View abstract.
  774. Roca AO, Jarjoura D, Blend D, et al. Dialysis leg cramps. Efficacy of quinine versus vitamin E. ASAIO J 1992;38:M481-5. View abstract.
  775. Riley JD, Antony SJ. Leg cramps: differential diagnosis and management. Am Fam Physician 1995;52:1794-8. View abstract.
  776. Sisto T, Paajanen H, Metsa-Ketela T, et al. Pretreatment with antioxidants and allopurinol diminishes cardiac onset events in coronary artery bypass grafting. Ann Thorac Surg 1995;59:1519-23. View abstract.
  777. Westhuyzen J, Cochrane AD, Tesar PJ, et al. Effect of preoperative supplementation with alpha-tocopherol and ascorbic acid on myocardial injury in patients undergoing cardiac operations. J Thorac Cardiovasc Surg 1997;113:942-8. View abstract.
  778. Yau TM, Weisel RD, Mickle DA, et al. Vitamin E for coronary bypass operations. A prospective, double-blind, randomized trial. J Thorac Cardiovasc Surg 1994;108:302-10. View abstract.
  779. Rolf C, Cooper TG, Yeung CH, Nieschlag E. Antioxidant treatment of patients with asthenozoospermia or moderate oligoasthenozoospermia with high-dose vitamin C and vitamin E: a randomized, placebo-controlled, double-blind study. Hum Reprod 1999;14:1028-33. View abstract.
  780. Suleiman SA, Ali ME, Zaki ZM, et al. Lipid peroxidation and human sperm motility: protective role of vitamin E. J Androl 1996;17:530-7. View abstract.
  781. Kessopoulou E, Powers HJ, Sharma KK, et al. A double-blind, randomized, placebo, cross-over, controlled trial using the antioxidant vitamin E to treat reactive oxygen species associated male infertility. Fertil Steril 1995;64:825-31. View abstract.
  782. Buzina-Suboticanec K, Buzina R, Stavljenic A, et al. Aging, nutritional status and immune response. Int J Vita Nutr Res 1998;68:133-41. View abstract.
  783. de la Fuente M, Ferrandez MD, Burgos MS, et al. Immune function in aged women is improved by ingestion of vitamins C and E. Can J Physiol Pharmacol 1998;76:373-80. View abstract.
  784. Pallast EG, Schouten EG, de Waart FG, et al. Effect of 50- and 100-mg vitamin E supplements on cellular immune function in noninstitutionalized elderly persons. Am J Clin Nutr 1999;69:1273-81. View abstract.
  785. Ravaglia G, Forti P, Maioli F, et al. Effect of micronutrient status on natural killer cell immune function in healthy free-living subjects aged >/=90 y. Am J Clin Nutr 2000;71:590-8. View abstract.
  786. Meydani SN, Meydani M, Blumberg JB, et al. Vitamin E supplementation and in vivo immune response in healthy elderly subjects. A randomized controlled trial. JAMA 1997;277:1380-6. View abstract.
  787. Peyser CE, Folstein M, Chase GA, et al. Trial of d-alpha-tocopherol in Huntington's disease. Am J Psychiatry 1995;152:1771-5. View abstract.
  788. Chan AC, Chow CK, Chiu D. Interaction of antioxidants and their implication in genetic anemia. Proc Soc Exp Biol Med 1999;222:274-82. View abstract.
  789. Johnson GJ, Vatassery GT, Finkel B, Allen DW. High-dose vitamin E does not decrease the rate of chronic hemolysis in glucose-6-phosphate dehydrogenase deficiency. N Engl J Med 1983;308:1014-7. View abstract.
  790. Hafez M, Amar ES, Zedan M, et al. Improved erythrocyte survival with combined vitamin E and selenium therapy in children with glucose-6-phosphate dehydrogenase deficiency and mild chronic hemolysis. J Pediatr 1986;108:558-561. View abstract.
  791. Eldamhougy S, Elhelw Z, Yamamah G, et al. The vitamin E status among glucose-6 phosphate dehydrogenase deficient patients and effectiveness of oral vitamin E. Int J Vita Nutr Res 1988;58:184-8. View abstract.
  792. Goldstein RK, Zillikens D, Miller K, Elsner P, Burg G. Local treatment of disseminated granuloma anulare with a vitamin E emulsion. Hautarzt 1991;42:176-8. View abstract.
  793. Wang GQ, Dawsey SM, Li JY, et al. Effects of vitamin/mineral supplementation on the prevalence of histological dysplasia and early cancer of the esophagus and stomach: results from the General Population Trial in Linxian, China. Cancer Epidemiol Biomarkers Prev 1994;3:161-6. View abstract.
  794. Dawsey SM, Wang GQ, Taylor PR, et al. Effects of vitamin/mineral supplementation on the prevalence of histological dysplasia and early cancer of the esophagus and stomach: results from the Dysplasia Trial in Linxian, China. Cancer Epidemiol Biomarkers Prev 1994;3:167-72. View abstract.
  795. Bukin YV, Draudin-Krylenko VA, Kuvshinov YP, et al. Decrease of ornithine decarboxylase activity in premalignant gastric mucosa and regression of small intestinal metaplasia in patients supplemented with high doses of vitamin E. Cancer Epidemiol Biomarkers Prev 1997;6:543-6. View abstract.
  796. Varis K, Taylor PR, Sipponen P, et al. Gastric cancer and premalignant lesions in atrophic gastritis: a controlled trial on the effect of supplementation with alpha-tocopherol and beta-carotene. The Helsinki Gastritis Study Group. Scand J Gastroenterol 1998;33:294-300. View abstract.
  797. Tahzib M, Frank R, Gauthier B, et al. Vitamin E treatment of focal segmental glomerulosclerosis: results of an open-label study. Pediatr Nephrol 1999;13:649-52. View abstract.
  798. Delanian S. Striking regression of radiation-induced fibrosis by a combination of pentoxifylline and tocopherol. Br J Radiol 1998;71:892-4. View abstract.
  799. Delanian S, Balla-Mekias S, Lefaix JL. Striking regression of chronic radiotherapy damage in a clinical trial of combined pentoxifylline and tocopherol. J Clin Oncol 1999;17:3283-90. View abstract.
  800. Ogunmekan AO, Hwang PA. A randomized, double-blind, placebo-controlled, clinical trial of D-alpha-tocopheryl acetate (vitamin E), as add-on therapy, for epilepsy in children. Epilepsia 1989;30:84-9. View abstract.
  801. Raju GB, Behari M, Prasad K, Ahuja GK. Randomized, double-blind, placebo-controlled, clinical trial of D-alpha-tocopherol (vitamin E) as add-on therapy in uncontrolled epilepsy. Epilepsia 1994;35:368-72. View abstract.
  802. Ludwig CU, Stoll HR, Obrist R, Obrecht JP. Prevention of cytotoxic drug induced skin ulcers with dimethyl sulfoxide (DMSO) and alpha-tocopherol. Eur J Cancer Clin Oncol 1987;23:327-9. View abstract.
  803. Teikari JM, Laatikainen L, Virtamo J, et al. Six-year supplementation with alpha-tocopherol and beta-carotene and age-related maculopathy. Acta Ophthalmol Scand 1998;76:224-9. View abstract.
  804. Teikari JM, Rautalahti M, Haukka J, et al. Incidence of cataract operations in Finnish male smokers unaffected by alpha tocopherol or beta carotene supplements. J Epidemiol Community Health 1998;52:468-72. View abstract.
  805. Tavani A, Negri E, La Vecchia C. Food and nutrient intake and risk of cataract. Ann Epidemiol 1996;6:41-6. View abstract.
  806. Seddon JM, Christen WG, Manson JE, et al. The use of vitamin supplements and the risk of cataract among US male physicians. Am J Publ Health 1994;84:788-92. View abstract.
  807. Leske MC, Chylack LT Jr, He Q, et al. Antioxidant vitamins and nuclear opacities: the longitudinal study of cataract. Ophthalmol 1998;105:831-6. View abstract.
  808. London RS, Sundaram GS, Murphy L, et al. The effect of vitamin E on mammary dysplasia: a double-blind study. Obstet Gynecol 1985;65:104-6. View abstract.
  809. Meyer EC, Sommers DK, Reitz CJ, Mentis H. Vitamin E and benign breast disease. Surgery 1990;107:549-51. View abstract.
  810. Ernster VL, Goodson WH III, Hunt TK, et al. Vitamin E and benign breast disease: a double-blind, randomized clinical trial. Surgery 1985;97:490-4. View abstract.
  811. Rohan TE, Howe GR, Friedenreich CM, et al. Dietary fiber, vitamins A, C, and E, and risk of breast cancer: a cohort study. Cancer Causes Control 1993;4:29-37. View abstract.
  812. Hunter DJ, Manson JE, Colditz GA, et al. A prospective study of the intake of vitamins C, E, and A and the risk of breast cancer. N Engl J Med 1993;329:234-40. View abstract.
  813. Watts JL, Milner R, Zipursky A, et al. Failure of supplementation with vitamin E to prevent bronchopulmonary dysplasia in infants less than 1,500 g birth weight. Eur Resp J 1991;4:188-90. View abstract.
  814. Chiswick M, Gladman G, Sinha S, et al. Vitamin E supplementation and periventricular hemorrhage in the newborn. Am J Clin Nutr 1991;53:370S-2S. View abstract.
  815. Fish WH, Cohen M, Franzek D, et al. Effect of intramuscular vitamin E on mortality and intracranial hemorrhage in neonates of 1000 grams or less. Pediatrics 1990;85:578-84. View abstract.
  816. Spencer AP, Carson DS, Crouch MA. Vitamin E and coronary artery disease. Arch Intern Med 1999;159:1313-20. View abstract.
  817. Rapola JM, Virtamo J, Ripatti S, et al. Effects of alpha tocopherol and beta carotene supplements on symptoms, progression, and prognosis of angina pectoris. Heart 1998;79:454-8. View abstract.
  818. Motoyama T, Kawano H, Kugiyama K, et al. Vitamin E administration improves impairment of endothelium-dependent vasodilation in patients with coronary spastic angina. J Am Coll Cardiol 1998;32:1672-9. View abstract.
  819. Ferns G, Williams J, Forster L, et al. Cholesterol standardized plasma vitamin E levels are reduced in patients with severe angina pectoris. Int J Exp Pathol 2000;81:57-62. View abstract.
  820. Zipursky A, Brown EJ, Watts J, et al. Oral vitamin E supplementation for the prevention of anemia in premature infants: a controlled trial. Pediatrics 1987;79:61-8. View abstract.
  821. Cristol JP, Bosc JY, Badiou S, et al. Erythropoietin and oxidative stress in haemodialysis: beneficial effects of vitamin E supplementation. Nephrol Dial Transplant 1997;12:2312-7. View abstract.
  822. Chan JM, Stampfer MJ, Ma J, et al. Supplemental vitamin E intake and prostate cancer risk in a large cohort of men in the United States. Cancer Epidemiol Biomarkers Prev 1999;8:893-9. View abstract.
  823. Kristal AR, Stanford JL, Cohen JH, et al. Vitamin and mineral supplement use is associated with reduced risk of prostate cancer. Cancer Epidemiol Biomarkers Prev 1999;8:887-92. View abstract.
  824. Deneo-Pellegrini H, De Stefani E, Ronco A, Mendilaharsu M. Foods, nutrients and prostate cancer: a case-control study in Uruguay. Br J Cancer 1999;80:591-7. View abstract.
  825. Hartman TJ, Albanes D, Pietinen P, et al. The association between baseline vitamin E, selenium, and prostate cancer in the alpha-tocopherol, beta-carotene cancer prevention study. Cancer Epidemiol Biomarkers Prev 1998;7:335-40. View abstract.
  826. Suthutvoravut U, Hathirat P, Sirichakwal P, et al. Vitamin E status, glutathione peroxidase activity and the effect of vitamin E supplementation in children with thalassemia. J Med Assoc Thai 1993;76:146-52. View abstract.
  827. Inal M, Kanbak G, Sen S, et al. Antioxidant status and lipid peroxidation in hemodialysis patients undergoing erythropoietin and erythropoietin-vitamin E combined therapy. Free Radic Res 1999;31:211-6. View abstract.
  828. Nemeth I, Turi S, Haszon I, Bereczki C. Vitamin E alleviates the oxidative stress of erythropoietin in uremic children on hemodialysis. Pediatr Nephrol 2000;14:13-7. View abstract.
  829. Joseph JA, Shukitt-Hale B, Denisova NA, et al. Long-term dietary strawberry, spinach, or vitamin E supplementation retards the onset of age-related neuronal signal-transduction and cognitive behavioral deficits. J Neurosci 1998;18:8047-55. View abstract.
  830. Yamada K, Tanaka T, Han D, et al. Protective effects of idebenone and alpha-tocopherol on beta-amyloid-(1-42)-induced learning and memory deficits in rats: implication of oxidative stress in beta-amyloid-induced neurotoxicity in vivo. Eur J Neurosci 1999;11:83-90. View abstract.
  831. Socci DJ, Crandall BM, Arendash GW. Chronic antioxidant treatment improves the cognitive performance of aged rats. Brain Res 1995;693:88-94. View abstract.
  832. Masaki KH, Losonczy KG, Izmirlian G, et al. Association of vitamin E and C supplement use with cognitive function and dementia in elderly men. Neurology 2000;54:1265-72. View abstract.
  833. Sano M, Ernesto C, Thomas RG, et al. A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease. The Alzheimer's Disease Cooperative Study. N Engl J Med 1997;336:1216-22. View abstract.
  834. Neunteufl T, Priglinger U, Heher S, et al. Effects of vitamin E on chronic and acute endothelial dysfunction in smokers. J Am Coll Cardiol 2000;35:277-83. View abstract.
  835. Horwitt MK. My valedictory on the differences in biological potency between RRR-alpha-tocopheryl and all-rac-alpha-tocopheryl acetate. Am J Clin Nutr 1999;69:341-2. View abstract.
  836. Clark JH, Russell GJ, Fitzgerald JF, et al. Serum beta-carotene, retinol, and alpha-tocopherol levels during mineral oil therapy for constipation. Am J Dis Child 1987;141:1210-2. View abstract.
  837. Becker GL. The case against mineral oil. Am J Digestive Dis 1952;19:344-8. View abstract.
  838. Tonstad S, Silverstein M, Aksnes L, Ose L. Low dose colestipol in adolescents with familial hypercholesterolemia. Arch Dis Child 1996;74:157-60. View abstract.
  839. Schwarz KB, Goldstein PD, Witztum JL, et al. Fat-soluble vitamin concentrations in hypercholestrolemic children treated with colestipol. Pediatrics 1980;65:243-50. View abstract.
  840. Elinder LS, Hadell K, Johansson J, et al. Probucol treatment decreases serum concentrations of diet-derived antioxidants. Arterioscler Thromb Vasc Biol 1995;15:1057-63. View abstract.
  841. Cywes C, Millar AJ. Assessment of the nutritional status of infants and children with biliary atresia. S Afr Med J 1990;77:131-5. View abstract.
  842. West RJ, Lloyd JK. The effect of cholestyramine on intestinal absorption. Gut 1975;16:93-8. View abstract.
  843. Hathcock JN. Metabolic mechanisms of drug-nutrient interactions. Fed Proc 1985;44:124-9. View abstract.
  844. Briggs GB, Freeman RK, Yaffe SJ. Drugs in Pregnancy and Lactation. 5th ed. Philadelphia, PA: Lippincott Williams & Wilkins; 1998.
  845. Mares-Perlman JA, Lyle BJ, Klein R, et al. Vitamin supplement use and incident cataracts in a population-based study. Arch Ophthalmol 2000;118:1556-63. View abstract.
  846. Takahashi O. Haemorrhagic toxicity of a large dose of alpha-, beta-, gamma- and delta-tocopherols, ubiquinone, beta-carotene, retinol acetate and L-ascorbic acid in the rat. Food Chem Toxicol 1995;33:121-8. View abstract.
  847. Aberg F, Appelkvist EL, Broijersen A, et al. Gemfibrozil-induced decrease in serum ubiquinone and alpha- and gamma- tocopherol levels in men with combined hyperlipidaemia. Eur J Clin Invest 1998;28:235-42. View abstract.
  848. Li D, Saldeen T, Mehta JL. Gamma-tocopherol decreases ox-LDL-mediated activation of nuclear factor- kappaB and apoptosis in human coronary artery endothelial cells. Biochem Biophys Res Commun 1999;259:157-61. View abstract.
  849. Moyad MA, Brumfield SK, Pienta KJ. Vitamin E, alpha- and gamma-tocopherol, and prostate cancer. Semin Urol Oncol 1999;17:85-90. View abstract.
  850. Rautalahti MT, Virtamo JR, Taylor PR, et al. The effects of supplementation with alpha-tocopherol and beta-carotene on the incidence and mortality of carcinoma of the pancreas in a randomized, controlled trial. Cancer 1999;86:37-42. View abstract.
  851. Varis K, Taylor PR, Sipponen P, et al. Gastric cancer and premalignant lesions in atrophic gastritis: a controlled trial on the effect of supplementation with alpha-tocopherol and beta-carotene. The Helsinki Gastritis Study Group. Scand J Gastroenterol 1998;33:294-300. View abstract.
  852. Heinonen OP, Albanes D, Virtamo J, et al. Prostate cancer and supplementation with alpha-tocopherol and beta-carotene: incidence and mortality in a controlled trial. J Natl Cancer Inst 1998;90:440-6. View abstract.
  853. McKeown-Eyssen G, Holloway C, Jazmaji V, et al. A randomized trial of vitamins C and E in the prevention of recurrence of colorectal polyps. Cancer Res 1988;48:4701-5. View abstract.
  854. Paganelli GM, Biasco G, Brandi G, et al. Effect of vitamin A, C, and E supplementation on rectal cell proliferation in patients with colorectal adenomas. J Natl Cancer Inst 1992;84:47-51. View abstract.
  855. Greenberg ER, Baron JA, Tosteson TD, et al. A clinical trial of antioxidant vitamins to prevent colorectal adenoma. Polyp Prevention Study Group. N Engl J Med 1994;331:141-7. View abstract.
  856. Roncucci L, Di Donato P, Carati L, et al. Antioxidant vitamins or lactulose for the prevention of the recurrence of colorectal adenomas. Colorectal Cancer Study Group of the Univ of Modena and the Health Care Dist 16. Dis Colon Rectum 1993;36:227-34. View abstract.
  857. Malila N, Virtamo J, Virtanen M, et al. The effect of alpha-tocopherol and beta-carotene supplementation on colorectal adenomas in middle-aged male smokers. Cancer Epidemiol Biomarkers Prev 1999;8:489-93. View abstract.
  858. Liede K, Hietanen J, Saxen L, et al. Long-term supplementation with alpha-tocopherol and beta-carotene and prevalence of oral mucosal lesions in smokers. Oral Dis 1998;4:78-83. View abstract.
  859. The Alpha-Tocopherol, Beta Carotene Cancer Prevention Study Group. The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. N Engl J Med 1994;330:1029-35. View abstract.
  860. Dabiri LM, Pasta D, Darby JK, Mosbacher D. Effectiveness of vitamin E for treatment of long-term tardive dyskinesia. Am J Psychiatry 1994;151:925-6. View abstract.
  861. Boomershine KH, Shelton PS, Boomershine JE. Vitamin E in the treatment of tardive dyskinesia. Ann Pharmacother 1999;33:1195-202. View abstract.
  862. Dorfman-Etrog P, Hermesh H, Prilipko L, et al. The effect of vitamin E addition to acute neuroleptic treatment on the emergence of extrapyramidal side effects in schizophrenic patients: an open label study. Eur Neuropsychopharmacol 1999;9:475-7. View abstract.
  863. Shriqui CL, Bradwejn J, Annable L, Jones BD. Vitamin E in the treatment of tardive dyskinesia: a double-blind, placebo-controlled study. Am J Psychiatry 1992;149:391-3. View abstract.
  864. Lohr JB, Caligiuri MP. A double-blind, placebo-controlled study of vitamin E treatment of tardive dyskinesia. J Clin Psychiatry 1996;57:167-73. View abstract.
  865. Sajjad SH. Vitamin E in the treatment of tardive dyskinesia: a preliminary study over 7 months at different doses. Int Clin Psychopharmacol 1998;13:147-55. View abstract.
  866. Adler LA, Edson R, Lavori P, et al. Long-term treatment effects of vitamin E for tardive dyskinesia. Biol Psychiatry 1998;43:868-72. View abstract.
  867. Anon. Vitamin E health claim falls short of significant scientific agreement - FDA. FDC Reports: The Tan Sheet. January 24, 2000;10.
  868. Losonczy KG, Harris TB, Havlik RJ. Vitamin E and vitamin C supplement use and risk of all-cause and coronary heart disease mortality in older persons:epidemiologic studies of the elderly. Am J Clin Nutr 1996;64:190-6. View abstract.
  869. Rapola JM, Virtamo J, Ripatti S, et al. Randomised trial of alpha-tocopherol and beta-carotene supplements on incidence of major coronary events in men with previous myocardial infarction. Lancet 1997;349:1715-20. View abstract.
  870. Stephens NG, Parsons A, Schofield PM, et al. Randomised controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study. Lancet 1996;347:781-6. View abstract.
  871. Virtamo J, Rapola JM, Ripatti S, et al. Effect of vitamin E and beta carotene on the incidence of primary nonfatal myocardial infarction and fatal coronary heart disease. Arch Intern Med 1998;158:668-75. View abstract.
  872. Kushi LH, Folsom AR, Prineas RJ, et al. Dietary antioxidant vitamins and death from coronary heart disease in postmenopausal women. N Engl J Med 1996;334:1156-62. View abstract.
  873. Rimm EB, Stampfer MJ, Ascherio A, et al. Vitamin E consumption and the risk of coronary heart disease in men. N Engl J Med 1993;328:1450-6. View abstract.
  874. Collaborative Group of the Primary Prevention Project. Low-dose aspirin and vitamin E in people at cardiovascular risk: a randomised trial in general practice. Lancet 2001;357:89-95. View abstract.
  875. Keith ME, Jeejeebhoy KN, Langer A, et al. A controlled clinical trial of vitamin E supplementation in patients with congestive heart failure. Am J Clin Nutr 2001;73:219-24. View abstract.
  876. Lonn E, Yusuf S, Dzavik V, et al. Effects of ramipril and vitamin E on atherosclerosis: the study to evaluate carotid ultrasound changes in patients treated with ramipril and vitamin E (SECURE). Circulation 2001;103:919-25. View abstract.
  877. Stampfer MJ, Hennekens CH, Manson JE, et al. Vitamin E consumption and the risk of coronary disease in women. N Engl J Med 1993;328:1444-9. View abstract.
  878. Yusuf S, Dagenais G, Pogue J, et al. Vitamin E supplementation and cardiovascular events in high-risk patients. The heart outcomes prevention evaluation study investigators. N Engl J Med 2000;342:154-60. View abstract.
  879. Vitamin E for neuroleptic-induced tardive dyskinesia. Pharmacist's Letter/Prescriber's Letter 1999;15:150105.
  880. Vezina D, Mauffette F, Roberts KD, et al. Selenium-vitamin E supplementation in infertile men. Effects on semen parameters and micronutrient levels and distribution. Biol Trace Elem Res 1996;53:65-83. View abstract.
  881. Geva E, Bartoov B, Zabludovsky N, et al. The effect of antioxidant treatment on human spermatozoa and fertilization rate in an in vitro fertilization program. Fertil Steril 1996;66:430-4. View abstract.
  882. Israel K, Yu W, Sanders BG, Kline K. Vitamin E succinate induces apoptosis in human prostate cancer cells: role for Fas in vitamin E succinate-triggered apoptosis. Nutr Cancer 2000;36:90-100. View abstract.
  883. Palli D, Russo A, Saieva C, et al. Dietary and familial determinants of 10-year survival among patients with gastric carcinoma. Cancer 2000;89:1205-13. View abstract.
  884. Leppala JM, Virtamo J, Fogelholm R, et al. Vitamin E and Beta Carotene supplementation in high risk for stroke: a subgroup analysis of the alpha-tocopherol, beta-carotene cancer prevention study. Arch Neurol 2000;57:1503-9. View abstract.
  885. Engelen W, Keenoy BM, Vertommen J, Leeuw ID. Effects of long-term supplementation with moderate pharmacologic doses of vitamin E are saturable and reversible in patients with type 1 diabetes. Am J Clin Nutr 2000;72:1142-9. View abstract.
  886. Boaz M, Smetana S, Weinstein T, et al. Secondary prevention with antioxidants of cardiovascular disease in endstage renal disease: randomised placebo-controlled trial. Lancet 2000;356:1213-8. View abstract.
  887. Sullivan C, Capaldi N, Mack G, et al. Seizures and natural Vitamin E. Med J Aust 1990;152:613-4. View abstract.
  888. Qureshi AA, Bradlow BA, Slaser WA, et al. Novel tocotrienols of rice bran modulate cardiovascular disease risk parameters of hypercholesterolemic humans. Nutr Biochem 1997;8:290-8.
  889. Qureshi AA, Bradlow BA, Brace L, et al. Response of hypercholesterolemic subjects to administration of tocotrienols. Lipids 1995;30:1171-7. View abstract.
  890. Tomeo AC, Geller M, Watkins TR, et al. Antioxidant effects of tocotrienols in patients with hyperlipidemia and carotid stenosis. Lipids 1995;30:1179-83. View abstract.
  891. Qureshi AA, Qureshi N, Wright JJ, et al. Lowering of serum cholesterol in hypercholesterolemic humans by tocotrienols (palmvitee). Am J Clin Nutr 1991;53:1021S-6S. View abstract.
  892. Mensink RP, van Houwelingen AC, Kromhout D, Hornstra G. A vitamin E concentrate rich in tocotrienols had no effect on serum lipids, lipoproteins, or platelet function in men with mildly elevated serum lipid concentrations. Am J Clin Nutr 1999;69:213-9. View abstract.
  893. Chappell LC, Seed PT, Briley AL, et al. Effect of antioxidants on the occurrence of pre-eclampsia in women at increased risk: a randomised trial. Lancet 1999;354:810-6. View abstract.
  894. Helson L. The effect of intravenous vitamin E and menadiol sodium diphosphate on vitamin K dependent clotting factors. Thromb Res 1984;35:11-8. View abstract.
  895. Frank J, Weiser H, Biesalski HK. Interaction of vitamins E and K: effect of high dietary vitamin E on phylloquinone activity in chicks. Int J Vit Nutr Res 1997;67:242-7. View abstract.
  896. Mark SD, Wang W, Fraumeni JF Jr, et al. Do nutritional supplements lower the risk of stroke or hypertension? Epidemiology 1998;9:9-15. View abstract.
  897. Clark LC, Combs GF Jr, Turnbull BW, et al. Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin. A randomized controlled trial. JAMA 1996;276:1957-63. View abstract.
  898. Blot WJ, Li JY, Taylor PR. Nutritional intervention trials in Linxian, China: supplementation with specific vitamin/mineral combinations, cancer incidence, and disease-specific mortality in the general population. J Natl Cancer Inst 1993;85:1483-92. View abstract.
  899. Hennekens CH, Buring JE, Manson JE, et al. Lack of effect of long-term supplementation with beta-carotene on the incidence of malignant neoplasms and cardiovascular disease. N Engl J Med 1996;334:1145-9. View abstract.
  900. Omenn GS, Goodman GE, Thornquist MD, et al. Effects of a combination of beta-carotene and vitamin A on lung cancer and cardiovascular disease. N Engl J Med 1996;334:1150-5. View abstract.
  901. Green A, Williams G, Neale R, et al. Daily sunscreen applications and beta-carotene supplementation in prevention of basal-cell and squamous-cell carcinomas of the skin: a randomized controlled trial. Lancet 1999;354:723-9. View abstract.
  902. Albanes D, Heinonen OP, Taylor PR, et al. Alpha-tocopherol and beta-carotene supplements and lung cancer incidence in the alpha-tocopherol, beta-carotene cancer prevention study: effects of baseline characteristics and study compliance. J Natl Cancer Inst 1996;88:1560-70. View abstract.
  903. Correa P, Fontham ETH, Bravo JC, et al. Chemoprevention of gastric dysplasia: randomized trial of antioxidant supplements and anti-Helicobacter pylori therapy. J Natl Cancer Inst 2000;92:1881-8. View abstract.
  904. Tzonou A, Signorello LB, Lagiou P, et al. Diet and cancer of the prostate: a case-control study in Greece. Int J Cancer 1999;80:704-8. View abstract.
  905. Hankinson SE, Stampfer MJ, Seddon JM, et al. Nutrient intake and cataract extraction in women: a prospective study. BMJ 1992;305:335-9. View abstract.
  906. Anon. Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Gruppo Italiano per lo Studio della Soprawivenza nell'Infarto miocardico. Lancet 1999;354:447-55. View abstract.
  907. Tseng M, Murray SC, Kupper LL, Sandler RS. Micronutrients and the risk of colorectal adenomas. Am J Epidemiol 1996;144:1005-14. View abstract.
  908. Gale CR, Martyn CN, Winter PD, Cooper C. Vitamin C and risk of death from stroke and coronary heart disease in cohort of elderly people. BMJ 1995;310:1563-6. View abstract.
  909. Salonen JT, Nyyssonen K, Salonen R, et al. Antioxidant Supplementation in Atherosclerosis Prevention (ASAP) study: a randomized trial of the effect of vitamins E and C on 3-year progression of carotid atherosclerosis. J Intern Med 2000;248:377-86. View abstract.
  910. Soares KV, McGrath JJ. The treatment of tardive dyskinesia- a systematic review and meta-analysis. Schizophr Res 1999;39:1-16; discussion 17-18. View abstract.
  911. Roche, Inc. Xenical package insert. Nutley, NJ. May 1999.
  912. Melia AT, Koss-Twardy SG, Zhi J. The effect of orlistat, an inhibitor of dietary fat absorption, on the absorption of vitamins A and E in healthy volunteers. J Clin Pharmacol 1996;36:647-53. View abstract.
  913. Ascherio A, Rimm EB, Hernan MA, et al. Relation of consumption of vitamin E, vitamin C, and carotenoids to risk for stroke among men in the United States. Ann Intern Med 1999;130:963-70. View abstract.
  914. Lee IM, Cook NR, Manson JE, et al. Beta-carotene supplementation and incidence of cancer and cardiovascular disease: the Women's Health Study. J Natl Cancer Inst 1999;91:2102-6. View abstract.
  915. Gann PH, Ma J, Giovannucci E, et al. Lower prostate cancer risk in men with elevated plasma lycopene levels: results of a prospective analysis. Cancer Res 1999;59:1225-30. View abstract.
  916. Zhang S, Hunter DJ, Forman MR, et al. Dietary carotenoids and vitamins A, C, and E and risk of breast cancer. J Natl Cancer Inst 1999;91:547-56. View abstract.
  917. Tribble DL. AHA Science Advisory. Antioxidant consumption and risk of coronary heart disease: emphasis on vitamin C, vitamin E, and beta-carotene: A statement for healthcare professionals from the American Heart Association. Circulation 1999;99:591-5. View abstract.
  918. Leppala JM, Virtamo J, Fogelholm R, et al. Controlled trial of alpha-tocopherol and beta-carotene supplements on stroke incidence and mortality in male smokers. Arterioscler Thromb Vasc Biol 2000;20:230-5. View abstract.
  919. White E, Shannon JS, Patterson RE. Relationship between vitamin and calcium supplement use and colon cancer. Cancer Epidemiol Biomarkers Prev 1997;6:769-74. View abstract.
  920. Baron JA, Beach M, Mandel JS, et al. Calcium supplements for the prevention of colorectal adenomas. Calcium Polyp Prev Study Group. N Engl J Med 1999;340:101-7. View abstract.
  921. Barton DL, Loprinzi CL, Quella SK, et al. Prospective evaluation of vitamin E for hot flashes in breast cancer survivors. J Clin Oncol 1998;16:495-500. View abstract.
  922. Kalayci O, Besler T, Kilinc K, et al. Serum levels of antioxidant vitamins (alpha tocopherol, beta carotene, and ascorbic acid) in children with bronchial asthma. Turk J Pediatr 2000;42:17-21. View abstract.
  923. Powell CV, Nash AA, Powers HJ, Primhak RA. Antioxidant status in asthma. Pediatr Pulmonol 1994;18:34-8. View abstract.
  924. Kelly FJ, Mudway I, Blomberg A, et al. Altered lung antioxidant status in patients with mild asthma. Lancet 1999;354:482-3. View abstract.
  925. Labriola D, Livingston R. Possible interactions between dietary antioxidants and chemotherapy. Oncology 1999;13:1003-8. View abstract.
  926. Vetrugno M, Maino A, Cardia G, et al. A randomised, double masked, clinical trial of high dose vitamin A and vitamin E supplementation after photorefractive keratectomy. Br J Ophthalmol 2001;85:537-9. View abstract.
  927. Baker JC, Tunnicliffe WS, Duncanson RC, Ayres JG. Dietary antioxidants and magnesium in type 1 brittle asthma: a case control study. Thorax 1999;54:115-8. View abstract.
  928. van Tits LJ, Demacker PN, de Graaf J, et al. Alpha-tocopherol supplementation decreases production of superoxide and cytokines by leukocytes ex vivo in both normolipidemic and hypertriglyceridemic individuals. Am J Clin Nutr 2000;71:458-64. View abstract.
  929. Baker H, Handelman GJ, Short S, et al. Comparison of plasma alpha and gamma tocopherol levels following chronic oral administration of either all-rac-alpha-tocopheryl acetate or RRR-alpha-tocopheryl acetate in normal adult male subjects. Am J Clin Nutr 1986;43:382-7. View abstract.
  930. Kiyose C, Muramatsu R, Kameyama Y, et al. Biodiscrimination of alpha-tocopherol stereoisomers in humans after oral administration. Am J Clin Nutr 1997;65:785-9. View abstract.
  931. Sano M, Ernesto C, Thomas R, et al. A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease. The Alzheimer's Disease Cooperative Study. N Engl J Med 1997;336:1216-22. View abstract.
  932. Morris M, Beckett L, Scherr P, et al. Vitamin E and vitamin C supplement use and risk of incident Alzheimer's disease. Alzheimer Dis Assoc Disord 1998;12:121-6. View abstract.
  933. Horwitt MK, Elliott WH, Kanjananggulpan P, Fitch CD. Serum concentrations of alpha-tocopherol after ingestion of various vitamin E preparations. Am J Clin Nutr 1984;40:240-5. View abstract.
  934. Cohn W. Evaluation of vitamin E potency. Am J Clin Nutr 1999;69:156-8. View abstract.
  935. Kayden HJ, Wisniewski T. On the biological activity of vitamin E. Am J Clin Nutr 2000;72:201-3. View abstract.
  936. Vatassery GT, Bauer T, Dysken M. On the biological activity of vitamin E. Am J Clin Nutr 2000;72:202-3.
  937. Burton GW, Traber MG, Acuff RV, et al. Human plasma and tissue alpha-tocopherol concentrations in response to supplementation with deuterated natural and synthetic vitamin E. Am J Clin Nutr 1998;67:669-84. View abstract.
  938. Jonas CR, Puckett AB, Jones DP, et al. Plasma antioxidant status after high-dose chemotherapy: a randomized trial of parenteral nutrition in bone marrow transplantation patients. Am J Clin Nutr 2000;72:181-9. View abstract.
  939. Meydani M. Effect of functional food ingredients: vitamin E modulation of cardiovascular diseases and immune status in the elderly. Am J Clin Nutr 2000;71:1665S-8S. View abstract.
  940. Surai PF, MacPherson A, Speake BK, Sparks NH. Designer egg evaluation in a controlled trial. Eur J Clin Nutr 2000;54:298-305. View abstract.
  941. Devaraj S, Jialal I. Low-density lipoprotein postsecretory modification, monocyte function, and circulating adhesion molecules in type 2 diabetic patients with and without macrovascular complications: the effect of alpha-tocopherol supplementation. Circulation 2000;102:191-6. View abstract.
  942. Skyrme-Jones RA, O'Brien RC, Berry KL, Meredith IT. Vitamin E supplementation improves endothelial function in type I diabetes mellitus: a randomized, placebo-controlled study. J Am Coll Cardiol 2000;36:94-102. View abstract.
  943. Corrigan JJ Jr, Marcus FI. Coagulopathy associated with vitamin E ingestion. JAMA 1974;230:1300-1. View abstract.
  944. Corrigan JJ Jr. Coagulation problems relating to vitamin E. Am J Pediatr Hematol Oncol 1979;1:169-73. View abstract.
  945. Corrigan JJ Jr. The effect of vitamin E on warfarin-induced vitamin K deficiency. Ann N Y Acad Sci 1982;393:361-8. View abstract.
  946. Kim JM, White RH. Effect of vitamin E on the anticoagulant response to warfarin. Am J Cardiol 1996;77:545-6. View abstract.
  947. Lavine JE. Vitamin E treatment of nonalcoholic steatohepatitis in children: a pilot study. J Pediatr 2000;136:734-8. View abstract.
  948. Marmor MF. A randomized trial of vitamin A and vitamin E supplementation for retinitis pigmentosa. Arch Ophthalmol 1993;111:1460-1. View abstract.
  949. Norton EW. A randomized trial of vitamin A and vitamin E supplementation for retinitis pigmentosa. Arch Ophthalmol 1993;111:1460. View abstract.
  950. Clowes DD. A randomized trial of vitamin A and vitamin E supplementation for retinitis pigmentosa. Arch Ophthalmol 1993;111:1461-2. View abstract.
  951. Fielder AR. A randomized trial of vitamin A and vitamin E supplementation for retinitis pigmentosa. Arch Ophthalmol 1993;111:1463;discussion 1463-6. View abstract.
  952. Gamel JW, Barr CC. A randomized trial of vitamin A and vitamin E supplementation for retinitis pigmentosa. Arch Ophthalmol 1993;111:1462-3. View abstract.
  953. Berson EL, Rosner B, Sandberg MA, et al. A randomized trial of vitamin A and vitamin E supplementation for retinitis pigmentosa. Arch Ophthalmol 1993;111:761-72. View abstract.
  954. McKevoy GK, ed. AHFS Drug Information. Bethesda, MD: American Society of Health-System Pharmacists, 1998.
  955. United States Pharmacopeial Convention, Inc., ed. Drug Information for the Health Care Professional. 19th ed. Englewood, CO: Micromedex Inc., 1999.
Mostrar más referencias
Mostrar menos referencias
Documento revisado - 09/04/2014




Página actualizada 27 octubre 2014